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ABSTRACT 
This study is an examination of ovarian and uterine cancer patients’ perceptions 
of chemotherapy-induced alopecia and how it impacts quality-of-life over the course of 
chemotherapy.  The chapters in this dissertation address the following research 
questions: How do ovarian and uterine cancer patients communicate about their 
experience of alopecia over the course of chemotherapy?  How does chemotherapy-
induced alopecia influence patients’ understandings of quality-of-life?  Longitudinal 
interviews were conducted with a patient population of twenty-three, and each patient 
was interviewed at least twice over the course of chemotherapy.  The data set was 
composed of fifty-five interviews, and a thematic analysis was performed across 
interview transcripts.  
Analysis of the data revealed four themes: 1) chemotherapy-induced alopecia and 
quality-of-life; 2) the “mirror moment”; 3) performance of social roles; and 4) gendered 
visibility.  Data indicate ovarian and uterine cancer patients’ experienced substantial daily 
distress related to chemotherapy-induced alopecia.  The ability to perform social roles 
deemed important to patients’ quality-of-life such as the familial roles of partner and 
mother/grandmother were negatively impacted by hair loss.  Patients’ distress concerning 
alopecia was strongly connected to the ability to function in the public sphere without 
feeling approachable or being approached by “strangers” because of their alopecia.  
vii 
Clinicians might consider repeatedly asking about chemotherapy-induced 
alopecia over the course of chemotherapy, both because it could help patients cope with 
the side effect and because it may generate dialogue related to other important concerns 
late-stage cancer patients may feel are too trivial to mention in clinical discussions.  
Women’s social and familial roles may be impacted by alopecia and chemotherapy in 
unique ways that deserve additional study.
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CHAPTER ONE:  
COMMUNICATION, CHEMOTHERAPY-INDUCED ALOPECIA, 
AND QUALITY-OF-LIFE 
Introduction 
“There is an immense connection between hair loss and quality-of-life…The Bible says 
hair is your crowning glory…When I first shaved my head I thought, gee, I look like my 
father, and I put my scarf on immediately…Hair loss did not become a concern until after 
the third round [of chemotherapy]” (Patient 16_2). 
“For me, [hair loss] matters because of the privacy issue…there are some assumptions 
that are being communicated…I know I’m not going to recover [and I spend] too much 
time explaining.  I have a life.  I have a career” (Patient 13_2). 
“Your head is speaking for you” (Patient 21_1). 
“I’m not around people without my hair [wig] because I don’t like to be without 
something on my head.  I don’t look at myself.  It’s just a constant reminder.  That’s all” 
(Patient 6_2).  
Chemotherapy- induced alopecia, or hair loss during cancer treatment, is often 
understood as the most significant change in appearance for cancer patients (Erdos, 
1992).  Inspired by Erdos’ (1992) argument, Pickard-Holley (1995) positions hair loss as 
the most traumatic side effect for female cancer patients, suggesting a need for more 
research to identify the multiple ways in which alopecia impacts quality-of- life over the 
course of treatment.  Batchelor’s (2001) research reports hair loss as ranking third among 
“the most distressing effects” of cancer treatment with nausea and constipation as first 
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and second.  Similarly, Mulders, Vingerhoets, and Breed (2008) report breast cancer 
survivors ranking hair loss among the fourth highest of concerning side effects of 
chemotherapy with nausea ranking fifth and fear of metastases, fatigue, and 
consciousness of being vulnerable ranking first, second, and third.   
Existing research (Can et al., 2012; Erol et al., 2012; Firth et al., 2007; Jayde et al., 
2013; Pickard-Holley, 1995) suggests there are complicated connections between alopecia 
and quality-of-life (QoL) warranting further examination.  Research on quality-of-life has 
been advanced by studies (see Gupta et al., 2013) arguing for the importance of measuring 
quality-of-life over time.  Most attempts to measure “quality” in healthcare settings reduce it 
to a quantifiable, single point in time measurement.  A more effective and valid analysis of 
“quality” requires qualitative measurement that takes place over time.  This makes sense 
when considering the subjective nature of “quality,” making it more difficult to measure 
than other variables in healthcare such as cost, speed, or length of time that are more easily 
quantifiable.  As 21st century medicine continues its evolution toward individualized patient 
care, the healthcare industry is looking for ways to better balance the need for high quality, 
patient-centered care with its “cheaper, faster, better” approach to practicing modern 
medicine.   
An issue worth noting in Gupta et al.’s (2013) argument for longitudinal testing of 
quality-of-life is their use of the QLQ-C30, a well-known and widely used QoL 
questionnaire (see Aaronson et al., 1993).  The QLQ-C30 excludes alopecia from its list 
of measurable symptoms of chemotherapy related to QoL, yet “financial difficulties” and 
“loss of appetite” are examples of what factors are included.  Gupta et al.’s (2013) 
research has bolstered the argument for longitudinal analyses, yet there remains a need 
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for a more thorough, empirical examination of how female cancer patients describe 
quality-of- life.  An analysis of how patients communicate their experiences of 
chemotherapy-induced alopecia may provide insight into ways patients conceptualize 
quality-of- life, thus gaining a better understanding of this element of cancer care.  
This dissertation positions communication in the center of the research problem 
with the intention to examine patterns of connection and/or disjunction between alopecia 
and quality-of- life so practitioners can better identity and treat patients who will or who 
are experiencing distress related to alopecia.  This aim of this project is especially 
important when the population of interest includes ovarian and uterine cancer patients in 
the late stages of their disease who are coping with the surgical removal of internal 
organs related to their sex/gender along with the external loss of their hair, a gendered 
identity marker (Batchelor, 2001; Cline, 1984; Frith, Harcourt & Fussell, 2007; Lemieux 
et al., 2008).   
Female cancer patients are particularly affected by changes in appearance because 
cultural norms circumscribe what is acceptable and expected of women with cancer 
(Hooper, 1994; Price Herndl, 2006).  Baldness and other visible bodily changes such as 
scars, weight gain or loss, and lopsided figures “function like billboards” (Gubar, 2014), 
signaling a woman’s status as a cancer patient.  Some feminist critiques (Lorde, 2009) call 
for resistance against social norms reinforcing appearance as a priority, especially for 
women facing serious and life-threatening diagnoses of cancers.  Patients who subscribe to 
Lorde’s (2009) argument against cranial prostheses (wigs) may be determined to resist 
“cosmetic deceptions” (Ehrenreich, 2009, p. 30) and work “to expose themselves publically 
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in order to witness and protest the epidemic” while others, Gubar (2014) explains, “become 
agoraphobic, unwilling to leave home.”   
Patients treated in major cancer research institutes, such as the site of research for 
this dissertation, are seriously ill and are often classified as complicated cases.  The ovarian 
and uterine cancer patients participating in this dissertation research have especially valuable 
perspectives on managing hair loss because of the severity of their type of cancer and the 
late stages of their disease.  Some participants are experiencing recurrence and have an 
unfortunate familiarity with hair loss.  Others know they “will not recover” and are making 
decisions regarding how they want to look during their final phases of life.  For the patients 
experiencing remission, they are making sense of “what recovery looks like” in terms of 
their mind, body, spirit, and appearance.  
This dissertation research uses an interpretative approach and longitudinal 
interviewing to examine the ways women communicate about chemotherapy-induced 
alopecia while undergoing treatment for ovarian or uterine cancer.  In the following 
section, extant literature relevant to the problem of inquiry is reviewed.  Goffman’s 
(1963) foundational work on stigma is used to conceptualize how social norms 
potentially influence how patients interpret their experiences of chemotherapy- induced 
alopecia.  The social implications and the science of chemotherapy- induced alopecia are 
discussed along with gender and technology.  Lastly, quality-of- life literature is examined 
to demonstrate the importance of its connection to patient experience, and current 
methods of assessing quality-of- life are challenged.  A rationale for the research project is 
provided prior to concluding the chapter.   
5 
CHAPTER TWO: 
LITERATURE REVIEW AND RATIONALE 
Introduction 
While ovarian and uterine cancer patients’ perceptions of chemotherapy- induced 
alopecia and its negative impact on quality-of- life have been documented (see Batchelor, 
2001; Choi et al., 2014; Dua et al, 2015; Freedman, 1994; Frith et al., 2004; Hansen, 
2007; Hesketh et al., 2004; Jayde et al., 2014; Lemieux et al., 2008; Munstedt et al., 
1997; Pickard-Holley, 1995; Rosman, 2004; Yeager & Olsen, 2011), there remains a 
need for more research examining the experience of alopecia over time and how patients 
describe quality-of- life in the context of undergoing chemotherapy.  Health 
communication can make a significant contribution to the body of mostly clinical 
research examining how patients negotiate what is means to cope with a side effect that 
can be understood as speaking for you.  Chemotherapy induced-alopecia (CIA) is a 
publically visible, aesthetic transformation involving sensemaking (Weick, 1995) on a 
personal and social level.   
Given the interdisciplinary interest in patients’ perspectives of chemotherapy-
induced alopecia and because my primary field of study has yet to produce patient-
centered research specific to chemotherapy- induced alopecia, I review clinical research 
alongside work in social science and the humanities to help formulate research questions 
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that may benefit researchers across disciplines as well as highlight the usefulness of a 
communication studies approach.  The literature review is divided into three sections 
with multiple subsections.  Relevant literature on the significance of chemotherapy-
induced alopecia and the gendered elements of hair loss are discussed.  Goffman’s (1974) 
work on stigma and research applying his theory to healthcare are presented as a 
framework though which the research problem may be conceptualized.  Lastly, quality-
of-life (QoL) studies useful to alopecia and side-effect management are presented as well 
as critiqued for how they measure subjective variables.  
Chemotherapy-induced alopecia (CIA) 
Chemotherapy and other appearance altering cancer treatments such as radiation 
or steroid hormones are emotionally, physically, and psychologically taxing and 
demonstrate the difficulty of being treated for a serious disease (see Wackers, 2015).  
Though there are different types of chemotherapy, the treatment itself can be broadly 
understood as a drug therapy that inhibits cell division or growth.  One of the most 
common cutaneous side effects, meaning a side effect that affects the skin, is alopecia 
(Dunagin, 1982).  Hair is often lost on all or most places the body has it, including the 
head, face, arms, legs, pubic area, and underarms (www.cancer.net, 2015).   
Understanding chemotherapy as a process helps bolster the argument for 
examining hair loss as a process (see Erol, Can & Aydiner, 2012).  Chemotherapy 
involving carboplatin and paclitaxel, for example, typically involves a time commitment 
of 4 months or more.  In addition to the time commitment and its disruption to everyday 
routine, the severity of treatment and its impact on the body varies over the course of 
treatment.  The results of Munstedt et al. (1997) longitudinal survey provide a framework 
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to argue for CIA as a process that should be analyzed over time.  Twenty-nine 
gynecologic cancer patients were surveyed before, during, and after hair loss using two 
scales (Frankfurt self-concept [FSKN] and Frankfurt body concept [FKKS]) to measure 
changes in self-concept and body image.  Following the third round of surveys 
administered during the regrowth stage of hair loss, 73% were less self-confident than 
before treatment, demonstrating the ongoing difficulty of coping with appearance altering 
side effects.   
Munstedt et al. (1997) would have benefitted from incorporating interviews into 
their method for a more in-depth analysis of how perceptions of self change over time, 
especially considering how practical this would have been with their number of 
participants (n=29).  Munstedt et al.’s (1997) work has been cited by quantitative and 
qualitative researchers for their finding of 47% of participants ranking hair loss as the 
most traumatic side effect of chemotherapy.  This contribution aside, their emphasis on 
longitudinal method has not been widely adopted as standard practice for analyzing 
patients’ perceptions of hair loss.  For example, qualitative researchers Power and 
Condon (2008) use Munstedt et al. (1997) to support an argument for the importance of 
studying women’s CIA but do not perform a longitudinal analysis, which is contrary to 
the study they are referencing.   
The science of hair loss.  Hair loss becomes more noticeable when it falls out in 
gradual sections, however not all chemotherapy causes hair loss, and not all patients who 
undergo treatment lose their hair to a degree where thinning occurs at a noticeable rate 
(www.cancer.net, 2015).  There are two types of chemotherapy- induced alopecia –
telogen effluvium and anagen effluvium (Yeager & Olsen, 2011).  Telogen effluvium is 
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less aggressive than anagen effluvium, usually resulting in significant thinning, where a 
patient can lose about fifty percent of the hair during chemotherapy.  This type of CIA is 
less noticeable to the public eye than anagen effluvium, which often results in baldness.  
According to Yeager and Olsen (2011, p. 433), anagen effluvium is a commonly 
associated with chemotherapy “because it is caused by drugs that target rapidly 
proliferating cell populations and attack neoplastic cells and rapidly growing normal cells 
like the hair matrix cells in anagen.”  Anagen is one of the three phases of hair growth 
and is the phase during which active growth takes place (Schwartz & Gascon, 2016).  
Chemotherapy weakens the hair’s anchoring to the point that it falls out from the scalp or 
breaks off when it reaches the surface of the scalp.   
Paclitaxel (the generic name for taxol) is one of the most well –known 
chemotherapeutic agents causing hair loss.  It results in a profound and often complete 
loss of hair (anagen effluvivum) and occurs within approximately two to three weeks 
after starting chemotherapy.  It should be noted some patients do not lose their hair until 
one or possibly two months into treatment.  Once the anagen (actively growing) phase 
hair shafts are lost, the patient’s hair will remain in the telogen phase, which is a period 
of no growth, and this will last until chemotherapy is completed.  Oftentimes, the anagen 
phase is quite slow, so a patient’s “prechemo” hair length often takes years to “regrow” 
and her hair usually does not return the same as it was (e.g., straight, light brown hair on 
the head could return as grey and wavy and take months to grow an inch in length).   
To further complicate the way a patient can experience hair loss, it is important to 
acknowledge the “sandwich method,” when surgery is sandwiched in the middle of 
chemotherapy.  During the surgery phase, a patient’s alopecia will stop and a bit of hair 
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may return only to have it fall out again when she restarts chemotherapy.  No literature 
could be found specific to a patient population enduring alopecia and the sandwich 
method, rather most literature focuses on hair loss and distress (Freedman, 1994; Hesketh 
et al., 2004; Kaderman, Kaderman, & Toonkel, 1999; Poulson, 1998) do not make 
distinctions between the sandwich method and regimens involving surgery before or 
surgery after chemotherapy.  
CIA: An interdisciplinary problem of interest.  The latter half of the twentieth 
century marked a time of emerging interest in examining alopecia and its effects on 
patients’ well being.  Research in the 1980s (Cline, 1984) focused on preventing hair loss 
and set a foundation upon which scholars could argue for in-depth analyses of hair loss as 
an emotional experience (Koszalinski & Williams, 2011; Pickard-Holley, 1995; Williams 
et al., 1999).  Narrative analysis (Williams et al., 1999) along with qualitative inquiry 
(Freedman, 1994) and mixed methods using smaller sample sizes (Carpenter & 
Brockopp, 1994; Munstedt et al., 1997) became popular ways to research chemotherapy-
induced alopecia, generating foundational insight cited across disciplines interested in 
oncology, hair loss, and patient care.   
Research using smaller sample sizes to analyze the nuances of CIA was not 
reserved for patients with one form of cancer, thus providing a range of perspectives from 
patients with various degrees of severity.  Freedman (1994) interviewed breast cancer 
patients about losing their hair, focusing mainly on the symbol of hair loss and the idea of 
womanliness in ways that impact the meaning of being a breast cancer patient.  As 
discussed earlier, Munstedt et al. (1997) survey analysis of 29 gynecologic cancer 
patients’ perspectives demonstrated CIA’s effects on self-concept and body image.  
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Williams et al. (1999) used a narrative approach from the field of nursing to interview 15 
patients with different cancers (13 women and 2 men).  Their findings presented hair loss 
as an experience that affects everyday life and personal identity.  Williams et al. (1999) 
use of “experience” was deliberate and foundational for conceptualizing patients’ hair 
loss as such.   
Like Williams et al. (1999), Carpenter and Brockopp (1994) also analyzed the 
perspectives of patients with different cancers.  They interviewed 30 women with varying 
degrees of hair loss (due to dissimilar chemotherapies).  While participants reported 
lower self-esteem during alopecia when compared to pre-diagnosis, Carpenter and 
Brockopp (1994) found participants making distinctions in the numbered responses 
between lowered self-esteem and low self-esteem, arguing for more research on patient-
specific interventions.  Despite the existing literature, an interdisciplinary focus on 
ovarian and uterine cancer patients’ experiences with hair loss remains limited and 
methods for collecting data need a stronger emphasis on longitudinal interviewing.  
The vast majority of research on chemotherapy- induced alopecia is generated by 
healthcare professionals in the fields of dermatology (Chon et al., 2012; Yeager & Olsen, 
2011) and oncology (Frith et al., 2007; Gunnars et al., 2001; Hesketh et al., 2004), 
including nursing in oncology (Borsellino & Young, 2010; Can et al., 2012; Cline, 1984; 
Freedman, 1994; Lemieux et al., 2008; Wagner & Gorely, 1979; Williams et al., 1999) 
and psychology in oncology (Choi et al., 2014; Dua et al., 2015; Koszalinski & Williams, 
2012).  Research efforts made by scholars outside health sciences are best represented by 
Hansen’s (2007) ethnography of Danish rehabilitation courses with women cancer 
patients and Rosman’s (2004) qualitative study of stigma with lung and breast cancer 
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patients in a Parisian cancer hospital.  Excluding Williams et al. (1999), most of the 
heavily cited literature on chemotherapy-induced alopecia and patient experience comes 
from Western nations outside the U.S. (e.g., Batchelor, 2001; Freedman, 1994; Frith et 
al., 2007; Lemieux et al., 2008; Munstadt et al., 1997).   
To date, there are few health communication studies in the U.S. researching 
chemotherapy-induced alopecia.  Such an absence suggests the existing interest in 
producing qualitative data on hair loss and patient experience will benefit from a health 
communication studies perspective focusing on the ways in which language and 
relationships constitute meaning making over time.  Such a perspective will enable an 
analysis of how ovarian and uterine cancer patients communicate about CIA how 
experiencing hair loss influences their quality-of-life.      
CIA: Gender and Loss of Privacy.  Distress associated with hair loss is 
discussed as a reactive process (Batchelor, 2001) depending on how important hair is to a 
patient in terms of how it relates to her identity (Williams et al., 1999) or “body 
perception” (Miller, 1991).  Clinical research (Lemieux et al., 2008), social science 
(Hansen, 2007), and humanities-based research (Freedman, 1994; Hooper, 1994; 
Redgrave, Clark & Lerner, 2004) argue chemotherapy-induced alopecia is a critical 
moment in the cancer experience because the loss places women patients in a position of 
having their bodies signal their health status.   
Freedman’s (1994) work on hair and social significance argues hair –particularly 
women’s hair– is a socially and culturally defined characteristic of personal choice and 
expression as well as a symbol of political and religious beliefs.  Hair can be viewed as both 
a private asset and a public symbol and so can the loss if it (Firth, 1973).  Hair can reflect 
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international trends of personal expression (Batchelor, 2001), signaling gender, age, health 
status, and group membership (Pickard-Holley, 1995).   The idea of hair or shaved heads 
as a “personal expression” mentioned in Pickard-Holley’s (1995) work is misleading 
when applied to chemotherapy and cancer patients because it implies a sense of agency 
that many ovarian and uterine cancer patients are not able to enact in the context of their 
hair loss.  Explained by Holmes (2014), “female baldness is an antithesis to the feminine 
ideal” (p. 66).  Being bald is highly gendered because it is a socially constructed aesthetic 
carrying well-known Western expectations that are projected onto female bodies 
(Holmes, 2014).  
The argument alopecia is a women’s issue has been complicated by research 
conducted in the Middle East (Can et al., 2013).  Using in-person interviews and two 
scales (Nightingale Symptom Assessment Scale and Body Image Scale) Can et al. (2013) 
compared a large sample of Turkish men and women with different forms of cancer to 
assess their experience of CIA.  Their findings suggested hair loss lowers patients’ body 
image regardless of sex, yet women reported lower scores than men regarding how hair 
loss impacted their psychological well-being.  While this study bolsters the argument for 
hair loss impacting body image across the sex and gender spectrum, the stronger 
connection women make between body image and psychological well-being suggests 
alopecia is a sexualized and gendered issue.  Considering the conceptual overlap between 
psychological well-being and quality-of-life, I interpret Can et al.’s (2013) findings as a 
base from which to argue for potential connections between hair loss and quality-of- life.   
Can et al. (2013) claim to analyze the “experiences of chemotherapy-induced 
alopecia,” yet they do not adequately consider the communicative aspects of an 
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“experience.”  The missed opportunity to engage patients’ perceptions of social norms 
and how they relate to baldness is demonstrated by their conclusion, “psychological well-
being of women was lower than that in men because the incidence of alopecia was higher 
in women” (Can et al., 2013, p. 255).  The rate at which alopecia occurs does not 
explicate the gendered and relational elements informing how women associate being 
bald with a lower sense of well-being to a stronger degree than men.  Can et al.’s  (2013) 
well-founded attempt to examine gendered differences and patient experience 
demonstrates the need for interdisciplinary scholarship that includes health 
communication scholarship.  Unfortunately, there is a lack of health communication 
research for scholars such as Can et al. (2013) to reference for methodological 
inspiration.  An analysis of experiencing CIA should account for the complex 
relationship between social norms and expectations (e.g., appearing feminine) and 
personal struggles with illness (e.g., the loss of control).    
Hair is a body part over which it is assumed one has at least partial control.  The 
loss of an asset suggests a forfeiture of ownership and control over the asset.  Hair loss 
transitions the patient out of the private sphere and into the public domain, signaling her 
status as a cancer patient (Firth, 1973).  Continuing to follow Price Herndl’s (1993) 
argument against blurring distinctions, it is important to recognize not all women cancer 
patients are stigmatized to the same degree, nor are all women equally concerned about 
hair loss.  
Chemotherapy-induced alopecia may be a reactive experience in that each patient 
has her own reactions to a changing appearance.  Being bald in Western society does not fit 
with normative standards of gendered aesthetics.  As members of Western society, ovarian 
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and uterine cancer patients are at least partially aware of these social standards (see Firth, 
1973; Power & Condon, 2008).  Because of this awareness, some patients may describe 
how they manage hair loss in proactive terms.  More research needs to be conducted 
examining the differences in tone and language patients use to describe alopecia.  An 
example of a proactive response or a reactive response to CIA is the timeframe during 
which a patient might purchase a wig and why.  Ovarian and uterine cancer patients’ 
decision-making regarding purchasing and wearing head coverings has not been fully 
addressed in existing literature.  Knowing when, how, and why these choices are made 
may provide a more complete understanding of the ways patients manage alopecia 
outside the clinic.  
There is little research discussing whether cancer patients view CIA as a 
permanent or temporary loss (or a combination of the two), so it is difficult to determine 
whether juxtaposing hair loss in permanent or temporary terms is a beneficial way to 
investigate the problem.  In contrast to the norm, Redgrave et al. (2004) directly address 
the emotional complexity of mourning a temporary loss.  Their narrative approach 
highlights the struggle of understanding why a temporary loss is difficult when “the big 
picture” of cancer “should” remain at the forefront of a patient’s concerns (Redgrave et 
al., 2004).   
Narrowing the focus of hair loss to the moment of her head shave, Redgrave et al. 
(2004) use photography and conversations with her adult daughter to document the 
experience.  Redgrave’s head shave is referenced throughout the latter half of the text and 
is specifically addressed in two pages (p. 54-55).  The top portion of the two pages 
features a series of photos taken before, during, and after the head shave.  Redgrave is 
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shown sitting, removing her wig while looking in the bathroom mirror.  Her daughter 
stands, holding electric clippers.  The camera is behind the two, out of view from the 
mirror’s reflection.  The following text is displayed below the photos: 
 “I know it will [be okay], I know it will…when it comes back, it’ll be like a new 
life won’t it...I don’t know why it’s so hard, [daughter]. I don’t know why.  
Because you don’t feel like yourself [her daughter says]…you’re still you. 
I know. That’s it. I think. Its true” (p. 54)…[but] when it’s coming off in the 
shower, it’s, it’s like you can’t…it’s like your whole self is falling apart. It’s 
just…this [head shave] is better…I can handle this better [than hair loss]” (p. 55). 
Concern for losing one’s hair during treatment should be an acceptable emotion to 
communicate, yet it can be interpreted as superficial by society, loved ones, physicians 
and providers, and even the patient herself (see Ehrenreich, 2009).  Though superficial 
concerns are often part of everyday life, the “life-or-death” situation cancer represents 
often elevates patients, particularly women, to the status of a “fighter,” transforming the 
role of performing “patient” into a fighter who focuses on survival and disregards the 
aesthetic (Ehrenreich, 2009, p. 30; Lerner, 2004).   
Hair loss and technology in women’s oncology: Hindrances and possibilities 
for communication.  One of the primary responsibilities of medicine is to continue 
developing and redeveloping technological procedures for treating forms of cancer 
(Mukherjee, 2010).  Aggressive drug treatments of the early 1900’s helped advance 
chemotherapy, while surgical procedures in the late 1800’s such as the radical 
mastectomy helped technologize women’s health.  Even so, modernization through 
chemical and surgical innovation does not coincide with advancements in interpersonal 
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or organizational communication among doctors and their patients (Lerner, 2014).  For 
instance, the outcome of a radical mastectomy involves physical disfigurement so severe 
that 20th century medicine shifted the surgery out of standard practice, reserving it for 
extreme cases.  Unfortunately, it took approximately 100 years for the medical 
community to reach this consensus partially because physicians who questioned the need 
for such a procedure were slow to communicate their concerns or did so in an ineffective 
manner.  
Questioning the methods used to move women’s oncology forward is difficult 
because it suggests healthcare practitioners actively recognize a problem exists within the 
system (see Hughes, 2004).  Questioning routine, especially a highly technical one such 
as a surgery or a drug treatment is difficult partially because it takes time (Hughes, 2004). 
For instance, wondering how the disfiguring procedure of a radical mastectomy has 
become standard procedure performed on breast cancer patients would require slowing 
down the healthcare system and taking time to communicate concerns.  This action slows 
down production and, as a result, slows the delivery of health care.   
In the context of hair loss, which is a less technical, non-life-threatening side-
effect of a larger process that is both technical and life-threatening, Yeager and Olsen 
(2011) report patients do not receive enough counseling time, nor do they have the 
opportunity to ask physicians to evaluate the feasibility of a chemotherapy regimen that 
incorporates scalp cooling technology to prevent hair loss.  Bringing patients into the 
decision-making process can mean slowing down the pace of medicine, which may seem 
difficult in the modern/post-modern era of rapid technological growth (Lerner, 2014) but 
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may yield higher returns in patient comprehension and patient-practitioner 
communication (Mulders et al., 2008).  
There is a scarcity of health communication research on old or mundane 
technology.  Saunders’ (2008) ethnography of diagnostic communication within 
computerized tomography (CT) suites takes place when CT scans and scanning rooms 
were more relevant and necessary than they are in 2017.  At the time of his examination, 
CT scans were considered a mundane technology, making the ethnography less about the 
technology itself and more focused on human interaction and the ways medical 
practitioners incorporate technology into the decision-making process.  With the ability to 
share CT scans electronically, the scanning room is used less as a space of in-person, 
shared decision-making and more as a space for processing the test.   
A wig is an example of an old and mundane technology.  It is certainly less 
obvious than a CT scan, but it is a health technology nonetheless.  Depending on the 
health insurance provider, a physician can write a prescription for a “cranial prosthesis” 
to cover some of the cost.  The classification of “prosthesis” elevates a wig’s status from 
a beauty product to a more formal health technology.  Conceptualizing a wig as a 
technological intervention for cancer patients further legitimizes the practice of covering 
women’s baldness.  This reinforces traditional hegemonic standards of gender 
performance while also providing more options to patients who value aesthetic-related 
health interventions.  Access and cost remain issues.  The classification of a prescribed 
“prosthesis” helps increase the cost of wigs, widening the gap of accessibility to wigs for 
women without insurance or those who have limited coverage. 
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How healthcare technologies are understood and used evolves over time (Hughes, 
2004).  It is useful to have research like Saunders’ (2008) examination of CT suites to 
help the field of healthcare chart its evolution.  How might healthcare researchers chart 
the technological evolution of non-technical technologies such as wigs?  It is worth it to 
approach the problem of hair loss in a way that accounts for embodiment and 
technological influence?  The subset of chemotherapy- induced alopecia research 
examining scalp cooling technology argues it is.   
Scalp cooling is the most popular and well-researched method for preventing 
chemotherapy-induced alopecia (Yeager & Olsen, 2011).  Depending on perspective, 
scalp cooling could be seen as a useful form of preventing hair loss or a risky and 
burdensome approach for those who want to preserve what needs to be lost during 
chemotherapy.  Most physicians in America prescribe cranial prosthesis to ovarian and 
uterine cancer patients as opposed to scalp cooling technology.  Many major cancer 
centers do not provide information on prevention methods, suggesting alopecia is a 
common and expected part of chemotherapy and patients are responsible for accepting 
and managing.  Scalp cooling and cold caps are not a focus of this dissertation, yet it is a 
form of intervention worth presenting in this literature review because of its connection 
to managing one’s appearance.      
Cold cap technology: An option not heavily pursued in America.  Scalp 
cooling by way of cold cap technology represents an interstice between cancer treatment 
and aesthetics.  Scalp cooling has been researched for over forty years with the majority 
of studies conducted in Europe (e.g., Lemenager, et al., 1997; Peck, Mitchell & Stewart, 
2000).  One way to “cool” the scalp during chemotherapy is by wearing a cold cap, which 
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is essentially a pieced together helmet of freezing cold gel packs.  Scalp freezing is a 
more accurate description than “cooling,” as these gel packs are placed on the patient’s 
head at -35 degrees F.  In Lofti-Jam et al.’s (2008) review of non-pharmacologic 
prevention methods, they argue scalp cooling is effective, suggesting it be recommended 
to patients who want to pursue hair loss prevention.  Yeager and Olsen (2011) classify 
scalp cooling as an advantageous “non-camouflage” treatment method, unlike turbans, 
wigs, and scarves, which function to camouflage instead of prevent.   
Incorporating cold cap technology into the regimen of chemotherapy might 
preserve a patient’s hair follicles, allowing her to keep most of her pre-chemotherapy hair 
(Grevelman & Breed, 2005; Peck et al., 2000).  The process of administering the cold cap 
is complicated.  Legally classified in the United States as personal property, cold caps are 
the patient’s responsibility (www.rapunzelproject.org, 2015).  Hospitals and cancer 
centers are not liable for cold caps nor do they regulate how patients use them, yet the 
institution and its employees are expected to accommodate the caps because they are 
classified as personal property that aids a patient’s treatment.   
The technology requires others to help position the cap tightly and evenly on the 
head.  A patient wears the caps for 8 hours during each round of chemotherapy, rotating 
the gel packs throughout the 8 hours so her head stays freezing.  Administering the caps 
begins hours before infusion and continues hours after, possibly extending the infusion 
process, especially in American infusion centers that are ill equipped to handle the extra 
time and effort involved.  Downsides to this technology are the physical pain (i.e., 
migraines or feelings of hypothermia) and the cost, as it is not covered by health 
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insurance in the United States and averages around four thousand dollars 
(www.rapunzelproject.org, 2015).   
The inconvenience of scalp cooling technology is apparent.  Upon observing the 
process of administering cold caps during infusion, I am confident arguing from an 
organizational perspective, the technology and the patient using it slow down the 
efficiency of the clinic because it requires accommodation to which most staff are not 
used to adhering.  This can create tension among patients, loved ones, and hospital staff. 
It adds discomfort to an already painful and time consuming process.   
From a critical communication perspective, I wonder to what degree scalp cooling 
would be perceived as a personal and organizational inconvenience if baldness was a 
socially stigmatized side effect for men and women instead of only women.  Would 
American health insurance be more likely to consider reclassifying scalp cooling as an 
acceptable form of side effect management?  As stated earlier, wigs are a non-technical 
technology, yet they are also gendered in a similar manner to that of scalp cooling and 
cold caps.  If CIA signaled illness across sexes, (Freedman, 1994) cold caps might be a 
more popular topic of discussion, or wigs at the very least.   
Stigma  
The discomfort experienced by those who are stigmatized and those who perform 
the stigmatizing is described by Goffman (1963) as “an infinite regress of mutual 
consideration” (p. 18), where a patient knows others are aware of her altered appearance 
and others sense the patient is conscious of their awareness.  Keeping this regression of 
perception in mind, it is critical to generate empirical data examining the degree to which 
alopecia-related stigmatization, or the perception of being stigmatized, takes place 
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throughout the course of treatment and how this informs how patients perceive their 
quality-of- life throughout the course of chemotherapy.   
Each person possesses at least one characteristic that sets him/her apart from the 
social norm or what is considered “normal” (Tyler, 1974, p. ix), yet the ways in which 
atypical traits are accepted or rejected is highly subjective and imbalanced.  The 
construction and maintenance of what might or might not constitute a normative 
appearance, behavior, or value is historically contingent.  For example, Warren’s (1980) 
research in sexuality studies demonstrates how stigmatization is historically contingent.  
Warren argues more attention needs to be paid to “the social roots of homosexuality in a 
society that stigmatizes homosexuals…and affects the adoption of a homosexual or lesbian 
identity and the formation of gay communities” (Warren, 1980, p. 123).   
Those who read Warren’s (1980) work might recognize the progress American 
society has made regarding gay right/human rights.  Even so, adjusting social norms is a 
slow process.  The historical and political struggle to become a more inclusive society 
persists, and identifying as gay or lesbian in American society continues to involve issues of 
stigma, especially when considering sexualities in addition to gay or lesbian that challenge 
heteronormativity (e.g., bisexuality or the sexuality of those identifying as transgender).  
Grounded in issues of health, uncertainty, social exchange, and perceptions of the self, 
Goffman’s (1963) work on stigma gives theoretical and practical grounding to argue 
individual experience is deeply embedded in the social sphere, which often works to solidify 
popular opinion and maintain cultural norms.   
Stigmatization is learned.  It is an active practice and is often reinforced over time by 
members of society as well as social institutions.  Those who stigmatize are often supported 
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by the social majority’s disapproval, frequently positioning those who are stigmatized in a 
reactive role (Goffman, 1963).  The everyday nature of stigmatization and its social 
acceptability demonstrates how it is a communicative process involving negotiation among 
individuals and the social systems in which they interact (Goffman, 1963; Warren, 1980).  
In the context of research on women’s health and side effect management, hair loss can be 
conceptualized as stigmatization because American society often interprets a woman’s bald 
head as a sign of having cancer, a stigmatized condition (Rosman, 2007).   
The complex relationship between managing one’s appearance and experiencing 
cancer is apparent when considering how the standards of “looking good” are culturally 
embedded (Hansen, 2007).  Don Delillo (1985), an American novelist known for his 
critiques of the public sphere, demonstrates the intimate relationship between illness and 
aesthetics, arguing “we seem to believe it is possible to ward off death by following rules 
of good grooming.”  It is difficult to “properly groom” a body undergoing the intensity of 
chemotherapy, where drugs such as paclitaxel (taxol) cause alopecia, scalp irritation, 
nausea and vomiting, fatigue, loss of appetite, diarrhea or constipation, swelling, mouth 
sores, joint paint, and neuropathy, among others (oncolink.org, 2017).   
In the context of cancer, the notion of warding off death has been appropriated by 
a discourse of battling disease (Lerner, 2004).  It is the patient versus the cancer, though 
both are stuck sharing the same body.  How then do patients describe their hair loss?  Do 
they suggest it is part of a “battle” with cancer or is the experience articulated within a 
different framework?  Juxtaposing the standards of “good grooming” with the reality of 
chemotherapy and its side effects, do patients view their baldness as a signal of their 
attempt to ward off death?  Do ovarian and uterine cancer patients perceive their peers as 
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using socially constructed standards of “good grooming” as a discursive frame to 
negotiate and make sense of one another’s roles during social interactions (see Goffman, 
1963)?   
Chemotherapy-induced alopecia involves personal and social “confrontation with 
the lethal nature of cancer” (Rosman, 2004, p. 333).  Goffman (1963) describes society’s 
classifications of non-normative physical features like chemotherapy-induced alopecia as 
“an abomination of the body” because it directly relates to a physical appearance that signals 
specific meaning to others and conveys illness and potentially dying.  The “specific 
meaning” signaled by a bald head is gendered, which is why hair loss during chemotherapy 
is a women’s health issue.  Considering the social and psychological significance of public 
opinion, is appearing as though you have cancer a concern that exists on a similar level of 
importance as the disease itself?  Does appearing as though you have cancer and actually 
having cancer issues worth separating or are they inextricable?  This is a question that has 
not been adequately addressed in the literature and warrants further examination, which is 
why interview participants will be asked if appearing sick makes a difference to their actual 
health status or how they perceive their quality-of-life.   
The degree of control patients have over disclosing a non-normative characteristic 
matters in the sense that those who can conceal their stigmatizing condition from the public 
eye can exert some autonomy over when and how confrontation with one’s stigma might 
occur (Goffman, 1963).  Disclosing your health status to others might distress a patient at 
risk of being stigmatized, especially when a stigma can lead to outright rejection rather than 
acceptance.  In contrast, patients may want to maintain some degree of uncertainty about 
their health status to keep the stigma of disease from “looming large” (Goffman, 1963) 
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during social interactions. 
Rosman’s (2004) research on hair loss among women with breast or lung cancer is 
one of the only studies of chemotherapy-induced alopecia that incorporates stigma.  
According to Rosman (2004), women with cancer who are bald experience stigma, and as a 
result, they often use wigs to maintain uncertainty about their health status during social 
interactions.  The decisions accompanying hair loss, including how, why, and when to wear 
wigs were perceived by Rosman’s (2004) participants as a problem greater than fatigue and 
pain because of the impact baldness had on social relationships, suggesting stigmatization –
or the perception of stigmatization– is an issue of concern during chemotherapy.  
Conceptualizing wigs as a form of prosthesis used to assimilate or cover (Yoshino, 
2006) a part of the body that runs the risk of being stigmatized suggests wearing head 
scarves or turbans is different than wearing wigs because they do not cover the stigma of 
having cancer in the same ways.  In their study of hair loss among Turkish women cancer 
patients, Erol, Can, and Aydiner (2012) position head covering as part of the alopecia 
process, arguing studies examining head coverings should separate wearing wigs from 
wearing headscarves because patients perceive them as different acts.  Turkey and America 
vary in degrees of secularism, and while the connection among religious head coverings and 
decision-making practices during chemotherapy-induced alopecia are not discussed at 
length in this dissertation or in Erol et al.’s (2012) article, their work demonstrates a need for 
specificity when patients are asked about their preferences.   
Stigma in the context of gender and illness.  Hair loss is an active process played 
out on a public stage, often involving active decision-making concerning whether to cover 
one’s head and how to go about doing so if you do.  The individual and social elements of 
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hair loss and subsequent decision-making position covering as a practice connected to 
identity politics (Yoshino, 2006).  Inspired by Yoshino (2006), Galman (2013) examines 
head covering in relation to religious affiliation and social assimilation.  Galman (2013) 
argues wearing a wig is an act of covering, while wearing a turban or headscarf is an act of 
uncovering “in the sense that [women] are choosing to actively resist the pressure to cover 
in the sense of choosing to nonconform” (p. 423).  Since headscarves do not conceal a 
stigmatizing health status in the same way a wig might, wearing a headscarf suggests an 
active decision to “uncover” (Galman, 2013) or reveal one’s diagnosis to the public sphere.  
More research is needed to address the decision-making involved in wearing 
scarves, turbans, and wigs.  Side-effect management studies would benefit from an approach 
that understands communication as central to decision-making.  There remains a lack of 
attention toward the relational elements of side-effects, such as how hair loss impacts a 
patient’s ability to perform certain social roles (e.g., grandmother, mother, career woman) as 
well as how patients communicate with strangers, loved ones/acquaintances, and fellow 
patients/survivors during and after CIA.  
Following Price Herndl’s (1993) warning against blurring distinctions within a 
patient population of interest, it is important to recognize not all female cancer patients 
are stigmatized to the same degree, nor are all females equally concerned about appearing 
as though they have cancer or the stigma which this carries.  Stigmatization is a socially 
constructed process that can, at times, be contested or renegotiated.  The emotional toll of 
functioning in accord with social norms to which you do not fit is not an equally 
distributed, shared experience among all females with cancer.  Even so, as Price Herndl 
(1993) explains, “while we are not all marked by physical invalidism, we are all marked 
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by cultural invalidity; we may not be invalid women, but we do have a certain solidarity 
with them” (p. 3).  Just as cancer is known as “the great equalizer,” stigmatization may be 
perceived as a great differentiator, thus we all have a stake in the process regardless of 
health status.   
The discourse of cancer and hair loss is gendered not only on a social level in the 
public sphere (Lorde, 2009) but also on an organizational level within healthcare 
institutions.  A key example of this is the “Look good, feel better” program put forth by 
the American Cancer Society and sponsored by cosmetic companies like Proctor & 
Gamble (lookgoodfeelbetter.org, 2012).  “Look good, feel better” (LGFB) targets female 
cancer patients, acting as a discursive frame to enforce the connection between self-
confidence, appearance, and perhaps what it looks like to perform a “good cancer 
patient” or a “woman with cancer.”  Feminist scholarship examining the social and 
political implications of performing patient and performing gender (Gubar, Oct. 9, 2014; 
Hooper, 1994; King, 2006; Korsmeyer, 2004; Lorde, 2009; Price Herndl, 1993) should be 
understood as foundational conceptual frames through which health communication 
scholars can best analyze how patients view and use the LGFB program.   
The American Cancer Society’s LGFB Program is among the primary sources of 
support –if not the only source of support –to which many oncologists refer patients for 
help in managing hair loss.  This is troubling because the program’s focus on cosmetics 
may be too narrow for patients who are concerned with seeking support related to 
managing a change in appearance known for being a side effect of cancer treatment.  
Social or familial pressure to “look less like a cancer patient” by using cosmetics is 
different than clinicians and other healthcare providers using LGFB as a primary referral 
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for emotional support and information, but interview participants might not perceive this 
difference as meaningful (which is why participants will be asked how they view the 
LGFB Program and their opinion of the motto, “look good, feel better”). 
Stigma and the feminine fighter.  Medical historical narratives of the 21st 
century propagate cancer as a battle for survival (Lerner, 2004).  Fulfilling the warrior 
role leaves little room for women with cancer to disclose their concerns for a changing 
aesthetic.  The grand narrative of battling cancer is further complicated when considering 
the rules and expectations for performing gender through physical appearance (see 
Butler, 1993) as well as the limited patience American society has for those who are ill 
(Ehrenreich, 2009).   
Regulating one’s physical appearance in an attempt to manage the emotional well 
being of others is often fueled by gendered expectations.  It is a form of what 
Hochschild’s (1989) refers to as emotional labor.  The warrior-based discourse our 
society employs to describe the expectations for how a patient should manage her 
symptoms and cope with disease exists in contrast with standardized social practices of 
femininity (Butler, 1993).  Consider the following contradiction: an ovarian cancer 
patient is expected to continue her gendered performance of “woman” and appear 
“womanly” while also communicating her willingness to “fight for survival” and “battle” 
her disease.    
There is a wealth of research on the social construction of the warrior/fighter 
trope to examine how women are expected to frame their experience (i.e., battle) with 
cancer (Ehrenreich, 2009; King, 2006; Lerner, 2004; Sulik, 2011).  From a Weberian 
(1930) perspective, the spirit of American survivorship values the individual’s struggle of 
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battling cancer as a successful venture in itself regardless of the outcome.  Aware of the 
social implications for what metaphors are appropriate to describe cancer (i.e., as a battle 
one fights), research should examine how these expectations might undermine a patient’s 
ability to communicate concerns related to alopecia that may not parallel the “fighter” 
frame.   
The perspectives of female patients who have little to no concern for losing their 
hair should also be included when examining social expectations of appearing 
“womanly” while simultaneously performing “fighter” during chemotherapy.  
Understanding the pressure to fulfill multiple roles and function in society might 
influence a patient’s quality-of- life.  Likewise, how a patient describes her quality-of-life 
before and during cancer treatment might impact how she interacts in public and private 
spaces.  Indeed, they may not be separate issues.  
Quality-of-life  
The public nature of hair loss combined with American society’s limited 
acceptance of difference in women’s appearances (see Lorde, 2009) might affect ovarian 
and uterine cancer patients’ quality-of-life (QoL) during chemotherapy, especially if QoL 
is defined in the context of relationships.  For instance, if a patient’s QoL is partially 
defined by time she spends with her grandchildren but they communicate hesitation and 
are physically distant when she is bald, there may be a strong connection between 
alopecia and a lower QoL.  The relational aspects of this example are rarely examined in 
this area of research, thus there are few studies to reference (see Freedman, 1994; Power 
& Condon, 2008).  How the individual experience of alopecia is embedded within the 
context of relationships is an issue needing further examination.  Incorporating quality-
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of-life studies into research on CIA gives us a more thorough frame though which we can 
conceptualize the communicative aspects of alopecia.   
Quality-of-life during cancer treatment has been a research interest for healthcare 
practitioners and organizations since the late twentieth century (see Aaronson et al., 1993; 
Osoba, 1994).  As discussed in the introduction, cost and delivery of care as well as the 
quality of care are among the key concerns of 21st century medicine (Gupta et al., 2013; 
Robinson et al., 2012).  The concept of quality is subjective, making it more difficult to 
measure than duration, speed, or cost of care.  Gupta et al. (2013) describe the concept of 
quality-of- life as a multidimensional construct including physical, social, psychological, 
and functional domains of life.  The World Health Organization (2002) defines quality-
of-life as “individuals' perceptions of their position in life in the context of the culture and 
value systems in which they live and in relation to their goals, expectations, standards and 
concerns” (WHOQOL, 2002, p.1).   
While quality-of- life (QoL) is heavily dependent on individual perceptions and 
cultural values, the assessment tools and strategies related to measuring QoL are usually 
standardized and quantitative, testing long and short-term effects of health status and 
functional ability using a series of closed questions with response options in the form of 
numbered scales.  For example, the World Health Organization (WHO) developed an 
expansive 132-question survey with 32 questions targeting issues of spirituality, 
religiousness, and personal beliefs (SRPB) and 100 questions testing multiple variables 
such as the ability to work, satisfaction levels related to mobility, sexual practices and 
health status as well as energy levels, amount of sleep and fatigue, and to what degree a 
patient “accepts her/his appearance” (WHOQOL, 2002).   
30  
 QoL surveys test different variables, suggesting there is no absolute standard of 
measurement (see Osoba, 1994).  For instance, the WHO’s survey tests for issues of 
appearance and body image, yet a 30-question quality-of-life questionnaire (QLQ-C30) 
developed by the European Organization for Research and Treatment of Cancer 
(EORTC) does not include any questions related to managing appearance.  The EORTC’s 
QoL survey is mentioned in the introduction of this dissertation because it is designed 
specifically for cancer patients.  The popularity of using the EORTC to measure cancer 
patients’ QoL suggests the issue of managing appearance and the issue of having cancer 
are seen by those who use the EORTC as unrelated or unimportant.  Excluding variables 
related to appearance-management suggests a lack of appreciation for how visible side 
effects such as hair loss can impact a patient’s quality-of- life during cancer treatment.   
 QoL assessments often use Likert-type scales, such as a 5 point scale with 1 
representing “not at all” or “very dissatisfied” and 5 representing “extremely,” 
“completely,” or “extremely satisfied.”  For example, Question F7.1 in the WHOQOL 
asks (in reference to the last two weeks), “Are you able to accept your bodily 
appearance?” with the following choices: 1= “not at all” 2=“a little” 3=“moderately” 4 
=“mostly” 5=“completely” (p. 10).  Similarly, question F7.4 asks, “how satisfied are you 
with the way your body looks?” 1= “very dissatisfied” 2= “dissatisfied” 3=”neither 
satisfied nor dissatisfied” 4= “satisfied” 5= “very satisfied” (p. 13).  There are two more 
questions directly addressing “looks” (F7.2, p. 6) and “appearance” (F7.3, p. 6).   
 To the best of my knowledge, there are no quality-of- life surveys specifically 
devoted to an examination of chemotherapy- induced alopecia.  Using the WHO’s survey 
tool or similar QoL survey tools (Osoba, 1994) as part of a project examining 
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chemotherapy-induced alopecia may provide a baseline assessment of patients’ values 
and attitudes, but it does not provide the opportunity for depth nor does it provide enough 
breadth to stand on its own in the context of an ongoing experience like hair loss and the 
emotions associated with it.   
 The argument for more in-depth quality-of- life research addressing the “why” and 
“how” associated with assigning numbers to feelings has been a problem of interest for 
decades (e.g., Gallagher, 1997; Wagner & Gorely, 1979).  Since the early 2000’s, there 
has been a more focused effort to generate more qualitative, interview-based research 
focusing on chemotherapy- induced alopecia as it relates to quality-of- life among female 
patients (Can et al., 2012; Erol et al., 2012; Firth et al., 2007; Jayde et al., 2013).  QoL 
research on chemotherapy- induced alopecia is lacking in its attention to gender and the 
gendered dynamics of the self and society that may be in play during chemotherapy and 
may influence the way a patient conceptualizes her quality-of- life and the ways her 
changing appearance impacts it.  Incorporating issues of gender into QoL studies is one 
way communication scholarship can contribute to the existing body of knowledge, 
especially as it relates to women’s health.    
 From a qualitative research perspective, the lack of an absolute standard for 
evaluating or defining quality-of- life suggests there is room for and openness toward 
developing new evaluation strategies and interpretations.  To advance the process of 
defining and describing quality-of- life, the field should look to qualitative scholarship 
produced by landmark scholars such as Charon (2004) who work to advance the voices of 
the participants through performative communication acts such as descriptive writing.  
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Influenced by this link of thinking, this dissertation’s interview process will ask patients 
to respond in writing to the following prompt: “to me, quality-of- life means…”  
 Epistemologically, the patient’s voice supersedes existing definitions, allowing 
QoL research to move forward as comparisons and contrasts can be made among 
institutional definitions and those of the patients’.  Whether or not interview participants 
mention hair loss or other side effects of chemotherapy is of interest and may further 
complicate the argument for connecting quality-of- life with alopecia.     
Rationale: Situating the problem of interest  
Situated in the field of health communication, this project’s major area of 
emphasis is in health communication and minor areas are in qualitative inquiry, quality-
of-life studies, women’s health, and side effect management.  An analysis of patient 
experience calls for a research method rooted in the epistemology of interpretive claims.  
The nature of the research questions and the method of semi-structured, compassionate 
interviewing (Ellis & Patti, 2014) allows for a discursive space of openness, which is a 
more natural fit with how we share experiences (Frank, 2013) and how we articulate our 
health status to others (Roscoe, Eisenberg, & Forde, 2016).   
This research functions with an epistemological understanding that there is no 
single starting point by which to measure patient experience nor is it possible to have a 
complete understanding.  Patients’ experiences are already being crafted, told, and retold 
before interviewing takes place and will continue to be storied after the interviewing is 
complete (Bochner, 2014; Charon, 2004; Frank, 2013; Roscoe et al., 2016).  This does 
not negate the opportunity to generate data that can improve the field.  
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Conclusion 
The majority of research on chemotherapy- induced alopecia has a clinical focus 
examining the psychosocial effects of alopecia or measuring its association with quality-
of-life through survey tools that pay little attention to hair loss.  It is critical to recognize 
the subjective nature of quality-of- life and identify the need for a methodological 
approach that investigates how perspectives change over time.  This project will 
strengthen the field’s understanding of the subtle differences as well as the patterns of 
communication among ovarian and uterine cancer patients’ perspectives of hair loss and 
its impact on quality-of- life during chemotherapy.    
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CHAPTER THREE: 
METHOD 
“Instead of viewing these events [of illness and loss] as tangential interruptions [during 
interviews], we treated them as opportunities to be present…in being compassionate 
listeners, we let the conversations go where they needed…and understood that losses 
accumulate…” (Ellis & Patti, 2014, p. 392). 
“After many years in the world of medicine and health care…I have come to think that it 
is not so much autonomy that lies at the basis of our lives as moral creatures…It is 
rather…the responsibility that each of us bears to respect the autonomy, the self and the 
life and humanity of the other. The one who is profoundly vulnerable thanks to illness…at 
whatever stage or condition of life that self or person may be and in appreciation of all 
its significant and subtle implications” (Zaner, 2004, p. xiii).  
Introduction 
The choice of research method is based on questions the researcher is interested in 
examining.  The link between the question and method is often described in most 
published research in a clear and concise fashion, but what about the steps beforehand? 
In addition to reviewing extant literature, what prompts the research questions and 
method, and how does a research project materialize?  To provide insight into the 
development process of this research project, I share the happenings of two especially 
momentous meetings.  There are four years worth of intellectually stimulating 
conversations with my major professor I could reference as helping inform my 
methodological approach, but I am sharing one from March of 2014 to historically situate 
the narrative.  The second meeting is between Dr. Mian Shahzad and me and takes place 
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in August of 2015.  I share these specific conversations and two life-changing mentors 
because they mark specific moments of progress in my dissertation journey toward 
helping improve the quality of communication in women’s oncology. 
Beyond the intention of detailing my development process, the following 
narrative exemplifies “behind the curtain” dialogue between student and professor.  In the 
larger sense, a “behind the curtain” account of my project and method parallels the 
overall function of this dissertation, which is to describe and interpret the all too often 
overlooked, “behind the curtain” problem of experiencing chemotherapy- induced 
alopecia (CIA).  In physical form, CIA is not a “behind the curtain” issue; rather it is 
embodied on public display, what Goffman refers to as “front stage,” visible 
communication (Goffman, 1956).  Even so, the social stigma of being a bald woman (i.e., 
cancer patient) suggests this is often experienced behind the curtains, thus is makes sense 
to perform compassionate, in-depth interviews devoted to unpacking patients’ 
perspectives of CIA and the connecting issues that inform their ability to manage 
“looking like a cancer patient.”  At the conclusion of the following narrative, the research 
method is described, including how and when data were collected, participant inclusion 
criteria along with approvals from the University of South Florida’s Institutional Review 
Board (IRB) and H. Lee Moffitt Cancer Center’s Scientific Review Committee (SRC).  
Interview procedures are discussed along with a description of how codes were 
developed and applied to the thematic analysis.  
Narrating method: A narrative account of the methodological process  
Like many progressive faculty members, Lori goes by her first name instead of 
Dr. Roscoe.  Lori and I regularly schedule “check-in” meetings, and this one is to discuss 
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potential sites of fieldwork for Chaim Noy’s ethnography class I am taking in the spring 
semester of 2014.   
“I keep coming back to Kang’s (2010) ethnography.” 
“Why?” Lori asks. “What makes it interesting?” 
“Well, she uses Hochschild’s (1979) theory of emotional labor to examine service 
work in a Korean-owned nail salon,” I respond with certainty.  
“Yes, but what makes it interesting? Why is her work useful? What does it 
contribute?”  
“Ok, I understand. For starters, it’s interdisciplinary.  Kang (2010) is a Women’s 
Studies and Asian Studies scholar, and her work is not bound by the specificities of one 
field. An MBA student could read her work (2010) and better understand labor relations 
on a macro, meso, and micro level. For me, the work contributes more to method than 
theory.  The way she conducted interviews is highly interpersonal, like a conversation 
with purpose.  The book is not a methods piece, so I find work like Ellis and Patti’s 
(2014) more applicable to an argument for the best practices of interviewing.  Regardless, 
Kang’s (2010) work lit a fire in me!” 
I’m speaking more quickly than I’d like.  I’m excited to discuss method.  I take a 
deep breadth, then say, “As I’m thinking of the dissertation, I move closer toward 
interviewing as the primary method and farther away from more classic ethnography, yet 
I’d like to maintain a similar methodological ethic as Kang.  She positions participants in 
the center of the analysis, which is what we do in this department! It’s what you do!  It’s 
what Kang does!  I want to contribute in the same vein.”   
“Good! This is good!” Lori smiles.  She can tell I have more to share.  
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“I’m fascinated by gendered spaces, Lori, and gendered aesthetic practices like 
nail care or hair care.  Nail salons are absolutely gendered, but does that make it an issue 
of women’s health?  What about gendered spaces of healthcare?  What would a study like 
that look like?” 
“What you’re saying reminds me of a former student who wrote a fabulous class 
paper on Moffitt’s hair salon. Do you know they have a hair salon?”  
“No, I didn’t.”    
“Yes they do! Hold on, I think I have a copy of her paper in my files.”  
Lori pulls open the bottom drawer of her filing cabinet.  “I know I have it 
somewhere.  Her name is Jennifer Pickman (n.d.).  She volunteered in the salon and was 
also a client.  She had cancer and passed away years ago.  Oh she wrote the best piece on 
waterskiing in a wig! The one I want to share with you though…here it is!”  
“Another Thursday hair appointment,” I read aloud.  “What a great title.” 
“Jennifer is how I know about the salon. The paper is short in length and has a 
strong first person focus because she’s writing from the perspective of a patient.  I’d 
expect you won’t find a lot of overlap with your methodological interests, but her work 
will serve as inspiration.” 
It certainly will!  This is excellent,” I say while flipping through the pages.  
“Consider checking out Moffitt’s salon and report back!” Lori says with 
enthusiasm. “It seems like a good blend of women’s health and gendered aesthetics, but 
you won’t know until you observe.” 
The day after our meeting, I am visiting Magnolias, Moffitt’s hair salon, asking 
for permission to perform preliminary observation for an ethnography class at USF.  
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Before then, I have not been inside Moffitt.  It’s less than half a mile from USF’s 
Department of Communication, but driving past it is the closest I have come.  
During my first visit, I speak with the stylist about Jennifer’s paper, explaining 
she wrote about her experience as a client and a volunteer in the salon, and it inspired me 
to come here.  The senior stylist remembers Jennifer, saying she was a supportive 
volunteer.  “I needed help keeping track of the finances, and she was really good with 
that.  She’d help me stay organized.”  The stylist laughs, saying, “Jennifer was always 
taking notes.  She said it was for a class.  It makes more sense now.  What’s she doing?”   
I share the sad news of Jennifer’s death.  The stylist reacts in a way that reflects 
her decades of experience working with cancer patients.  “That’s how it is –taken too 
soon and too young.  So many of these women are on their way out…maybe her stuff can 
come back to life through you.” I sigh then say, “I hope so. I hope she’d be proud of me 
and us, and what’s going on here…I know she’d be proud of you and the decades of work 
you’ve done here.  I still have a lot to prove, but I’ll get there.”  She replies, “of course 
you will, Mare-a-deeth,” saying my name in an accent that is not hers.  We both laugh.  
The salon door opens and we stop laughing. “Hi, how can I help you?” she asks in 
a professional tone.  “We’re here for a wig,” the patient says.  After getting her informed 
consent for observation and an interview, I learn she and the woman accompanying her 
are lifelong friends who met decades ago while working as flight attendants.  She retired 
a few years ago and carries a “from hello…to bye-bye” card her colleagues made.  She 
gives me the card to remember her, and I treasure it.  Still having a full head of hair, she 
insists it is thinning and explains her reason for visiting.  “I’m preparing to lose my 
hair…oh, it’s so important.  Being a flight attendant for 20 years, I’ve always taken my 
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appearance seriously…it’s about how others see you, how I see myself…or how I think 
others see me…I’m not sure what’s the difference between those things. They all overlap 
to me.” She continues, “I want to look feminine at any age because I am feminine and I 
want people to see me with hair…I’ve always gotten compliments on my hair.”  
(Interviews from the salon are not part of data under analysis from this dissertation, yet I 
am sharing a part of this patient’s description of the importance of wearing a wig to give 
insight into how this project evolved).   
I visualize the retired flight attendant and her friend sitting in the exam room.  
What will they discuss while waiting for the oncologist?  Will her list of concerns and 
questions for the doctor have “my hair” on it?  Why or why not?  Because it is 
understood as inevitable, is it equated to unimportant?  Would a she wear a wig to the 
appointment?  Why?  Because hair loss is a side effect of a life saving/life prolonging 
treatment, is it trivial?  If not, does its degree of importance change as chemotherapy 
continues?  With the limited time she has with the doctor, maybe alopecia does not make 
it into to conversation.  Does she speak with a nurse?  What about speaking with me 
outside the salon?  What would an in-clinic consent process and interview look like?  If I 
could, I would ask her similar questions to the ones I do in the salon, like “how do your 
opinions about hair loss change over time or have they stayed the same?”   
This particular patient is extremely concerned with the loss of her hair, while 
others are not.  Yet they share the common thread of visiting the salon, where the focus is 
on managing appearance.  How do patients communicate their experience of hair loss in 
the clinical context, a space less focused on aesthetics?  What about phone interviews? 
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That could contextualize their perspectives further, where they are sharing the clinical 
and everyday lived experience.  
*** 
Over the spring and summer of 2014, preliminary observations yielded enough 
intrigue to apply for IRB and SRC approval.  The IRB and SRC are two different review 
boards with separate policies and operating systems.  University of South Florida’s 
Institutional Review Board (IRB) grants approval after Moffitt Cancer Center’s Scientific 
Review Committee (SRC) issues approval, making it extraordinarily difficult for a non-
Moffitt employee, student-researcher of the humanities to conduct research within their 
institution.  It was rare to come across other students, but those who I met were medical 
students.  The process of IRB and SRC approval is explained in more detail later in this 
chapter.  
For the sake of this narrative, it is important to know I conducted ethnographic 
observation and interviews in the salon from September 2015 to March 2016.  This salon 
is different than most because its only clients are cancer patients and it exists within a 
major cancer research institute.  Over time, I observed and participated in a variety of 
interaction among patients, caregivers, and stylists that led me to wonder if and how hair 
loss was discussed in the clinical context.  Interviews and observational data that took 
place in the salon are not analyzed in this dissertation because they extend beyond the 
focus on this project.  The research provided rich information and influenced how the 
development of the research questions and the interview guide.  Time spent in the salon 
provided context for interpreting my findings.  
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*** 
The following is an except from an e-mail I sent Lori in late July 2015: 
“Hi Lori, I hope you’re doing well. Writing to share good news. I have a meeting 
August 3rd with Dr. Mian Shahzad. He’s a gyn oncologist at Moffitt. Thanks to 
some ob/gyn networking, he’s agreed to a meeting where we’ll discuss research 
opportunities. I’m hoping he’ll be open to the idea of granting access to his clinic 
to do research specific to hair loss, but at this point, I’m just excited to have his 
advice on how to address the issue from a clinical perspective. Hooray!” 
She replies one hour later: “This is excellent M! Let me know how it goes –Lori” 
The August 3, 2015 meeting between Mian and me changed the direction of this 
dissertation. 
“I looked over your C.V. before our meeting. It’s impressive,” Mian says as he 
gestures toward the chair. There are a few chair options in his office, so I hover for a 
moment weighing my options. 
“Take a seat here if you’d like. It was a gift. It’s my favorite one.” 
“It’s red! How unique.”  
We speak casually about the ways communication studies can inform the ways 
healthcare is practiced and we discuss the specific of side-effect management. I ask his 
opinion on chemotherapy-induced alopecia and its impact on his patients.   
“Oh yes, alopecia can have a significant impact on my patients. For some of them, 
it’s very distressing. My dissertation was on stress and how it can increase tumor growth, 
so I try to speak with my patients about ways they can manage their stress during 
chemotherapy.”  
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I share a synopsis of my experience in Moffitt’s hair salon, including how I 
witnessed many head shaves and observed the different ways patients reacted to their 
sudden change in appearance.  We talk about head coverings and womanliness.  Given 
my academic training and previous research in hospitals, he is assured I understand the 
subjective nature of managing alopecia.  Head shaves happen outside the clinic, so I share 
some detail though I am confident he has already reflected on it or he would not have 
agreed to our meeting.   
“Some women bring support systems while others march in alone saying, ‘let’s 
get this over with. I don’t have much time!’ Some are too sick to leave their room, so the 
stylist goes to them.  Most who get their shave and try on wigs during the same 
appointment tend to be more comfortable by the time they walk out then those who leave 
bald.   
I remember when a woman brought friends from work and it was anything but 
supportive.  I’ve spent enough time in the salon to recognize nonverbals signaling 
hesitancy, and this woman was extremely anxious.  Once the clippers turned on, the 
patient started shaking.  Her colleagues were unable to handle it.  The salon is feminine –
it has pink everywhere –but the tone isn’t celebratory.  I think these women expected it to 
be, and they hadn’t thought through the severity of the situation.  Tears were streaming 
down her face, and she didn’t say a word.  The friend responded to her crying saying, 
‘Oh, you’re going to be fine…this isn’t so bad.’ And another said, ‘oh, you look great. I 
could never pull this off!’ And someone said, ‘Yes, girl, you look just as beautiful! Who 
knew! The patient was speechless. The friends hovered and cross-talked about how good 
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the patient looked, all the while excluding her.  It was her moment.  Her illness.  Yet 
there was no room for her to speak.”  
“I’m sorry to hear this.  Support is sometimes complicated.  I see this in the clinic. 
Some family and friends are there more for themselves than for the patient.  Let’s talk 
about wigs.  Not all patients wear wigs or want to.  If there was a clear connection saying 
if you wear a wig, it will help you cope with your alopecia, then we could simply 
recommend wigs to patients and they’d have a stronger sense of self.” 
“Yes, but it is more complicated than that,” I say. 
“Exactly. Correlations might exist but it seems causations do not…” he wonders 
aloud, “What are the factors that make this so complicated?”  
We speak about the decisions patients faced and how they interpret the stigma of 
“looking like a cancer patient” in a society with certain ideas of womanliness. 
“I have a clear answer to why it’d be useful to work with ovarian and uterine 
cancer patients to study alopecia, but I’d rather hear it from you. Why these patients, 
Meredith?” 
*** 
I expected Mian to ask this question. It’s an important one. Because of the hair 
salon ethnography, I met women (and some men) with different forms of cancer and 
various degrees of severity related to their hair loss and stage of disease.  Seeking the 
opportunity to work with gynecologic cancer patients was sparked by the salon space.  
Once my interest was set in motion, I read extant literature on alopecia and made deeper 
connections between embodied experience and social stigma.   
44 
The gendered aesthetic of the salon is highly feminine.  In addition to the two 
head shaving stations and a wall of wigs, there are shelves of pink hats, nail polish, and 
jewelry.  King’s (2006) argument about pink washing certainty applies to the salon 
culture.  Her argument is more focused on the politics of philanthropy, but those issues 
permeate the space.  The interactions taking place within the salon are partially 
influenced by the shelves of items related to “ribbon culture” (see King, 2006).  An issue 
needing critical examination but beyond the scope of this project was the client 
demographic, including how and why women grossly outnumbered men.   
I wrote a conference paper on the gendered implications of the salon space, and 
while a full examination is beyond the scope of this dissertation, the argument challenged 
the hospital’s decision to locate a women’s-centered space in the basement far away from 
any clinic a patient regularly visits.  Clients of the salon often struggled to find the salon 
and regularly complained about its small size, and rightly so because it was 
approximately 400 square feet yet expected to serve all of Moffitt’s clientele.  An 
interview participant said going to the salon made her feel like she was being transported 
to the 1950s.  I argued the healthcare organization should disregard for side effect 
management specific to women and needed to reevaluate its standards.  
Months into fieldwork, I began wondering how the communication about hair loss 
in a gendered, women-centered clinical space would compare to the communication I 
was observing in the hair salon.  In the world of cancer care, what clinical space is more 
women-centered than a gynecologic oncology clinic?  My research interests shifted to 
communication in the clinic about hair loss, a not-so-clinical side effect of chemotherapy. 
As I reviewed existing studies on the subject, I better recognized the complexity of the 
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problem.  Some women visiting the salons for wigs or a head shave were in stage I of 
their disease.  As an outsider, each patient’s account of her cancer was heart wrenching.  
The stage IV ovarian cancer patient I met during a wig fitting whose “silent killer” 
resulted in “everything inside being taken out” helped me better understand the 
particularities of this patient population.  I wanted to learn how the side effect of hair loss 
was communicated among gynecologic oncology patients, and I needed Dr. Shahzad’s 
guidance.  
*** 
Responding to Dr. Shahzad’s question regarding why this patient population, I 
say, “Thank you for asking.  The patients you treat are seriously ill, so their perspective 
on a side effect some might deem trivial is highly valuable because they’re in an extreme 
state of managing their disease.  These are significant surgeries, and so is the 
chemotherapy and radiation that’s involved.  We’re going to the top of the mountain here. 
If your patient population perceives alopecia as a top concern, what does that suggest 
about the severity of the experience?  It says a lot.  It says this warrants in-depth 
examination.  Furthermore, ovarian and uterine cancer patients endure surgeries 
removing anatomy specific to their sex.  Managing internal and external losses of parts of 
the body that are gendered might intensify the embodied experience of alopecia.” 
“This is an interesting dissertation topic, Meredith.  It needs ironing out.  Your 
passion for the subject is clear, and I see the potential of this research.  Let’s schedule a 
meeting where you present your proposed research to Dr. Roscoe and me then we will 
narrow the scope and have you present to our tumor board.  I predict they’ll also be 
supportive of this project because it can benefit our patients.” 
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“Outstanding, Dr. Shahzad! Thank you!  I have been reading literature on the 
subject and there seems to be three main issues that are lacking.  First, this is a research 
problem that should be examined using a longitudinal approach so we establish a more 
thorough understanding of the problem.  What if a patient shares competing views from 
her first and second interviews?  It’ll also be useful to see how patients elaborate on their 
experience since time is such a high commodity when you’re sick.  Secondly, alopecia 
should be conceptualized as an issue of communication because it is personal as well as 
socially constructed.  Thirdly, I suggest a qualitative method of data collection using 
interviewing.  The ethnography of Moffitt’s hair salon gave me a deeper understanding of 
individualized patient care in a nontraditional space.  Alopecia is a gendered side effect. 
That work will inform how I conceptualize the clinic and how I conduct interviews.      
“So what’s the next step?” he asks. 
“The next step is to submit an amendment to the protocol approved by the IRB 
and SRC.” 
“How long do you think that will take?  A week?” he asks with confidence, 
suggesting his previous studies have been approved in a short timeframe.  This is not 
surprising.  He is a physician-researcher.  He is an insider who works in teams that share 
responsibility.  I am none of the above.  I am a doctoral candidate and student of the 
humanities and hold little clout with a major cancer center.   
“Dr. Shahzad, the IRB and SRC process took a year.  This is an amendment, so 
I’m guessing a month or so.” 
“No way! Really? We need to do this faster so you can begin!” he says.  
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 “This isn’t my first time with IRB.  I actually like going through the process 
because it validates the work.  I’ve submitted and acquired approval from the IRB on 
several studies besides this one, and the process was speedy each time.  The difficulty is 
going between two distinct institutions and doing it alone.  Moffitt speaks a different 
language.  For example, as the SRC reviews the amended protocol, I’ll go through a 
check-and-balance system with the manager of Moffitt’s Division of Population Science 
and a research services administrator to account for what I’m doing and how.  This is 
similar to working with the IRB, which I’ve done numerous times, but it’s different 
enough to require additional training.  It’s a challenge that will set me ahead of the 
learning curve, but it also means the wheels move more slowly than we’d like.” 
“I can’t image approval taking so long, but I hear what you’re saying.  A lot of 
back-and-forth and institutional red tape” he says.  “We go about this in teams so the 
responsibility is shared.  The workload is shared.” 
“Yes, that’s what I’m doing next time!  The context is key here.  I was a complete 
outsider trying to do research in a clinical setting, submitting a protocol to do qualitative 
research using interpretative methods,” I say.   
“It’s not the typical study conducted here.  That’s part of what makes it 
interesting,” he replies.  
“I had two meetings with the head of the SRC to discuss ethnography who was 
candid enough to say, ‘Meredith, I’m just not sure what ethnography is or how it can be 
done in a hospital setting.’ The meetings had a supportive tone.  The fact I made it this far 
was not an accident.  From an axiological perspective, the gatekeepers were intrigued, but 
our epistemologies were not aligning.  We went back and forth for months reframing the 
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protocol until we reached a consensus.  It’s certainly prepared me for the grant-funded 
research process.  Before this, I understood the process as more clear-cut where a project 
was accepted or rejected –revise and resubmit, then revise again and gain approval.  This 
was not the case.  This was a negotiation of epistemology, and I was fortunate enough to 
work with Nina Naas, who works in the Division of Population Science managing 
projects.  We had multiple training sessions.  She shepherded me through an opening that 
barely existed.  Without access to the institution, I wouldn’t be prepared to ask for your 
help with access to your patients.”  
“Sounds like extensive vetting. But you’re in now?” he says with a smile.  
 “Yes, I’m in!  Your institution is extraordinarily protective of its patients and 
electronic medical records system.”  
He nods in agreement, suggesting what I said was obvious.  Classified as a 
“student in health behaviors and outcomes,” I entered the Moffitt system in multiple 
ways.  For example, I entered as if I was a new employee, so I had an off-site drug test, 
background check, blood test, and vaccinations.  I attended an orientation and took a 
“new employee” quiz online.  I also entered the institution as a “research coordinator,” 
meaning I was trained in HIPPA compliance.  The training sessions were a bit amusing 
because I was the only one doing qualitative research and the only one coordinating 
alone, so there was a bit of a divide between me and the other folks in the room who were 
all postdocs conducting projects in the hard sciences. 
“Are you ready to use our EMR system, Meredith?  Are you familiar with Oncore and 
how to read PowerChart?”   
“I am trained in Oncore and need your help reading charts.  To me, they’re written in a  
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different language.” 
“That’s fine.  We can teach you in-clinic,” he offers.  
  “Wonderful, thank you. I have an ID badge classifying me as a student with 
formal access for about two and a half years.”  I stop to take a deep breadth, realizing my 
previous description of the SRC process was overkill.  The clock reads 10:57 a.m., and 
we were scheduled to end at 11:00 a.m.  I reach for my backpack as a gesture to show I 
realize it is time to close the conversation.  
I follow Dr. Shahzad into the hallway.  “Thank you for agreeing to work with me. 
I’m thrilled you want to study this area of care and hopefully improve the field.  You 
round out a group of rock stars!  My dissertation committee already has four tenured 
faculty, and now an M.D., Ph.D. is joining the think tank!  What a range of perspectives! 
This is going to change everything!” I exclaim.   
“Good! Please e-mail to schedule the two presentations dates.  I look forward to 
meeting Dr. Roscoe…Lori Roscoe, studying end-of-life communication?” 
“Yes, Lori.”  
“This will be good.  A lot can be done here.  See you soon,” he says.  
By November of 2015, the amended protocol and consent forms were approved 
by Moffitt’s SRC and USF’s IRB.  A month before I presented the revised study and its 
intentions to Lori and Mian.  We agreed research on experiencing chemotherapy-induced 
alopecia should examine issues of quality-of- life and how they are perceived to influence 
one another.  The research questions were revised and I was ready to recruit participants.  
The next section introduces the research questions.  Following, details concerning the 
50  
interview process are provided and are followed by a description of coding and thematic 
analysis.  
Research Questions 
The epistemology of examining the ways in which patients communicate their 
experiences and share their perceptions calls for research questions rooted in an 
interpretative approach.  To better understand how ovarian and uterine cancer patients 
articulate their experiences of chemotherapy-induced alopecia and its connection to quality-
of-life, this study poses the following research questions:  
RQ1: How do ovarian and uterine cancer patients communicate about their 
experience of alopecia over the course of chemotherapy? 
RQ2: How does chemotherapy-induced alopecia influence patients’ 
understandings of quality-of- life?  
An intended outcome of data collection and analysis is to identify patterns of 
communication particular to ovarian and uterine cancer patients whose experiences will help 
the field understand the specifics of hair loss and quality-of-life to better meet the needs of 
patients who have distress related to chemotherapy-induced alopecia.   
Interviewing 
Clearance: Moffitt’s SRC and USF’s IRB process.  Moffitt’s Scientific Review 
Committee (SRC) and University of South Florida’s Institutional Review Board (IRB) 
approved this study in 2015.  Following university and institutional standards, SRC 
approval was obtained before the protocol was submitted to USF’s IRB.  The application 
for both the SRC and the IRB is titled “expanding conceptions of patient care,” numbered 
18102 for the SRC and 19393 for the IRB.   After approval was gained, I submitted an 
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amendment that was approved by the SRC and IRB in January 2016.  I originally had 
access to the site until July 2016 then submitted for an extension, which granted my 
access to recruit new patients until September 2016 and access to the site until May 2017. 
Follow-up interviews extended beyond the recruitment expiration, which was also 
approved.  
Inclusion criteria.  Participant recruitment spanned October 2016 – September 
2016.  To qualify for participation patients met the following criteria: 1) 18 years of age or 
older 2) had a primary diagnosis of ovarian or uterine cancer 3) receiving treatment from 
Moffitt Cancer Center’s Gynecologic Oncology Clinic 4) about to begin or had just begun 
chemotherapy 5) currently treated or had been treated with paclitaxel (taxol), the 
chemotherapy drug that induces hair loss.   
Risks, benefits, and goals.  The objective of this study is to contribute an 
empirical understanding of how ovarian and uterine cancer patients experience hair loss 
and managing their appearance during cancer treatment.  A primary aim during data 
collection and analysis is to foster a form of participation that places patient safety and 
informed consent first.  I identify the institution (Moffitt Cancer Center) by name as well 
as the research site (gynecologic oncology), but I do not identify the names of 
participants.  There are no experimental procedures in this study, so the risk is minimal.  
Describing the research site.  Data collection and informed consent takes place in 
H. Lee Moffitt Cancer Center & Research Institute’s Gynecologic Oncology Clinic located 
in Tampa, Florida.  Though some patients refer themselves to Moffitt, most are referred 
by physicians practicing medicine elsewhere.  A referral to a gynecologic oncologist 
might be interpreted as a frightening suggestion because their treatment plans have been 
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described as the “last chance for hope before death” (personal conversation with a 
referring gynecologist, Feb., 2016).  Moffitt’s gynecologic oncology clinic has two 
locations.  The main clinic is located on the University of South Florida campus and the 
other is located in Southwest Tampa in the International Plaza (referred to as MIP) 
adjacent from Tampa’s International Mall.  This project took place in the main clinic on 
the university campus.   
There are four gynecologic oncologists in the clinic.  Each of the four has a 
designated day of the week during which she/he treats patients in the main campus clinic.  
If it is not their main clinic day, physicians are usually performing surgery and making 
rounds, treating patients at MIP, or addressing issues related to research.  Recruitment 
mainly took place on Wednesdays because that is Dr. Shahzad’s day of the week during 
which he sees patients.  
The clinic exists within the larger organizational structure of Moffitt Cancer Center.  
As a major medical research center, Moffitt functions within the larger context of the 
American healthcare system, thus it is important to consider what the data might imply 
about the individual patient experience as well as the healthcare system at large and the 
systems of interaction within it.  These organizational systems of interaction structure 
communication within the clinic, thus impacting the process of collecting data.   
Structuration theory (Giddens, 1984) and social construction (Berger & Luckmann, 
1966) allow for an understanding of how the organization of the clinic guided (at least 
partially) the ways in which rules, roles, and norms were enacted and negotiated among 
doctors, patients, providers, and loved ones (Giddens, 1984).  Throughout the 210 hours 
spent collecting data in the clinic, particular attention was paid to how language functioned 
53  
in the clinic and during interviews to challenge as well as legitimize social norms that 
structure patient experiences of alopecia (Berger & Luckmann, 1966).  Knowing language 
constitutes the social process of meaning-making (Bartesaghi & Cissna, 2009; Berger & 
Luckmann, 1966), it was critical to be mindful of the language patients used during 
interviews as well as the language I used as an interviewer.  Mindful use of language and 
listening with intent does not equate to interviewing that follows a tightly script.  Semi-
structured interviews were performed using a tone inspired by Ellis and Patti’s (2014) work 
on compassionate interviewing. 
Semi-structured interviews.  The methodological intention of this study is to 
collect data that will generate findings to help address the concerns of female patients1 
who are faced with making sense of a changing appearance signaling their health status 
and how these concerns may change over time.  Because of its emphasis on 
communication and co-construction, semi-structured interviewing is the best way to 
collect data highlighting the central role of the patient in 21st century healthcare.   
Existing qualitative research in health communication using semi-structured 
interviews to examine patient-centered care (see Dean et al., in press; Roscoe et al., 2013) 
and female cancer patients’ experiences of illness (see Anderson, 2014) serve as 
examples for this methodological approach and guide the decision to use semi-structured 
interviews for this dissertation.  The context of an interview can be critiqued as limited in 
comparison with more inductive processes such as postcritical ethnography (Noblit et 
al.’s, 2004) or autoethnography (Adams, Holman Jones & Ellis, 2015; Berry, 2016; 
Bochner & Ellis, 2016).  Previous experiences conducting interviews in teaching 
                                                 1 Refer to Donovan et al., 2014 for more details on research addressing community-specific concerns 
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hospitals (Clements, 2013) have helped me understand how participants in medical 
settings often prefer having prompts rather than engaging in impromptu conversations, 
especially during the initial interview.  Purposeful questions can encourage disclosure 
from both the interviewee and interviewer (Anderson, 2014).   
This dissertation intends to further Kleinman’s (1988) conceptualization of 
interviews as acts of telling to suggest interviews have the potential to surpass explaining; 
rather, becoming acts of sharing (see Ellis & Patti, 2014; Noblit et al., 2004).  An 
interview has the potential to be a dialogic space of becoming, where participants share 
their biases, emotions, memories, or expectations in ways that can reformulate the topic 
of conversation (Radley, 1999).  Though I hold the position of interpreting the data, it is 
important to remember where transcriptions originate, which is in the co-construction of 
dialogue.  The flexibility of a semi-structured interview may encourage participants to 
share in ways I may not expect (Merriam, 2009).  
Intention and tone.  The problem of interest, the time requirement, and 
participants’ health status were approached with sensitivity, and the method of data 
collection needed to reflect this.  Compassionate interviewing (Ellis & Patti, 2014) best 
fits the overall methodological intention because it frames interviews as collaborations 
and encourages emotional exchange.  Interviewing for this dissertation uses SRC and 
IRB approved questions to serve as prompts to help stimulate the exchange while 
unexpected turns in the conversation are expanded upon (refer to Appendix 1 for interview 
guide).  
A close reading of the World Health Organization’s (WHO) expansive survey 
tool used to measure quality-of- life (WHOQOL, 2002) serves as an example of 
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methodological excess that could lead to patients experiencing participation fatigue, 
particularly when working with patients who are seriously ill in stages III or IV of their 
disease.  Because scholarship in quality-of- life uses surveys so frequently and because 
Likert-type scales can provide evidence of a problem and the degree to which it exists, 
this dissertation incorporated a QoL interview question using a 5-point scale.  
Participants were asked to rank their quality-of- life in numerical form with 1 representing 
the lowest possible QoL and 5 representing the highest.  Participants were asked to 
follow their numbered response with an explanation.  The rationale behind the number is 
often missing in scale-based questions, or the “why” and “how” are measured through a 
multitude of additional survey questions.   
From a qualitative perspective, the number of questions asked matters less than 
the participant’s degree of disclosure or willingness to provide insight applicable to other 
variables.  For example, question SP3.2 in the WHOQOL (2002) asks, “to what extent do 
you feel spiritually touched by beauty?” 1= “not at all” 2= “slightly” 3=”moderately 
4=”very” 5=”extremely” (p. 21).  This question is more related to aesthetics than 
appearance, which is less problematic than the fact that this is a confusing question.  The 
phrase, “touched by beauty” seems more like language from an interview where the 
researcher can provide explanation or an open-ended questionnaire where the participant 
can write through the confusion.  Testing an aesthetics-related variable such as this 
suggests QoL studies are attempting to examine complex issues but may be missing the 
mark.  The field’s attempt would be bolstered by a qualitative approach with a 
longitudinal focus, which is the intention of this dissertation research.   
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Longitudinal interviewing with compassion.  To the best of my knowledge, 
longitudinal interviewing within the clinical context is rarely used to examine 
chemotherapy-induced alopecia (CIA) and quality-of-life.  The benefit of using a 
longitudinal analysis to examine CIA is demonstrated by Munstedt et al.’s (1997) 
longitudinal study that used surveys to examine self-concept and body image among a 
patient population similar to those participating in this dissertation project.  Research 
discussed in the literature review shows the importance of collecting data over the course 
of chemotherapy (Gupta et al., 2013; Munstedt et al., 1997) and highlight how the field 
continues to lack interview data, leaving sufficient room for empirical research intended 
to describe, interpret, explain, and better understand.   
Analyzing how women articulate the lived experience of chemotherapy- induced 
alopecia and quality-of-life while confronting a life-threatening disease requires 
methodological sensitivity.  Ellis and Patti (2014) advance the idea of compassionate 
interviewing as an opening through which interviewer and interviewee work together to 
generate new insight.  The agenda of the interview shifts away from a question-and-
answer format and is driven by the need to be mindful during the conversation as 
opposed to trying to maintain control over the direction of the interview or waiting to 
receive responses fitting the agenda of the interview.  Ellis and Patti’s (2014) format 
encourages adaptability and can create possibilities for intimate dialogue because the 
emphasis is on emergent communication between participants.  Redirecting the attention 
to the participants instead of the question-and-answer transaction requires a sense of 
presence, suggesting these interviews can be emotionally strenuous, requiring the 
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interviewer to have respect for the process and the context in which the patient is 
participating.  
This project’s method follows Ellis and Patti’s (2014) approach to interviewing 
and is inspired by their agenda.  Their intended outcome to foster long-term friendships 
with participants differs from the relational intentions of this dissertation.  Similar ethics 
of interviewing are followed, but their call to offer support comparable to that of family 
and friends (Ellis & Patti, 2014, p. 392) is not answered in this dissertation.  I maintain 
relationships with a few patients, but it is not on the same plane as a supportive partner, 
friend, or adult child.  As transcripts show, most interviews are highly personal and 
opinionated. At times, they are emotionally productive and discursive.  From the 
perspective of the researcher, all interviews I conducted are revelatory but some were 
seen as such by the participant.   
There are three main reasons why these interviews did not parallel the relational 
outcomes (i.e., long-term friendships) argued by Ellis and Patti (2014) as fitting the call 
to conduct compassionate interviewing.  First, this approach emerged from longitudinal 
interviewing between the researcher(s) and one participant.  Ellis works for years with 
Jerry (see pp. 393-398) and Patti with Sal (see pp. 393-403) both of whom are Holocaust 
survivors.  I consented almost thirty women.  Fostering truly supportive relationships 
with all thirty over years to come would be difficult and probably insincere.   
At the time of publication, Sal has died, which demonstrates the second point of 
my argument.  Most of my interview participants are not only in the late stages of aging, 
they are seriously ill, going in and out of the hospital, experiencing waves of pain and 
other life-altering side effects like depression and anxiety in addition to low mobility.  
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For example, the difference between the first interview with Patient 9 and the second was 
remarkable.  The first interview lasted two hours.  She disclosed fifty-five pages worth of 
insight into her cancer experience, including hair loss, quality-of- life issues, and more.  
We laughed a little.  At times, she cried.  Some chunks of conversation involved me 
listening to disjointed details about her hobbies and making decisions about who would 
inherit what.  It was compassionate interviewing in action.   
The second interview lasted approximately twenty minutes and took place over 
the phone.  Her tone was indicative of the how aggressive her cancer had become.  She 
was dying.  “Yes, [my hair’s] growing back, but not fast enough,” she says. “Dr. [name] 
said I have 6 months to a year to live…I need it to come in faster.”  She was anxious, 
saying she was angry during her last rounds of chemo, and struggled to share a point she 
wanted to make without it being the same statement as she made only moments ago.  
This is where a long-term relational outcome does not fit the situation.  Some patients are 
too sick to participate in a way that enriches the interview-interviewee relationship.  All 
shared insight that will benefit how we understand the patient experience, but some were 
uninterested in deepening our connection.  That said, many patients were eager to 
continue a working relationship and encouraged me to follow-up again for another 
interview when needed.  I provide more detail related to this in the last chapter of this 
dissertation.  
Finally, the choice to recruit and consent patients in a clinical setting suggests a 
clinical tone might follow throughout the interviewer-interviewee exchange, despite my 
efforts to enact compassion.  Of course, the clinic is a space of compassion, but usually 
not in the same way Ellis and Patti (2014) share where, for example, Ellis and Gerry 
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(interviewee) meet for lunch (p. 393).  The idea of a clinical communication ethic guiding 
our conversations is not strongly supported in the transcripts.  This is probably because 
all are aware of my position as a student-researcher at USF studying communication and 
all the details I cover during informed consent.   
On rare occasions, a patient or her adult child would ask me a medical question, 
and I would remind them I was not a nurse or a doctor and could not answer the question.  
For example, a patient shared “I’m going to ask Dr. Shahzad about my legs.  I have so 
much pain in my thighs and they get puffy.  What do you think?” I replied, “well I don’t 
know, I’m not a doctor.  Asking Dr. Shahzad sounds like a good idea.  Puffy thighs and 
leg pain sounds horrible, though.  Is that one of your top concerning side-effects right 
now?”  Almost all participants were almost always clear on my position as a student-
researcher, and I was trained by a member of Moffitt’s Division of Population Sciences 
on how to confirm consent upon interviewing (i.e., remind patient of the study’s 
intention, her voluntary role in it, and my position) then subsequently observed to assure I 
was following appropriate informed consent procedure.  There were a few instances 
when I referred patients to the social worker assigned to gynecologic oncology clinic.  I 
shared the social worker’s business cards when needed and followed up with her when 
appropriate.   
Regardless of the particular patient and our relational connection during 
interviewing, there remained an undertone of clinical communication.  Given the 
population of interest, their health status, and the context of what was discussed, I am in 
favor of having a clinical communication undercurrent because it helped foster a tone of 
safety.  Some of what was discussed was uncomfortable.  Having hair loss and quality-of-
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life as the central focus was at times uncomfortable to some, but the tone was inclusive 
and the discursive space of the interview was safe partially because of the clinical 
context.  As cancer patients, they are familiar with disclosing the personal.  Our 
interviews addressed how the social influences the personal and vice-versa.  Knowing I 
was trained by Moffitt (and USF) and overseen by Dr. Shahzad and the clinical staff 
added legitimacy to the interview process.  This probably damaged the opportunity to 
cultivate support paralleling that of a friend of family member (Ellis & Patti, 2014), but 
having such an opportunity was not part of this project’s aim.  
Applying Method  
The method used to perform a thematic analysis is explained in the following 
section.  I discuss the interview timeframe and how interviews were recorded and 
transcribed.  Data were analyzed using a coding method, and I describe how codes and 
themes were developed.     
Interviewing took place from October 2016 to April 2017.  Supplemental data 
consisted of over 200 hours of organizational observation.  Every interview was audio 
recorded except for one.  In the one case it was not, detailed notes were taken and notes 
were typed immediately after the interview ended.  There were times I had conversations 
following the consent process that were not recorded because of their brevity, or the setting 
was too public, or they were too personal and turning on a recorder was not appropriate.  
These conversations were not categorized as interviews and do not contribute to the total 
number of interviews.  Each of these instances was noted in an Excel file where notes about 
each interview were categorized.   
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Audio files of interviews were transcribed by a HIPPA compliant transcription 
service specializing in medical transcription.  After the audio files were transcribed, I 
performed audio checks to ensure transcription was accurate.  During the checks, I took 
detailed notes and listened to audio files and read transcripts multiple times between 
December 2016-April 2017.  
Open, axial, and selective coding.  My coding procedure was influenced by Strauss 
and Corbin’s (1990) and Charmaz’ (2000; 2006) work in comparative analytics, where 
codes and themes are generated and revised throughout the analysis to show relationships in 
the data.  Codes were developed based on Strauss and Corbin’s (1990) three-stage approach. 
The first stage is open coding and involves the researcher examining, comparing, and 
categorizing data (p. 61).  I listened to audio files and read through transcript data several 
times to create tentative labels for chunks of data based on interpretations emerging from 
actual interviews.  Properties of the code (i.e., descriptors) are listed as evidence of the open 
code and participants’ narratives are placed next to properties (open code, properties, 
narratives).   
The second stage, axial coding suggests researchers examine context and 
consequences of interaction to develop a procedure “whereby data are put back together in 
new ways after open coding by making connections between categories” (p. 96).  The 
properties that helped generate open codes are no longer needed, and open codes are 
listed next to axial codes to show consistency and progression.  Lastly, selective coding is 
performed to determine core categories, “systematically relating [core codes] to other 
categories, validating those relationships, and filling in categories that need further 
refinement and development" (p. 116). 
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The three stages of coding data were completed based on mutual consensus 
among research team members using a representative sample of interviews transcripts. 
Once a consensus was reached, a coding schema was developed using open, axial, and 
selective codes then collapsed into selective codes representing broad categories 
representing patients’ experiences of chemotherapy- induced alopecia.  The schema was 
designed to recognize data relevant to the research questions guiding the study (Roscoe et 
al., 2016).  Potential or existing discrepancies during interpretation and categorization 
were discussed and resolved in meetings with members of my dissertation committee.  
The table shown on the next page is an excerpt from the coding document and 
exemplifies the coding process that resulted in the selective code and category “gendered 
visibility” to address research question one. 
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TABLE 1: CODING EXAMPLE 
RQ1: How do ovarian and uterine cancer patients communicate about their 
experience of alopecia over the course of chemotherapy? 
Open 
Codes 
Properties of 
Open Codes 
Axial 
Codes 
Selective 
Codes 
Data 
Changing 
Appearance 
Public 
Visibility 
Recognizing 
self as someone 
different  
Attributes 
gender as a key 
factor in being 
recognized 
when sick  
Visibility in 
Public 
Visibility at 
home 
Gender 
Gendered 
Visibility 
“I don’t want people to know 
I’m a cancer patient. Being in 
public is a huge issue I want 
my privacy, and hair loss is 
such a public symbol. I’m 
different than all the other 
women who have hair. I’m 
singled out.”  
(Patient 15_1, p. 3) 
“I changed the way I dressed. I 
intentionally wore big jewelry 
to look like somebody who 
wore scarves” 
(Patient 23_2, p. 3) 
“I can see they’re thinking, oh 
poor girl, that doesn’t have any 
hair or they’re afraid…I just 
smile and I let them know it’s 
okay” 
(Patient 3_ 2, p. 4) 
The practice of constant comparison encourages researchers to become deeply 
familiar with their data and maintain a sense of openness toward adjusting codes and themes 
when needed.  Theoretical concepts emerge from the process of constantly comparing the 
data to existing codes and thematic categories to “create a conceptual story line or theory” 
(Roscoe et al., 2016, p. 1158) to best address the research questions.  This is a practical 
approach to coding because it takes emergence into consideration.  Some codes are less 
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useful than initially perceived while others require the researcher to revisit specificities 
within the data set and revise codes appropriately.   
Conclusion  
Research questions and methods rooted in an epistemology of interpretation stand in 
contrast to the majority of research generated in major medical institutions.  Researching 
potential connections between quality-of-life and chemotherapy-induced alopecia using 
compassionate and longitudinal interviewing may enrich the field’s understanding of the 
problem and hopefully improve patient-centered care.  As an interlude to welcome readers 
into the data analysis, I share two published poems inspired by my time spent with 
patients during data collection.  I also include an e-mail sent by a patient who wanted to 
share her interview experience with Drs. Roscoe and Shahzad.   
Interlude: Poetry from Process  
The following e-mail sent by a patient (name redacted) reflecting on her interview 
experience.  The e-mail is included because it exemplifies the meaningful interaction that 
took place during interviews and the co-constructed nature of the interview format.  The 
two poems were written during data collection and analysis.  The interview process was 
emotional for patients and me.  Patients like the one who sent the e-mail inspired these 
poems, and I have shared them with some participants who communicated interest.   
65 
Figure 1. Patient e-mail describing her interview experience. 
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POETRY ANDONCOLOGY
17 Lines About Chemo
Meredith L. Clements, MA
All along there’s been a tumor
Distant friends and strangers can’t see my diagnosis.
It’s my secret to reveal
Until I lose my hair.
How do I respond to a child at church
Who says I look scary without eyebrows?
I’mmissing my Self
Missing the days I complained about the baby weight
Missing the ability to have a bad hair day.
Another women is taking my place as the attractive soccer mom
And I’m ashamed to admit I care.
Is there space in our society to talk about chemo and aesthetics
Or am I bound to play the role of a fighter
Whose only concern is survival?
Am I allowed to say
There are times I want to give up the chemo
For one more day of looking like my normal Self?
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Figure 2. Poem inspired by patient population.
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AD LIBITUM
Having Cancer and Seeking the Point
Each
 
morning,
 
I
 
sip
 
coffee
 
on
 
the
 
porch
 
Watching
 the
 
backyard
 
come
 
alive
Deer
 
walk
 
their
 
usual
 
path
 
through
 
my
 
garden
 One
 
locks
 
my
 
gaze,
 
and
I
 
remember
 
to
 
breathe
She
 
recognizes
 
me
I
 
sit
 
straight,
 
trying
 
to
 
present
 
my
 
best
 
Self
Yet
 
she
 
remains
 
underwhelmed
 
by
 
my
 
presence
 
In
 
this
 moment
 
I
 
become
 
more
 
mindful
There
 
is
 
humor
 
in
 
thinking
 
nature
 
might
 
stop
 
for
 
me
Perhaps
 
the
 
point
 
of
 
cancer
Is
 
to
 
recognize
 
the
 
uncomplicated
 
nature
 
of
 
dying?Like
 the
 
deer,
 
I
 
am
 
not
 
intimidated
I
 
have
 
locked
 
death's
 
gaze
Refusing
 
to
 
blink
 
ﬁrst
I
 
am
 
as
 
furious
 
as
 
I
 
am
 
thankful
For
 
this
 
new
 
state
 
of
 
normal
Cancer
 
brings
 
me
 
to
 
a
 
point
 
of
 
understanding
 How
 
dying
 
is
 
easier
Than
 
our
 
medicalized
 
society
 
suggests
This
 
is
 
my
 
truth
 
I
 
keep
 
from
 
those
Who
 
are
 
yet
 
to
 
be
 
burdened
 
by
 
disease
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Figure 3. Poem reflecting patients' experiences with death and dying.
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CHAPTER FOUR: 
FINDINGS AND ANALYSIS 
Introduction 
Florida is a heavily populated, steadily aging state hosting residents with serious 
medical problems, which makes it a strong site for conducting research that advances 
patient-centered care related to side effect management and quality-of- life during 
chemotherapy.  This dissertation project took place in a major cancer research institute in 
Florida and helps address the need for more interpretative analyses performed by health 
communication scholars examining how cancer patients communicate experiences in the 
clinical context of major cancer centers (see Ellingson, 2003; 2005; Roscoe et al., 2013).  
Efforts to improve patient-centered care can benefit from learning how patients actually 
experience the potentially knotted entanglements (Sheep et al., 2017) of quality-of- life 
and chemotherapy- induced alopecia.  Because patient-centered research is meaning-
centered research, an emphasis on communication is critical.   
In this chapter, the findings from the data analysis are argued from the perspective 
of health communication studies.  The data provided rich insight into ovarian and uterine 
cancer patients’ experiences of chemotherapy- induced alopecia (CIA) and its connection 
to quality-of-life (QoL).  A thematic analysis of interview transcript data resulted in four 
major themes that will be presented in this chapter.  Excerpts from the data set of 55 
interview transcripts are presented as evidence in support of four themes:  
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1) chemotherapy- induced alopecia and quality-of-life; 2) the “mirror moment”; 3)
performance of social roles; and 4) gendered visibility.  Some excerpts from interview 
transcripts have been altered for phrasing purposes.  For example, an excerpt from the 
transcript of Patient 23’s second interview is used to exemplify how her role as a career 
woman influenced how she managed alopecia.  The eight sentences she speaks in 
explanation are shortened to three by excluding repetitive sentences and using ellipses.  
The communicative context is not altered, nor is the intent of patients’ perspectives.  
These four themes establish that chemotherapy- induced alopecia is a quality-of-
life issue for patients who experience distress related to hair loss.  How patients 
communicate about their experience of alopecia and strategies to cope with it over time 
exists in tension with how they communicate about quality-of-life.  Sheep, Fairhurst, and 
Khazanchi’s (2017) work on dialectical knotting based on Baxter and Montgomery 
(1996) and Baxter (2011) is used to explain the tensions between quality-of- life and 
chemotherapy-induced alopecia.   
Sheep et al. (2017) explain, “Knotted tensions can be amplifying (exacerbating) 
or attenuating (improving) in their effects on one another” as they tighten and loosen over 
time (p. 463).  Each knot has a different consequence to patient care and quality-of- life 
during hair loss, coexisting as a web or network of experiences that forms an “inseparable 
entanglement of interdependence” (Sheep et al., 2017).  Similarities and disjunctions 
across patient interviews form a network of knots consisting of tensions among 
experiences.   
While the two research questions that guided this research were useful in 
organizing the literature review and developing interview questions, the findings reveal a 
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single research question is a more useful framework for examining CIA and QoL over 
time.  The revised research question is: How do ovarian and uterine cancer patients 
communicate about their experience of alopecia and its impact on quality-of- life over the 
course of chemotherapy?  
Ovarian and uterine cancer patients may feel more supported and able to discuss 
CIA if healthcare practitioners put it in conversation with quality-of- life.  The inverse is 
also applicable.  Efforts to evaluate patients’ quality-of- life should incorporate hair loss 
into clinical conversations because it is a topic that often leads patients to disclose other 
issues of concern.  Doing this can better gauge the degree to which a patient’s concern for 
the public’s perception and perception of self will impact her quality-of- life during and 
shortly after cancer treatment.  This is discussed further in this chapter and in the 
concluding chapter.  A frame through which the data are conceptualized is argued in the 
following section of this chapter.  A description of participant demographics follows, and 
the coding process used to analyze data is reviewed.  Four primary themes are presented 
along with sub-themes and excerpts from the transcripts to exemplify each theme.  
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Participant Demographics   
A demographic table is listed below detailing data concerning who was 
interviewed and what demographic information was collected.   
TABLE 2: PARTICIPANT DEMOGRAPHICS  
 
Demographic Variable % 
Ovarian Cancer 
Uterine Cancer 
Recurrence 
74 
26 
35 
Married/Partnered 
Single/Divorced/Widowed 
61 
39 
With Children 
Without Children 
Unspecified 
74 
13 
13 
Heterosexual/Straight 
Homosexual/Lesbian 
Unspecified 
91 
4 
4 
Caucasian 
Hispanic 
African American 
79 
17 
4 
With Health Insurance 
Unspecified 
Hospital Charity Care Program 
52 
35 
9 
College/Some College/Technical 
Unspecified 
Postgraduate 
High School/Some High School 
39 
30 
17 
13 
 
Total Participants (n= 23) 
*Avg. Age= 62 years (39-83 years) 
 
 
Longitudinal qualitative interviews resulted in a data set composed of 55 
interview transcripts, yielding approximately 1,750 minutes of audio (29 hours) from a 
population of 23 ovarian and uterine cancer patients.  Interviews averaged 76 minutes 
total per patient and were performed over 14 months beginning in February of 2016.  
Interview duration ranged from 34 minutes to 132 minutes.  Each of the 23 participants 
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was interviewed at least twice either in-person or via telephone after informed consent 
was gained in-person.  Seventy percent of participants were interviewed twice and 30% 
were interviewed 3 or 4 times.  More specifically, 16 patients were interviewed twice, 5 
were interviewed three times, and 2 were interviewed four times.  The average interval 
between interviews was 19 weeks (4.8 months).  The shortest interval was 1 week and 
occurred between interview 2 and interview 3 with Patient 1, while the longest interval 
was 44 weeks between interview 1 and interview 2 with Patient 9 and Patient 11, 
resulting in a range of 1 week to 44 weeks.  The two range points (1 week and 44 weeks) 
are outliers, as the most common intervals between interviews was approximately 4 
weeks to 12 weeks (among 43% participants).   
Each patient considered the cancer center where this research was conducted as 
her primary provider of cancer care.  Almost all participants identified as 
straight/heterosexual.  Of the two patients who were insured through Moffitt’s “charity 
plan” one said her high quality-of-life (4.5 out of 5) was strongly associated with this 
coverage.  She explained, “Before I was accepted, my quality-of- life was a 1. I knew 
what it was. I knew the cancer was growing and there was nothing I could do.  I was 
filling out the paperwork for Hospice when I found out I was accepted to receive charity 
care. 
Among the demographic data collected, age, martial status, and parental status 
were the three that had noteworthy influences on patients’ perceptions of managing 
alopecia and its connection to quality-of- life (QoL).  Women with children and 
grandchildren almost always mentioned how their alopecia affected their role as a mother 
or grandmother, and most were hyperaware of covering their heads when interacting with 
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children.  There was a division in perspective among participants as to whether age was a 
factor in experiencing alopecia.  Some described their age as one of the primary reasons 
they could manage being bald while others said they would have similar feelings at a 
younger or older age toward being bald and being recognized in public.  Patient 13 
explains the importance of age saying, “Yes, age is a factor.  I’m in my fifties.  If I were 
younger, it would have been far worse.  If I were in my thirties or forties, it would have a 
stronger impact.  For me, it matters because of the privacy…but it’s not a top concern” 
(Patient 13_3, p. 13).  
Age was often an impetus for rich discussions about their romantic lives and 
marital status.  While marital status is not synonymous with a specific degree of romantic 
activity or a certain level of appearance management, it was for many participants who 
were married or partnered.  Findings argue age and romantic status are entangled.  All 
who were widowed said they would be more concerned with their hair loss if their 
husbands were still alive.  Patient 22 explained, “Age is not a factor. It depends on the 
circumstances and needing to appear attractive to others…of being in search for 
something or someone.  I’m not in search of someone.  I became a widow 26 years ago.  I 
would handle hair loss differently if he was alive” (Patient 22_2, p. 8).   
For some, romantic/marital status and age were not understood as an “either/or” 
but rather a “both/and” issue with one taking precedent.  For example, when asked how 
age and martial status impacted her experience, Patient 16 suggested both were central.  
“…When you are young, it would bother you more…If I live long enough for my hair to 
come back, who knows” (Patient 16_1, p. 2).  It is worth noting Patient 16 lived long 
enough for her hair to grow back and decided to purchase a wig but did not want others to 
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know she is wearing one.  More details on how age, martial status, and parental status 
impact the experience of alopecia are provided within the descriptions of the four themes 
generated from the data.   
The 29 hours of audio recording transcribed for analysis make up approximately 
15% of the total time I spent in the clinic.  From February 2016 to November 2016, I 
spent approximately 210 hours in the clinic.  For 5 months after November 2016, I 
continued to visit the clinic but only for brief periods of time to conduct follow-up 
interviews or to use the computer system and maintain relationships with staff.  I did not 
count that time toward the 210 observational hours because I did not take observational 
notes except for notes directly pertaining to the time spent conducting interviews.   
Over the fourteen months spent in the clinic, I became familiar with the 
organizational culture and was able to focus my research efforts on interacting with 
patients and less time learning the workflow of the clinic, particularly how patients are 
moved through their appointments.  Interviews relied on participant availability, but a 
patient’s schedule is largely out of the patient’s control.  An appointment in the 
gynecologic oncology clinic often takes place between multiple appointments in other 
clinics within the cancer center.  Also, a participant might be visiting the gynecologic 
oncology clinic for a routine visit while others involved critical decision-making to 
determine changes in a patient’s treatment plan.  Because of this, phone interviews 
became more common, especially during the middle phases of participants’ 
chemotherapy, and I continued to check-in with them in-person.  
 The consent process spanned February 2016 to August 2016.  The first round of 
interviews was completed by the end of August 2016, and I remained in formal contact 
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with some patients until April 2017 though some of our interactions include informal 
check-ins to maintain relationships and thank patients for participating.  I still maintain 
informal contact with a few patients but do not include our communication as data for 
this analysis.   
Twenty-eight participants consented to participate.  Upon further review of 
inclusion criteria 2 did not quality.  Three of the 28 were unable to work interviews into 
their treatment schedule.  None of the 5 who were excluded from the data set voiced 
concern for participating or directly stated they wanted to withdraw from the study, but it 
was clear their participation needed to be discontinued because of the demands of 
treatment.  Therefore, 82% of those who consented completed two or more interviews 
and were included in this dissertation’s data set.  
One of the original goals of data collection was to interview each participants 2 to 
3 times, but the reality of these patients’ illnesses and the demands of treatment prevented 
consistency.  The range in numbers of interviews per participant shows the reality of in-
depth interviewing with seriously ill patients undergoing chemotherapy.  Data collection 
of this type is messy.  There were many times conversations occurred but were not 
recorded because it did fit my ethic of interviewing and would have been insensitive to 
interrupt and ask for permission to record.  Aligning with Ellis and Patti’s (2014) 
argument for compassionate interviewing, participants’ well being was positioned ahead 
of a self-determined goal to amass a certain number of interviews according to a fixed 
schedule.  After all, this project analyzes quality-of-life, thus it makes sense to practice 
methodological sensitivity and embrace the inconsistencies of the data set and interpret 
the complex messiness that is the patient experience. 
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Thematic Analysis 
A thematic analysis of the data revealed four primary themes: 1) chemotherapy-
induced alopecia and quality-of- life; 2) the “mirror moment”; 3) performance of social 
roles; and 4) gendered visibility.  Excerpts from the data set of 55 interview transcripts 
are used as evidence in support of each theme.  
Theme 1: Chemotherapy-Induced Alopecia and Quality-of-Life  
Analysis of the data reveals chemotherapy-induced alopecia (CIA) as a quality-of-
life (QoL) issue that changes in its importance over time.  The relationship between CIA 
and QoL exists in tension, what Sheep et al., (2017) refer to as a knotted tension, where 
the strength of connectivity tightens and loosens depending on other variables such as 
how effective the chemotherapy is or how supported the patient feels, among other 
interrelated issues.  The theme, “chemotherapy- induced alopecia and quality-of- life” was 
developed based on multiple axial codes including: public interaction, functioning/active, 
isolation, dying, managing appearance, control/loss of control, relationships, loss, 
abnormal/normal. 
Theme 1 of the analysis explains how CIA impacted patients’ QoL over time.  
The language used to describe CIA as “temporary” was complicated by patients’ 
perceptions of their health status.  Unfortunately, if a person has been diagnosed with an 
end-stage disease, life itself is temporary along with other symptoms, issues, and 
relationships.  An interview question asking patients to rank their QoL from 1-5 over the 
course of chemotherapy yielded data suggesting the ineffectiveness of scale-based QoL 
questions unless they are paired with follow-up questions asking “why?”  In addition, the 
“falling out” and “mirror moment” stories and the head shave were identified as specific 
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moments along an uncertain trajectory of chemotherapy with patients interpreting the 
shave as a way of enacting control over a largely powerless situation.  The “mirror 
moment” will be discussed in greater detail in the second theme.    
One of the more useful findings to emerge from the data was the need to expand 
what is and is not included in discussions of quality-of- life.  Patients who were not in 
remission explained how their failing health status continued to mutate their imagined list 
of “quality,” shifting certain priorities and reinforcing others.  Patient 13 explained: 
“It’s not like I’m going to recover and get my hair back and live the rest of 
my life, which is the case for a lot of breast cancer patients.  They’re going to lose 
their hair and eventually going to get it back and go on with their life…For me 
it’s more of, ‘okay it’s a different life now.’  Nothing is the same.  None of the 
rules are the same…I can see where women would feel [the way I do] because 
I’ve always had longer hair” (Patient 13_2, p. 6). 
Patient 13 lost her hair twice and almost always wore a wig in public.  Though 
exercising and eating healthily remained important elements in maintaining her quality-
of-life, Patient 13 clarified how the meaning of “being healthy” has shifted over the years 
of living with ovarian cancer.  The idea of transitioning out of treatment and out of 
baldness does not apply to her lived reality.  Patients who shared this viewpoint said 
“getting back to my normal self” and “looking like my normal self” were impossibilities 
because of the severity of the cancer and the corresponding treatment plan.  Patient 19 
said QoL with recurrence involves mindfulness in recognizing “your new normal.”  
Patient 9 reported a similar shift in “quality,” saying she always associated QoL with 
family and having interests (i.e., hobbies) but CIA made her feel like she had to “look 
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more normal” for family and hobby-related friends in order to continue having 
meaningful interactions. “[I want to] look as close to normal as possible to make other 
people who are bothered by you not having hair, to make them feel better” (Patient 
9_1, p. 52).  Social/familial relationships and her appearance were not as strongly 
associated before CIA as they were after she lost her hair.   
Many of the first-round interviews with patients who were enduring 
chemotherapy for the first time included descriptions of CIA as “temporary.”  In contrast, 
patients experiencing recurrence rarely used words like “temporary” to describe their 
baldness because most thought of their alopecia as part of their dying process.  Patient 9 
said her hair was not returning fast enough to keep up with the pace of her dying, saying 
it needed to grow faster so she would not have to wear hats and caps for the remainder of 
her anticipated six months of living.  Another patient in recurrence said, “If I live long 
enough for my hair to come back, who knows” (Patient 16_1, p. 2).  These participants 
and others who shared similar stories did not see alopecia as a fleeting side effect because 
it was more of a lasting aspect of their lives as they moved in and out of treatment or they 
neared the end of life.   
Other patients reiterated Patient 13’s point about “nothing being the same” in 
reference to their overall lived experience, including issues of aesthetics.  Having “always 
had long hair,” Patient 13 did not perceive ultra short hair as a significant improvement.  
For Patient 13, managing appearance used to be motivated by personal preferences, but 
chemotherapy changed this.  Years of alopecia along with slow phases of regrowth then 
beginning chemotherapy again shifted her perception, saying she wore wigs “mainly for 
others.”  For Patient 13, appearing professional and “maintaining professionalism” were 
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contributing factors to quality-of- life.  Wearing wigs became a way to maintain 
professionalism because “they are less of a distraction.”  Because of this, hair loss and 
wearing wigs became part of her quality-of- life in terms of her professional interaction. 
Some participants made strong connections between their actual hair and their 
quality-of- life.  Patient 5 described losing her hair as “I miss my hair…it was the 
hardest thing. It’s what I do [as a career]. It’s what I did. I didn’t expect for this to 
happen…”(Patient 5_1, p. 4).  This was a shift from the first interview before losing her 
hair when she said it “is just part of the process,” framing it as temporary and 
unimportant.  “I’m not going to wear wigs I don’t think. [Hair loss] is inevitable and I 
have cancer and hair loss is part of it…I’d feel fake…my mom thinks I 
should…”(Patient 5_1, p. 4).  Her perspective continued to shift, saying, “When I first 
got the wig, and found out I couldn’t sleep in it I thought, oh damn it…[but] it’s not 
as important as I thought ” (Patient 5_2, p. 11).  Over time, CIA oscillated in 
importance, from a non-issue, to a major concern impacting social interaction, to 
becoming less of a concern.   
Another example of how perceptions of CIA change over time is exemplified in 
an excerpt from Patient 16’s interview.   
“There is an immense connection between hair loss and quality-of-life…The 
Bible says hair is your crowning glory…When I first shaved my head I 
thought, gee, I look like my father, and I put my scarf on immediately…Hair 
loss did not become more of a concern until after the third round [of 
chemotherapy]” (Patient 16_2, p. 14). 
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Wearing a scarf immediately after her head shave suggests an attempt to assuage the 
shock of sudden change, what Yoshino’s (2006) work on covering calls “a toning down 
of disfavored identity to fit into the mainstream” (p. ix).  The initial shock withstanding, 
Patient 16’s experience of alopecia worsened over time.  She continued:   
“I guess it would be like someone who has breast cancer losing their breasts. 
I feel like they’ve lost their femininity...Losing my hair was horrible.  I was 
prepared [to lose it], but they have this darn television commercial that says if you 
are on –and they listed my drug!  The next time I saw Dr. [name] I said, just tell 
me if it won’t grow back…your dignity is your hair” (Patient 16_2, p. 5).  
Following Sheep et al.’s (2017) argument for relationships existing in a state of 
tension, data show patients who identified with a feminine perspective established strong 
connections between QoL and CIA.  The social standards of femininity do not resonate 
with all patients who reported alopecia as a top concern during chemotherapy.  For 
example, Patient 7 said she and her husband were bohemian and neither had cut their hair 
for years.  “I have long hair like an old hippie, keep it in a ponytail.  No maintenance.  
After [hair loss] I wanted to approximate that look as quickly as I could” (Patient 7_1, p. 
3).  To prepare for hair loss, she cut off her ponytail “wrapped it in tissue paper and 
stuffed it in a Ziploc bag” (Patient 7_1, p. 2).   
For most participants, CIA became an issue of greater concern over time 
following the trajectory of chemotherapy.  This makes sense considering how the initial 
concern, for most, is enduring chemotherapy for the sake of surviving.  As the concern 
for survival dissipates, concerns for aesthetics often increase.   
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“Survival and treatment were [my main concerns]…now it’s not as much of a 
priority since my health is coming back.  You start concentrating on other things 
like appearance and your hair.  Hair loss was number four of my top concerns 
but moved up the ladder after I settled down from the initial shock and 
started chemo” (Patient 15_3, p. 8).  
Patient 15’s perspective illustrates the experience of many.  Patient 1 was more detailed 
in describing how her concern for CIA changed over time.  During the third interview, 
she shared the following: 
“What’s changed?  My hair, that’s it.  Yeah you want to cover it up.  Before it 
didn’t bother me that much.  But when I go out now, I cover myself.  Before I 
couldn’t care less, so now I’m starting to feel better so I want to ya know try 
and look better…but I’m not feeling like I look good.  I put lipstick on.  I mean I 
lost a lot of weight.  I can see that.  I haven’t got to a point where I feel 
comfortable.  I haven’t gotten to a state where I feel, gee I look good” (Patient 
1_3, p. 2).   
When asked to define quality-of- life, Patient 1 wrote, “going out to eat with 
family, being my own person, not to be waited on by anyone, walking by myself, being 
me."  Social interaction was a key component in Patient 1’s quality-of- life, and CIA 
prevented her from enjoying outings like going to restaurants and the beauty parlor.  She 
elaborated further on the issue of CIA and QoL when chemotherapy had ended but her 
hair had yet to return.      
“It’s annoying.  You know, it bothers me because I look to see if it’s growing 
back [because] I can’t wear the wig all the time” (Patient 1_4, p. 3).  She 
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continued, “I miss the hair…a lot of times I think about going to the beauty 
parlor [but] I cant go [because] I got no hair” (Patient 1_4, p. 10).  
Patient 1 was less prepared for the slow return than the falling out, struggling to 
understand how she was still unable to engage in social activity in the ways she wanted 
though she had completed chemotherapy.  Patients were well aware their hair would fall 
out during the first phase of chemotherapy and reported being told this during the consent 
process before chemotherapy.  Most remembered the nurse who did the consenting 
telling them and/or their physician.  According to participants, the “telling” happens only 
during pre-chemo conversations.   
Data provide evidence of the CIA experience growing increasingly more difficult 
over time, yet the initial pre-alopecia/ pre-chemo conversation is the one conversation 
participants referenced.  Few patients reported feeling unprepared for hair loss.  When 
asked why, almost all said, “because Dr. [name] said it would happen.”  For example, 
“They didn’t offer any suggestions, but he told me when it would fall out.  You know, 
how many days after the first chemo” (Patient 23_1, p. 1).  Preparation seems to be 
adequately addressed in the clinic, yet the “during” phase of CIA seems to garner little 
attention from the patients’ perspectives.  This is a missed opportunity for ongoing 
communication that could lead to a higher quality of care.  An excerpt from Patient 15’s 
third interview transcript exemplifies distressing thoughts some patients experience 
during CIA but do not share in the clinic.  
“There is a question, Meredith, that you should be asking.  I don’t know my 
answer to it yet, but you should ask, ‘if you have to go through chemo again 
and you know you’re going to lose you hair, would you do it?’  Because I’m 
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thinking, if I have to do this again and have the taxol and lose my hair [pauses, 
takes a deep breath] would I do this…I guess I would but geeze that’s probably 
the first thing [laughs] I’d think of is, I’m going to lose my hair again.  Not 
I’m going to get neuropathy or I’m going to be constipated, it’d be I’m going 
to lose my hair again.  That would be, ugh, that’s hard…it would distress me 
thinking of doing that again” (Patient 15_3, p. 11). 
Another participant inadvertently responded to Patient 15’s question when 
describing how she feels about CIA after completing chemotherapy.  
“I could much more easily go without makeup than my hair…If somebody said 
to me we’ll heal you and let you keep your hair obviously I’d [prefer 
that]…I’m sure there would come a point in your disease where you 
wouldn’t be physically able to have a wig on and that’s very sad.  God willing 
I won’t get to that point before [recurrence] and my hair will be coming 
back” (Patient 6_2, pp. 9-10).  
Patient 6’s statement along with her description of CIA as a trauma she had to overcome 
position CIA as a quality-of- life issue.  As Patients 15 and 6 reflect on the possibility of 
recurrence, hair loss and being bald are immediate concerns.   
Unlike Patients 15 and 6, Patient 11 is experiencing recurrence.  The first time 
Patient 11 lost her hair, she was shocked and rarely left the house.  A self-declared realist, 
Patient 11’s perspective shifted, now compartmentalizing CIA using a business-like 
approach from her years in business.   
“This is my second time around [with cancer] so I knew I was going to lose my 
hair.  No doubt, I had zero hope for keeping my hair this time…I’ve changed 
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over time” (Patient 11_1, p. 3).  She later stated, “It is kind of like a business 
thing to me.  It’s like okay, it is part of my life I set aside when it is necessary to 
think about” (Patient 11_2, p. 1).   
Patient 11 was told she outright both times she would lose her hair, yet she kept hoping 
she would be the exception.  Such hope speaks to the larger experience of being a 
seriously ill patient, holding onto hope against odds, highlighting only the “probably” in 
the statement, “you will probably lose you hair.”  Now retired, she “ran” her cancer and 
chemotherapy as a business, attempting to separate issues of cancer from other areas in 
her life like church and music that brought her enjoyment. 
Patients had difficulty providing overall reflections of a six-month to multiple 
year account of one’s experience with CIA and were not expected to do so.  As natural 
storytellers, participants most commonly shared their hair loss experience by telling two 
specific stories: a “falling out” story detailing the time they realized their alopecia was 
actually happening and the head shave story about their decision to shave or not and why 
it mattered.   
The falling out story.  Every patient shared a “falling out story,” accounting 
specific moments when their hair loss became a reality.  Some descriptions span the 
length of a page or two, including when hair loss began and the rate at which it happened. 
They shared where they were, what they were doing, who was with them, how they 
reacted, and what they did with the excess hair.  Patient 7, for example, added her clumps 
of loose hair to a bird’s nest in her backyard, thinking it could be put to use instead of 
discarded.   
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The falling out story was usually told in conjunction with descriptions of their 
head shaves, which were perceived as a way to take control of a largely powerless health 
situation.  The falling out story was told differently from the head shave story, which was 
more closely linked with control.  Both the falling out story and the head shave were 
critical moments in the alopecia process because they marked specific times when their 
status as a cancer patient became visible.  For some, the initial phase of CIA was the most 
distressing because it “made it all real” but for most the head shave was the most 
dramatic and traumatic.   
The falling out story was most commonly told using three, overlapping subjects.  
First is a story of surprise and curiosity (e.g., “I woke up with tiny hairs all over my 
pillow and thought, what is happening to me”) while another is a more organic, process-
based story of acceptance (e.g., “I kept brushing my hair until it all eventually came 
out”).  Lastly, some patients’ spoke of taking action, telling their falling out story to 
segue into their head shave story (e.g., “then I went and did something about it”).  Patient 
6 exemplifies the idea of surprise in saying, “We don’t really think about it [falling 
out] until big clumps of hair start coming out and then it’s like oh my gosh is this 
really happening and then you have to deal with it…” (Patient 6_2, p. 9).  
Patient 6’s idea of alopecia did not include clumps of hair and calls attention to 
the difference between being bald and being bald because of chemotherapy.  Likewise, 
Patient 5 told her story using a process-based description with a bit of unexpectedness. 
“I didn’t lose my hair when I was supposed to so I thought I would keep it. 
Then surprise, it started coming out in splotches.  I kept the long strands and 
gradually cut it.  It’s coming out again in wisps” (Patient 5_2, p. 8).  
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Though Patient 5 was told pre-chemotherapy she would lose her hair, the loss was 
surprising.  Patient 5’s treatment plan involved the sandwich method, where patients 
undergo surgery in the middle of the six cycles of chemotherapy.  Because of this, she 
had a small amount of hair return then lost it again after restarting chemotherapy.  Most 
patients who spoke of hair loss happening twice (or more) did so in reference to 
recurrence, but Patient 5 was halfway through her first chemotherapy.  Yet it made sense 
Patient 5 would speak about CIA as happening “again” given how highly she valued her 
hair.  Patient 3 communicated less attachment to her hair, telling her falling out story as a 
series of action steps. 
“I had patches [of missing hair], so I said well I don’t look any good with this 
so we called a friend of ours who is a hairstylist and she came to our home 
and shaved it.  I feel much better without the hair because of the patches.  I 
didn’t look good” (Patient 3_1, p. 2).  
Other participants reiterated Patient 3’s comment about “feeling better” after 
taking action.  Some said they experienced physical discomfort during “the falling out.” 
Some described their hair as feeling heavy and their scalp tender.  Patient 10, for 
example, developed sores on her scalp and face, which she listed during the second 
interview as one of her top concerns.   
Patient 12’s falling out story is memorable for taking action almost immediately. 
Her falling out story shows the curiosity behind the phenomenon of experiencing 
alopecia, as she continued gently pulling out her hair until she felt it was time to shave it. 
She describes:  
87  
“After the first treatment, I started losing my hair…[a few days later] I was 
sitting on the front porch and a bug flew in my hair, and by the time I ran my 
fingers through my hair [to get the bug out] I had a handful.  I turned around 
and just kept doing it, running my hand through my hair and by the time I 
finished, I had a pile of hair in front of me on the ground probably four 
inches tall.  I just sprinkled it in that one area.  My daughter saw, and I said, ‘well 
you might as well shave it.’  I can’t even cook food for anybody because I’ll 
get hair in the food…”(Patient 12_1, pp. 9-10). 
Cooking and enjoying meals are an aspect of Patient 12’s quality-of- life.  When 
asked to describe what quality-of- life meant to her, Patient 12 mentioned spending what 
time she had left with her family.  When asked what her top concerns were during 
chemotherapy, not being able to cook while her hair was falling out was among the top 
three.  These responses demonstrated how QoL is often conceptualized as a “deathbed” 
moment reserved only for a few top tier issues.  In Patient 12’s case, these top tier issues 
were family and time and lower tier issues were appetite, hair loss, and cooking.   
Including the lower tier issues can enhance the conversation and enable a better 
understanding of Patient 12’s perceived difficulties in managing the side effects of 
chemotherapy.  During both interviews, she repeatedly mentioned how unsettling it was 
to cook for the family only for them to find her hair in the food.   These stories made her 
laugh and cry.  Hair in her family’s food was an emotional element of chemotherapy.  
Patient 12 was one among other participants to make this connection, which is 
understandable when considering the import role of food in social gatherings and familial 
relationships.   
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Quality control: The head shave.  Head shaves were communicated as specific 
moments during chemotherapy- induced alopecia when patients took control over a 
largely powerless health situation.  All of the 74% who shaved their heads communicated 
control regarding where it happened, how, when, and sometimes who was included.  The 
head shave was significant because it marked a specific moment during chemotherapy 
when participants became recognizable as cancer patients, yet they had some control over 
when this happened.  Deciding where, when, and how something health-related happens 
was rare during chemotherapy.  The head shave is the tipping point for a changing 
appearance that leads to a mirror moment and heightened gendered visibility.  Both of 
these themes are discussed in detail later in this chapter.  The mirror moment theme 
addresses the personal elements of seeing oneself as a cancer patient, while the gendered 
visibility theme speaks to the social experience of being recognized as a woman with 
cancer.   
 Those who shaved their heads were sure of their decision, saying they would 
advise other patients to plan a head shave.  
“Some people expect [hair] to completely fall out on a certain date…they 
should consider shaving it to just get it over with quick” (Patient 23_1, p. 6).   
 
“Once my hair started falling out I just wanted to get it shaved off…I don’t want 
to see it piece by piece, I can’t.  I know it’s going to happen.  Just do it” 
(Patient 22_1, p. 1).  
Patients 23 and 22 communicated a “get it over with” and “just do it” approach, 
identifying head shaving as the easier method of managing alopecia.  Patients 2 and 8 
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shared stories that support Patients 22 and 23, framing the head shave as a relief instead 
of a troubling experience. 
“My hair was getting in my face, my eyes, my mouth and I felt it falling down 
my back…I said it’s one of two things.  You take me to the salon and let them 
shave it or you can cut it…It was a relief really” (Patient 2_3, p. 5).    
“Saturday night when I woke up I felt prickly all over because there were hairs 
sticking in my face.  I live with [adult daughter] during this time, and I asked her 
to please shave it off because I don’t want patches and I don’t want to deal 
with the tickling.  And she did” (Patient 8_1, p. 5).  
Patients often chose to have a loved one shave their heads in their homes for privacy or 
practicality, which was highlighted in Redgrave et al.’s (2004) autobiographical research 
and inspired how the data was coded for the head shave story and mirror moment theme. 
Patient 21’s head shave story best illustrates the connection between control and 
the head shave and the important role the head shave plays in the post-shave experience 
of confronting a mirror’s reflection, leading to the “mirror moment” theme.  
“I cut off the majority of it myself and then my son just buzzed it off.  I think 
it would be more traumatic to have it start falling out on its own…I felt like I 
was starting [chemotherapy] in control.  My diagnosis I couldn’t control, but 
the losing the hair part even though it all left, I could control that” (Patient  
21_1, p. 4).  
Controlling the planning of her head shave led to an understanding of head coverings as 
issues of control as well.  She later said, “It’s all about control…If I don’t wear a hat I 
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feel exposed, like I’m going to be approached…so control and not exposing 
myself…”(Patient 21_1, p. 20).  In analyzing the transcript data, it seems the way she 
approached the head shave framed the outlook for how she approached head coverings, 
demonstrating the connection between a specific moment (the shave) along the trajectory 
of managing alopecia (wearing head coverings).   
Patient 21 shared a photo of the moment described above.  As mentioned in the 
literature review, Redgrave et al.’s (2004) work features a similar photograph.  The image 
shows Patient 21 seated in front of the bathroom mirror wearing a black smock.  She is 
looking in the mirror without smile or frown, holding the cell phone camera at shoulder 
height to capture a straightforward angle.  Standing directly behind her, her son’s face is 
aimed downward, kissing his mother’s newly shaved head.  Patient 21’s decision to 
document the head shave moment through photography was profound and further 
demonstrates how controlling the timing of the moment does not neutralize the emotional 
experience.   
Some of the six who did not shave their heads did so to avoid the emotional 
experience represented in Patient 21’s excerpt.  Patient 19 explains, “I didn’t shave my 
head.  I just allowed it to fall out as it wanted to.  Little by little it fell out then on day, 
I’m bald.  [Shaving] is too emotional.  Too shocking.  Too much”  (Patient 19_1, p. 1). 
 Of the total, 74% of participants shaved their heads.  Others reiterated her sentiment, 
saying shaving would be “too drastic.”  Patient 19 went on to say, “…some women 
they’re pretty strong to have their hair shaved off.  It’s such a shock. Truly” (Patient 
19_1, p. 9).  Her strong opinion against shaving her head was uncommon in the data set, 
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yet it attests to the control patients demonstrate over deciding when and how to approach 
a head shave, including rejecting the idea and “allowing it to fall out as it wanted.”  
The head shave can become a social moment in CIA.  Multiple participants shared 
stories of support involving loved ones.  For example, Patient 10 planned a “head shave 
party” with friends and family, saying she was making a dark situation lighter.  The first 
excerpt featured her pre-shave planning and the second excerpt is from months later.    
“One way I’m going to try and make it a little easier, I’m going to have a head 
shaving party when the time comes.  I have a friend that’s a hairdresser…a lot 
of friends and family are going to go.  Some have already said they’re going to 
shave their heads too.  My mom wants to do it but I won’t let her.  I’ll host a 
party and maybe a pub-crawl after just to try and lighten the situation I 
guess.  They’re all looking forward to it” (Patient 10_1, p. 3). 
The second interview began with a discussion of if the head shave party happened and 
how it went.  Similar to another participant, Patient 10 wanted to get ahead of the process 
and “shave it off before it all fell out” (Patient 14_2, p. 9).  Patient 10 describes the 
important of controlling the timing. 
“I was trying to schedule [the shave] with my sister’s work schedule and one 
day, my hair just like fell out so bad.  I had this huge clump of hair in the 
shower.  I said, by any chance can we do it this evening when you’ve closed?’ 
And she said sure.  I called my friends and mom and we got a bunch of wine.  
We were all laughing and crying.  It was a good event to have them…we were 
all crying (Patient 10 _2, p. 1).   
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When asked to define what quality-of- life meant to her, part of Patient 10’s 
response was: “spending time with family and friends.”  Patient 10 was one of four 
participants who wrote “friends” as part of their QoL definition.  This value was enacted 
by they way she organized the head shave, making it an event and controlling the place, 
time, and who was there.  A couple of male friends shaved their heads in support, and she 
was the only participant who mentioned having friends do this (some have family 
members).   
In a way, the head shave story encapsulated patients’ cancer stories.  It included 
primary elements of struggle and control.  For Patient 10, her head shave story spoke to 
how she defined quality-of- life through time spent with family and friends.  And it set the 
stage for patients sharing deeper connections among hair loss, personal reflection, and 
social interaction.  In addition to the head shave story, participants were asked to respond 
to a scale-based QoL question where they ranked their QoL from 1-5 and explained their 
choice of number.    
Using a scale: Ranking QoL from 1-5.  Over the course of the interview 
process, participants were asked to rank their quality-of-life on a scale from 1-5 with 5 
being the highest.  There was an overall willingness to participate in the scale-based 
quality-of- life question though a few were unable to assign a number to their QoL 
because it was “too limiting.”  For example, Patient 2 would not respond with a number, 
but provided an overall assessment.    
“To me [low QoL numbers] make a lot of sense if it hurts you to do anything. 
I mean, when your joints and your fingers hurt and your elbows and your 
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nails and your hip…everything hurts.  I can’t have any [quality-of-life]” 
(Patient 2_4, p. 7) 
An indirect opting out of choosing a number to QoL was the first indication of the 
ineffectiveness of scale-based questions to measure a problem of interest as subjective as 
quality-of- life.  The majority of participants responded to the scale-based question at least 
twice over the span of multiple interviews.  This question was designed with the 
expectation that participants would provide a number during each interview and pair the 
number with an explanation.  In actuality, patients assigned multiple numbers to one 
moment in time or provided one number and explained their choice of number in a 
complicated manner that suggested the number was fleeting.  An excerpt from Patient 14 
demonstrates patients’ wavering.    
“It depends on what part of [QoL] I’m looking at.  Probably between a 3 or 
sometimes a 4.  I don’t know, occasionally a 2 [laughs].  It depends not only on 
how I feel physically but I don’t like uncertainty.  I have this new –I don’t know if 
it’s a tumor and I have a trip planned.  That’s the quality-of-life, the tumor.  
But as far as how I feel probably more a 3, some good days a 4.  It depends.  I 
get tired” (Patient 14_2, p. 3).  
In analyzing the QoL scale used during interviews, two issues of interest emerged.  
First, data revealed difficulty and confusion when ranking QoL on a numerical scale.  
Second, most participants associated low numbers with specific negative experiences 
(e.g., “I will not attend church without my hair”) and high numbers with overall health 
status (e.g., “Completing chemo puts me at a 5, but I’m a 4.5 until my hair returns”).   
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“I guess I would say a 5 because I’m cancer free now…I did want to go on a 
cruise but I don’t want to go it until I have a little bit of hair.  I’ll knock off a 
.5 because of the hair…I can’t complain” (Patient 17_1, p. 34).      
Almost all QoL numbers wavered, with 9% of respondents providing consistent 
QoL numbers throughout chemotherapy.  Interestingly, this 9% responded “5 out of 5” 
each time they were asked to provide a ranking, with one patient citing God as her 
reasoning.  The other patient credited her daughter, grandchildren, and openness to dying 
as her reason for maintaining a 5 in QoL.  The remaining 91% tended to link low 
numbers (which indicated a low QoL) with specific negative experiences and high 
numbers (which indicated better QoL) with larger issues and “deathbed” types of 
reflection (e.g., “My CA-125 numbers are low, so I can’t complain;” “I’m realizing what 
really matters now, and I’m doing alright”).  From the data, it was apparent this patient 
population had difficulty associating numbers with lived experience, not because they did 
not understand the task, but because it did not resonate.  Patient 9’s response 
demonstrates how some women provided a number for the purpose of responding to the 
question then explained its higher ranking with “deathbed” reflection.  
“I’m probably a 3 because Dr. [name] said I have 6 months to a year to live” 
Interviewer: I’m sorry to hear that.  That’s heartbreaking.  So with this news, why 
are you not at a 1?  What brings you up to a 3?  
“Well [laughter] people tell you, you’ve got to fight.  You’ve got to fight.  So 
you do what you can do but you know, I don’t know what’s happening” 
(Patient 9_2, p. 4). 
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Patient 9’s response if evident of how the scale-based question did not yield clear 
or concise responses as it was expected to.  For the sake of validity, it was critical to ask 
“why” when patients provided a numerical response.  Asking “why” or “how so” may 
seem natural to interpretative researchers, but the current quality-of-life research using 
scales rarely do so (Can et al., 2013; Munstedt et al., 1997, Osoba, 1994; WHOQOL, 
2002) which was useful for an interpretative study such as this because conclusions can 
be drawn from the messiness.   
Everyday life during chemotherapy and overall “deathbed” reflections became 
jumbled, leading to confusion or wavering responses.  Some patients experienced 
confusion, which is represented in the following excerpt: 
Interviewer:  Do you think hair loss relates to quality-of- life? 
“When my hair first starts falling out, it really bothered me because it was 
kind of long…so I want to say [my QoL] is a 3.5.  I would love to have 
somebody come in and take all the furniture out of the house, redo the whole 
house and put in something all new and different and let me work with that.  
I’m tired of looking at my surroundings” (Patient 19_2, p. 1). 
Data have determined the QoL 1-5 score is an ineffective measure if it is used on its own.  
It is a starting point, not a stopping point.  It is a conversational opening that can uncover 
meaningful issues important to the patient.  A numerical scale for quality-of- life is an 
exercise in what Hyde’s (2012) work calls an opening for dialogue that raises the 
consciousness of patients’ experiential reality as it is happening in the moment.  QoL 
scale-based questions are effective starting points to gauge patients’ willingness to look 
inward.   
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Summary.  Considering chemotherapy-induced alopecia a quality-of- life issue 
first requires being open to the possibility of living a meaningful life while enduring 
chemotherapy.  This can be difficult for some patients and their loved ones as it is 
difficult for society at large to place quality-of- life and having ovarian and uterine cancer 
in the same conversation because of the pain and terrifying uncertainty of such serious 
diseases.  As Patient 12 said, “I got my diagnosis, looked it up online and said, ‘Okay, 
I’m going to die.”  The death sentence and/or survivor mentality (see Lerner, 2004) can 
hinder conversations about the everyday lived experience of chemotherapy.   
Research encouraging patients to share stories that focus on chemotherapy-
induced alopecia provided data on how most patients’ concern for hair loss increased 
over time, yet they reported having CIA-related conversations with healthcare providers 
only during the beginning of chemotherapy.  Data highlighted the complications of using 
language like “temporary” to describe hair loss.  Though many patients use the phrasing, 
those offering support, such as healthcare providers, should not emulate it because it 
often fails to resonate with patients.   
Descriptions of the actual loss represented “falling out” stories that created 
openings for patients to share overall perspectives on coping with alopecia and 
chemotherapy.  This provided insight into how individual patients approach their disease.  
Those who told their “falling out” story using a “taking action” tone tended to approach 
their disease in the same way, speaking to the importance of controlling what they could 
when they could.  Most used their “falling out” story to transition into an account of their 
head shave.  The head shave involved interpersonal elements of relationships between 
patients and their loved ones.  Also, it marked a specific moment of control, which is 
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useful for conducting research on an ongoing problem that changes over time.  The 
“falling out” and the head shave stories are used as points of analysis to research shared 
experience.  
Theme 2: The “Mirror Moment:” Perception of Self and Reflection of Self 
Of the 23 participants, 65% explicitly said mirror(s) in reference to “looking into 
the mirror” at home a total of 28 times across the 55 transcripts.  Having a mirror moment 
is a reflective act and an embodied experience.  The theme “mirror moment” represents 
the private moments of hair loss when patients are alone with their reflection.  Patients’ 
“mirror moments” materialized differently but illustrate a shared experience.     
The “mirror moment” theme emerged as a selective code based on multiple axial 
codes, including identity, changing appearance, recognizing mortality, self-perception, 
and misrecognition.  Data indicate participants often discuss chemotherapy-induced 
alopecia in a way that frames it as a social phenomenon experienced among others in the 
context of the public sphere.  The “mirror moment” theme interprets data that are more 
personal than social, providing a more complete understanding of an extreme change in 
appearance.   
Acceptance and avoidance.  Some patients (22%) discussed avoiding mirrors, 
and how this effort was part of their acceptance process.  Patient 10 describes:  
“We were all crying [after the head shave].  Still, we made the best of it.  It 
was weird.”  
Interviewer: What made it weird? 
“I don’t know.  I couldn’t look at myself.  Like when I came home that night, I 
wouldn’t look at any mirrors.  But I eventually got used to it.  It was just a little 
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bit of a shock first…. Like that first night when I came home, actually in my 
bathroom, I put a towel over the mirror.  I didn’t think I ever wanted to look 
at it…” (Patient 10_2, pp.1-2).    
Placing a towel over the bathroom mirror is a deliberate act of distancing herself 
from the mirror’s reflection.  This was unique to the home, since she obviously could not 
cover mirrors in public places.  After the first half of chemotherapy, another woman 
spoke about her baldness, saying, “I hated looking at myself…” (Patient 17_1, p. 22).  
Patient 17 always wore wigs in public and some type of covering in the house, while 
Patient 10 almost never wore a wig in public but did wear some form of covering.  
Despite their preferences, they shared a serious dislike for the mirror’s reflection.   
Patient 11 was experiencing recurrence of ovarian cancer.  Like Patient 17 
mentioned above, she always wore one in public and often inside the home, yet the wig 
did not help with the problem of avoiding mirrors.  “… I didn’t look at myself that 
much in the mirror and I was at home so it wasn’t… I’m not really attached to my 
hair that was not a big deal but I wasn’t prepared for [losing] it” (Patient 11_1, p. 1). 
Patients 17 and 10 had long hair and saw it as part of their identity.  Both patients were 
younger than Patient 11, and each had a different marital status from each other.  
Interestingly, Patient 11 was “not attached” to her hair, yet she held wigs in high regard, 
almost always wearing it while Patient 10, who covered her mirror with a towel, only 
wore her wig a few times throughout chemotherapy.  Though preferences for head 
covering were different, patients shared a similar struggle with the mirror.  Each 
discussed mirror moments to illustrate difficultly and progress.   
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One may assume it would take a moderate to long period of time to transition 
from avoiding the mirror reflection to accepting it.  This is not always the case.  Patient 
12’s head shave story illustrates immediacy between acceptance and avoidance.   
“When I first thought about [being bald], I'm like, ‘What? I can be okay with that. 
I see women on TV bald all the time.’ But then when it actually happened, 
reality hit.  I looked in the mirror and turned away.  I looked ugly, and then 
my daughter went in and shaved her head so that she would say, ‘Look mom, 
you're not ugly.  Am I ugly? I'm bald. You're beautiful.’  Then after that, it 
got okay” (Patient 12_2, p. 5).  
The adult daughter shaving her head in solidarity helped shift her mother’s mirror 
moment from avoidance, shock, and disappointment to one of disappointment and 
comfort, potentially leading to acceptance which could help the alopecia coping process 
and strengthen the mother-daughter relationship.  Patient 12’s mirror moment exemplifies 
how the personal is also relational.  It calls attention to the emotional strain of accepting a 
reflection that does not parallel a patient’s perception of self.  
 In contrast to Patient 12’s emotional response to her reflection and similar patient 
responses featured in extant literature (see Redgrave et al., 2004), Patient 18 reported 
having a “non-reaction.”  
“…And I, you know, came in the house after [the head shave in the yard] and 
looked at myself in the mirror, and I was like, well, I guess that’s what I look 
like, you know, without any hair.  I really wasn’t, you know, it didn’t bring me 
to my knees or anything, I was just looking really, basically a non-reaction, I 
just kind of accepted it as okay, there we are” (Patient 18_1, pp. 1-2).  
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Patient 18’s curiosity is natural.  Immediately “kind of accepting it” and having a “non-
reaction” were not common among interview participants.  Instead, data indicate ovarian 
and uterine cancer patients were commonly surprised by their reflection, suggesting a 
sub-theme of  “looking worse than I feel” within the mirror moment theme.  
Looking worse than I feel.  Some patients (17%) reported difficulty with mirrors 
because they looked sicker than they felt.  This problem continued throughout 
chemotherapy and after chemotherapy while hair was slowly returning.  Two patients 
who were in the first half of their chemotherapies describe:  
“You have days when you’re sick, there are days when you’re burdened, days 
when you’re bad and some days are good.  And you look at yourself and how 
sick you look.  You know, I never look sick, but I look sick from my hair 
because my hair was falling out and you see it and you look in the mirror and 
you just start crying because you know you’re sick… So I mean, it was 
emotional but I could still go out in public and do stuff” (Patient 17_1, p. 3). 
“…My biggest reason is because if I see myself, I like to look good. And I can 
say to everybody it does matter, but if I'm going through this and I go over and 
look at the mirror and I see somebody that doesn't have hair and I look sick, 
I will feel sick.  I don't feel sick.  I feel like I can do this” (Patient 4_2, p. 5). 
Both narratives exemplify tension between an external image and an internal 
feeling.  This tension contributes to patients’ sense of self and state of being.  The 
American Cancer Society’s “Look good, feel better” (LGFB) Program 
(lookgoodfeelbetter.org, 2012) targeting female cancer patients uses discourse to 
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reinforce the connection between self-confidence and appearance.  The discursive frame 
of “Look good, feel better” is not useful to patients who say they feel good but look 
worse than they feel.  An ovarian cancer patient explains:  
“Anyway, I did it [head shave] and it took me quite a while to look at myself in 
the mirror.  I scared myself the first time I saw myself.  And eventually, I just 
decided that’s the way it’s going to be… For me, it took a week.  For me, that’s a 
long time.  I was already dwelling.  One time I saw myself, so I quit looking at 
myself in the mirror then it got easier.  As I just got out of the shower I 
would walk away from the mirror.  That first chemo really did me in and I 
really look awful.  I really looked like death run over, and I think I scared 
myself.” 
Interviewer:  Do you think how you appear impacts how you feel? 
“No, I looked worse than I felt” (Patient 22_1, p. 1).  
The last statement in this excerpt is key.  Because Patient 22 looked worse than 
she felt, she avoided looking.  The “Look good, feel better” (LGFB) Program argues 
improving external appearance will result in feeling better, yet it does not parallel the 
experience of women like Patient 22 who avoid mirrors, yet when confronted with their 
reflection, recognize how much better they feel than their appearance suggests.  For 
Patient 22’s experience to resonate, the LGFB Program’s motto would need to change to 
“Feel good, look better eventually” or “Feel good, avoid looking.”  When asked about the 
LGFB Program, Patient 22 communicated disinterest, repeating throughout the 
experience of chemotherapy- induced alopecia that her appearance did not match how she 
felt.   
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Patient 22’s approach to coping with mirror moments was to simply avoid the 
mirror.  For others, it was more difficult.  Mirror moments can lead a patient to feel worse 
than she did prior to looking into the mirror.  Patient 23 explains:  
“You have your doctor’s appointment and they say, ‘You’re cancer-free right 
now.’ You’re going home and you think I’m a healthy person again.  And then 
you look in the mirror and still look like a sick person.  And it’s going to have 
an impact on getting well because you still look –you still come to face the 
face of the sick person every day, for a long time.  Even though you’re cancer-
free, you’re still a cancer patient. 
Interviewer: That’s very well said… 
“Definitely. And I’ll be looking like a cancer patient in my mind until I have a 
hairstyle” (Patient 23_1, p. 21). 
Patient 23 anticipated the tension between internal feeling and external image would 
dissipate once her hair returned to a length long enough to style.  Throughout treatment, 
Patient 23 resisted wigs, saying they were “false,” choosing to wear scarves and soft caps 
always in public and almost always in her home in case a friend visited unannounced.  
Patient 23’s second interview took place after she completed chemotherapy.  She 
continued wearing head coverings because “you can still see my scalp and I just didn’t 
like it when I looked in the mirror and I just didn’t look like me” (Patient 23_2, p. 3).  
As Patient 23 described how she made sense of her end-of-life stage, she continued to 
reference her changing appearance and the mirror.   
Nearing the end of her life, Patient 23 reported still looking sick and was planning 
ways to change her image in an effort to lessen the gap between perception of self and the 
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mirror’s reflection.  She was not in pursuit of looking like she did before cancer.  “My 
whole image is going to change,” she said.  “I’m going to experiment with hair dye.  
Maybe blue!  I’m doing things with my look I would’ve never done…but I have to fit ten 
years of hairstyles into one, she said.”  Patient 23’s emphasis on post-chemo hairstyles 
speaks to Freedman’s (1994) argument for hair as a characteristic of personal choice and 
expression.  Her plans are also an act of autonomy, communicating a willingness to 
improvise with an appearance that is forever altered, especially on days when she feels 
better than she looks.  Unlike Patient 23 who was clear about having to make a serious 
effort to shift her perception of self when looking in the mirror, a small number of 
participants referenced their mirror moment as an experience that made them feel better 
about their state of illness.  
Looking better than I feel.  In contrast to the previous section discussing how 
the mirror’s reflections were perceived as worse then perceptions of self, two patients 
with recurrent ovarian cancer referenced unspecific moments of looking in the mirror and 
liking what they see.  This was rare.   
During her explanation of why dating is complicated for women who are going 
through CIA, Patient 20 said, “I know when I look in the mirror all the time I say, oh, 
I don’t even look sick” (Patient 20_3, p. 7).  She contextualized her statement describing 
how gender, sexual activity, and romantic involvement impacted how a patient manages 
her alopecia, which I address further in the “role of partner” section of this analysis.  For 
the sake of this section, her reference to the mirror demonstrated a direct confrontation 
with her health status.  Patient 20 was in stage IV of her recurring cancer.  The first time 
we met she was terrified and, like most patients on the day of receiving devastating news, 
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did not care about her hair.  Of course she did not.  No one would.  As she progressed 
through treatment, she continued to communicate confidence in her appearance.   
The word “confidence” was almost never used in the data, and excerpts like the 
one from Patient 20’s interview were uncommon.  How could Patient 20’s perception of 
self during chemotherapy differ so greatly than the majority?  Simply stated, following 
the trajectory of chemotherapy treatment plans is critical.  Patient 20 was moved off the 
drug that caused alopecia and experienced regrowth far earlier than most.  This had a 
drastic impact on how she coped with chemotherapy.     
Patient 19 also spoke about the mirror and its reflection as a way to reinforce 
confidence.   
“If nobody ever said to [other female patients] wow you look good, then when 
they look in the mirror, they never look at themselves and say, wow I look 
good.  I still have men hitting on me.  That’s what I find amazing.  I think, 
what?  I’m old enough to be your mother” (Patient 19_2, p. 4).  
Patient 19’s career as a holistic esthetician better prepared her for mirror moments.  She 
used phrases like “doing fabulous” and was adamant about the relationship between 
aesthetics, mindfulness, and quality-of- life.  She connected self-affirmation to quality-of-
life, saying patients’ frames of mind are influenced by “what they put out and what they 
take in.”  She also acknowledged how exhausting this way of thinking and speaking was.  
“People ask how you’re doing, and you say, I’m doing fabulous.  Fabulous darling.  But 
sometimes, it’s just exhausting,” she shared.  The multilayered responses Patient 19 
shared during our interviews illustrate the complicated nature of responding to “why” and 
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“how” questions related to an aesthetic of illness.  At times, patients’ responses were 
contradictory or changed over time. 
Encouraging patients to reflect on past experiences with CIA in reference to 
present day provided insight into their process.  For some, it was an evolution.  For 
example, Patient 19 is also referenced in the upcoming sub-section, “shock and 
misrecognition.”  Her excerpt above about having a positive association with the mirror is 
in reference to her current mind frame.  When reflecting on past experiences related to 
CIA, Patient 19 said she was shocked and unprepared to confront her appearance.  
Shock and misrecognition.  The most common shared experience contributing to 
the mirror moment theme was one of shock and misrecognition.  Of the total participants, 
30% mentioned looking into the mirror and experiencing some form of disturbance 
explained as shock and/or misrecognition.  My time spent in the cancer center’s hair 
salon observing head shaves and wig fittings contributed to my assumption that shock 
occurred during and immediately after the head shave or perhaps for a brief period of 
time during an adjustment phase.  This is not the case.  There are times when shock and 
misrecognition did not dissipate over time.  For some, the shock of being bald and feeling 
unrecognizable was prolonged or postponed.   
Patient 8 had difficulty recognizing her reflection immediately after the head 
shave and continued to feel this way over time.  
“[The head shave] was on a Sunday morning and I did not feel bad at all.  I 
looked at it.  I thought to myself, gee, I look like my father when he was 
balding.  I put my scarf on it immediately.  I didn’t want anybody to see me 
without the scarf.  The only person ever saw me was my daughter because she 
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would help me shower at that point.  But no one else ever saw” (Patient 8_2, p. 
10).  
Patient 8 made an unwavering commitment to wearing head coverings throughout 
chemotherapy.  In the first phase of alopecia she had anxiety thinking she could be the 
statistical outlier whose hair never returned.  The shock of being bald morphed into 
prolonged distress that reduced her quality-of- life.   
Patient 16 was bald for months before experiencing shock and misrecognition 
related to her alopecia.   
“I look in the mirror and I laugh ... when I take this [soft cap] off…This is 
ridiculous I mean… 
Adult Daughter: Why? Why ridiculous? 
“I look in the mirror and say oh who’s that ugly woman?  I want to look  
more like my natural self” (Patient 16_3, p.2). 
Patient 16 completed chemotherapy but was not “cancer free.”  During the third 
interview, Patient 16 described a slow transition from not caring about hair loss and 
rejecting the idea of wigs to wanting a wig and an appearance that “looked more natural.”  
The mirror’s reflection was used as evidence of their feelings.  Patient 16 judged herself 
and her desire for a wig as “ridiculous.”  This excerpt highlights the difficulty of 
verbalizing concern for an aesthetic side effect that does not relate to surviving cancer.  
Recognizing your reflection as “ugly” or as other patients said, “looking terrible” or 
“looking like death” are feelings, so they are discounted as “ridiculous” in the context of 
life and death.  This is the core of the problem.  The grand narrative of cancer 
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(Mukherjee, 2010; Lerner, 2004) leaves little room to reflect on what quality-of- life looks 
like.      
Patient 15 struggled to manage her alopecia.  Looking into the mirror reminded 
her of death and dying.    
“Because I look like, I look like a chemo patient, like, I want to say like the poor 
people that were, you know the Holocaust survivors that’s what I feel like, I 
feel like you know they all lost their hair because of the way they were treated, I 
just feel like that. I feel like I look terrible. Like I'm going to die or 
something.”  
Interviewer: I'm sorry to hear that.  
“…So I had [my hair cut short] right away.  They did say that sometimes it’s 
easier to deal with it cut shorter, so that didn’t bother me too bad…but probably 
when I've lost 70% of it, I looked in the mirror and then you just don’t see 
yourself anymore.  You know you see somebody else looking back at you…It 
grew progressively sadder and sadder [laughter] but you know, you kind of 
know that's what's going to happen and even though you know that's going 
to happen it's still harder to deal with” (Patient 15_1, p. 4; p. 9).  
Another patient with recurring ovarian cancer had a similar experience, saying she 
“blending in” was not an issue until she reflected on her actual reflection in the mirror.  
Subsequently, she described her significant weight loss and hair loss as terrible and 
shocking.  
“I somehow was optimistic that they said 90% chance your hair is going to fall 
out.  Well, it was 100%...I had shoulder length hair.  It just kind of came out in 
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clumps and I didn’t look at myself very much in the mirror and so like once I 
finally did, it was...It was terrible.  My husband didn’t say how terrible it 
looked...He doesn’t even pay attention which I guess is good but…we had a big 
boat at the time and we’re out.  I remember this.  It’s weird.  We’re out in the 
river in the boat like a 50-foot boat…I was out without a wig or anything on.  I 
just have these little chunks of hair and I didn’t even realize I looked like 
that until I got home and I was getting ready to take a shower.  You mean 
people were looking at me like this…you know and they didn’t have any 
reaction.  They were strangers.  They didn’t want to gawk…(Patient 11_2, pp. 9-
10). 
Some patients who shaved their heads shared a similar experience with Patient 11 
where they do not realize the degree of their hair loss until they returned home and 
looked into the mirror.   
“It could be stressful, yeah. Because I remember standing in the line at the 
grocery store and some guy was looking at the back of my head and when I 
got home, I looked – we had a mirror with sides – I looked and there was this 
great big bald spot.  And I said, oh my God, this is awful, and I felt really 
bad.  But then the next day I said, okay we’re going to do something about 
this” (Patient 19_2, p. 8).  
For Patients 11 and 19, these mirror moments were the impetus for shaving their heads.  
The shock of being in private with one’s reflection and realizing the image in the mirror 
was the object of unwanted attention is an example of how public and private experiences 
of CIA overlap.  
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By the time participants entered the early-middle phase of chemotherapy, it was 
an almost guarantee they were bald.  Among the 17% whose “mirror moment” took place 
during the beginning phases of chemotherapy, Patient 14’s description was the strongest 
exemplar: 
“I think a lot of this to do with identity.  You can get used to seeing yourself in a 
way.  It is a shock when you look at yourself in the mirror and you have no 
hair.  It's like you're looking at a different person.  I guess depending on your 
age and your amount of vanity that you have maybe or just how secure you are or 
whatever.  It can be a difficult thing to deal with.  I thought I was pretty vain.  
But I think I've lost a lot of that feeling [Laughs]” (Patient 14_2, p. 8).  
Summary.  The “mirror moment” represents the personal, embodied elements of 
alopecia and how it was experienced in the privacy of patients’ homes.  The “mirror 
moment” was discussed as a struggle that continued throughout chemotherapy and after, 
including remission/survival stages as well as recurrence and end-of-life.  For some, the 
experience grew “progressively sadder” over time.  
 Participants often coped with the disconnect between external image and internal 
feeling by avoiding mirrors, while others confronted the mirror and did not recognize its 
reflection as their own.  The mirror theme provided evidence to suggest the American 
Cancer Society’s “Look good, feel better” Program’s motto was not useful for patients 
who reported looking better than they felt.  Unfortunately, the “Look good, feel better” 
Program is one of the only resources to which clinicians refer patients who have CIA-
related concerns.  
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Some participants had difficulty communicating concern for an aesthetic side 
effect that did not relate to surviving cancer.  This could be why patients used the mirror 
are a reference point to help explain the impact of alopecia on their everyday lives. For 
instance, Patient 22 entered and exited her shower differently to avoid the bathroom 
mirror, and Patient 10 covered her mirrors with towels.  These mirror moment stories 
about small changes in behavior signify larger shifts in quality-of- life while living with 
alopecia.  
One of the most telling illustrations of the difficulty in communicating concern 
for alopecia while enduring late-stage cancer was exemplified in Patient 16’s third 
interview transcript (the excerpt was shared in the sub-section above).  Her preferences 
changed from rejecting wigs to now wanting one.  She qualified her interest in wigs as 
“ridiculous” yet said she looked in the mirror and wondered, “who is this ugly woman?”  
Following her story, how would wanting a wig to feel less “ugly” be “ridiculous?” 
Because sharing thoughts of feeling “ugly,” or as other patients said, “looking terrible” or 
“looking like death,” suggest a concern for appearance.  By society’s standards, such 
feelings should be discounted as “ridiculous” in the context of life and death.  The grand 
narrative of cancer (Lerner, 2004; Mukherjee, 2010) leaves little room to reflect on what 
quality-of- life looks like.   
The mirror moment reveals a shared experience that extends beyond preferences 
for head coverings, though head coverings remain an issue of importance.  During CIA, 
the mirror’s reflection and perception of self are in tension.  External image and internal 
feeling impact quality-of- life in terms of sense of self and state of being.  The subsequent 
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theme analyzes data pertaining to role taking.  The roles of parent, career woman, and 
partner influenced how participants interpreted their hair loss and quality-of- life.   
Theme 3: Performing Social Roles  
Chemotherapy is a brutal experience spanning months and sometimes years.  One 
participant described it as “poison for your body.”  Beyond the physical effects, one of 
the most trying aspects of enduring the side effects of chemotherapy over time was 
maintaining the social roles patients valued as part of their everyday lives.  The social 
roles participants performed before chemotherapy influenced how patients experienced 
alopecia.   
The theme of performing social roles was central to understanding how 
chemotherapy-induced alopecia (CIA) was enacted outside the clinic and how these roles 
contributed to patients’ quality-of-life.  The analysis of the data identified the roles of 
parent, career woman, and partner as key components of how participants interpreted 
their hair loss and quality-of- life during chemotherapy.   
Hair loss often hindered the role of mother/grandmother and the act of mothering.  
The role of partner and the role of mother/grandmother were hindered most drastically 
during the beginning and middle phases of chemotherapy.  In contrast, CIA continued to 
impede the role of career woman throughout chemotherapy, including post-chemotherapy 
when hair was returning.  Performing the role of partner was intimately connected with 
how patients manage their alopecia.  The role of partner and women’s roles as parents 
were usually separate issues in patients’ stories.   
Performing the role of career woman: Bald in the workplace.  Of the total 
(n=23), 57% explicitly mentioned their work status and how it impacts managing 
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alopecia.  Twenty-six percent explicitly mentioned retirement when explaining their 
decisions to wear coverings, and each devoted a large amount of time across interviews 
to explaining how not having hair would be more of an issue if they were still in the 
workplace.  Two of those five women were adamantly opposed to wearing wigs because 
they no longer felt they had to wear a “sweaty” or “fake” wig to fit social standards.  
Patient 2 explains, “I’m retired now.  I’ve spent all the years I am going to try and 
impress bosses and peers and being perfect” (Patient 2_1, p. 2).  Patient 2 associated 
autonomy with retirement, and referenced having more choices in deciding “who [she] 
wants to please” and “how [she] wants to look.”  
The issue of class flows throughout this data set and dissertation, yet a thorough 
analysis of class and access is beyond the scope of this dissertation.  Even so, it must be 
mentioned, especially when discussing work and employment in ways that imply 
participants have a choice in working when they might not.  The phrasing of this sub-
theme, “career woman” is used because most patients who mentioned work described 
their work life as a career.  Current or former “career women” did not use more inclusive 
terms like “employee” or “worker” when explaining how being bald and appearing sick 
was a concern while they were in the workplace.   
The demographic of this patient population is mainly middle class with the 
exception of a few patients’ stories that suggested low socioeconomic status.  While 
Patient 12’s work status remains unclear, it is important to understand access to 
outstanding cancer treatment is not synonymous with access to resources in other areas of 
life, especially when discussing the social role of a career woman.   
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Some participants who were gainfully employed with jobs they enjoyed were 
“forced to retire” because cancer and its side effects became too taxing.  Patient 5 
continued to work until about halfway through chemotherapy.  “Even to work I wore 
[the wig] and they could not tell” (Patient 5_2, p. 4).  Wigs were not part of Patient 5’s 
initial plan for how she was going to manage her alopecia.  Partially because of work and 
her “love life” with her husband, wigs and hats became increasingly important.  Patient 5 
never left home without wearing a wig or hat.   
I was visiting the cancer center’s hair salon when Patient 5 and her husband came 
in for an appointment to try on wigs.  She was frail and in a wheelchair.  This visit took 
place after the third or fourth time we had spoken but was in between our two formal 
interviews.  Her voice was hoarse and difficult to understand, yet she declared, “I’m here 
to try on wigs. I’m open to a wig.”  I could tell she used a fair amount of her already 
limited energy to make such an upbeat declaration.  Perhaps she was able to muster the 
strength because of the familiarity of her surroundings.  For over 20 years, Patient 5 
worked as a cosmetologist.  Unlike others who did not have exposure to wigs, Patient 5 
explained how her work life made it both easier and more difficult to cope with hair loss.  
She comprehended the alopecia process better than most patients yet she also lost “what 
she does” by no longer being able to style her hair or work as a cosmetologist.     
Some women who worked from home reiterated the opinions of those who were 
retired.  For example, Patient 21 said, “I used to be the type of person that wouldn’t 
leave my house without makeup or doing my hair.  I was like that until I started 
working from home” (Patient 21_1, p. 11).  Following the change in workplace and her 
diagnosis, Patient 21 left the house less frequently.  When she did, it was never without a 
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wig, cap, or scarf, but her reasons were no longer related to work.  If she still had to 
report to an office, Patient 21 said interacting with colleagues and customers would lead 
her to be more self-conscious about her baldness.  Goffman (1963) explains patients’ 
angst toward workplace interaction as a constant state of consciousness for others’ 
awareness of an undesirable appearance that signals an undesirable illness.   
Of the 57% who reported their career as having a role in their experience of hair 
loss, 30% reported working for profit throughout the entirety of chemotherapy.  Of the 
total (n=23) 39% recounted specific examples of hair loss and appearance being an issue 
at work.  Few reported receiving comments they perceived as supportive, and most 
shared stories of inappropriate stares or “strange” comments from co-workers like being 
“jealous” of weight loss or their hairstyle.  Because of aesthetic-related side effects such 
as hair loss and weight loss or gain, some patients said co-workers had difficulty 
exchanging surface level greetings and would no longer make eye contact.  Other stories 
included comments on wigs looking “real” when they “obviously were not” (i.e., having 
a short blonde wig when her hair was naturally long and brown).   
Patients adjusted their roles in workplace relationships to accommodate 
chemotherapy-induced alopecia.  For example, Patient 13 would not attend work 
meetings without a wig because being bald would distract colleagues from listening to 
her point.  She describes: 
“The only time I’d go without the wig is going to the fitness center. I’ll wear a 
scarf then.  I’m a retired professor so I run into people and I just feel like I need 
to look professional.  I have always thought I need to look professional…I have 
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all these other things I can talk about and [without the wig] the only thing they 
want to talk about [is cancer]” (Patient 13_2, p. 3)   
In contrast, Patient 11 shared a retrospective story of support. 
“…I was blessed with a really good career.  Made a whole lot of money.  I did 
what I loved…I worked with people that I loved and they loved me…But it 
was challenging to take the fork in the road after cancer because I was forced into 
retirement.  Without cancer, I’d still be working and stressed out and who 
knows” (Patient 11_2, p. 4). 
Patient 11 retired before she lost her hair.  The harsh reactions received by patients who 
endured alopecia while working do not parallel the experiences of those who kept their 
hair before leaving the workplace.  
Performing mother: The role of mother and grandmother.  The majority of 
participants (74%) were mothers or grandmothers.  Mothering had a significant impact on 
how the majority experienced chemotherapy- induced alopecia.  Patient 14, who lost her 
hair four times, compared enduring chemotherapy and alopecia to having children.  “I 
think I will never do this again, and then I forget about how horrible it was.  Then I 
think, ‘You can do it again, one more time.’  So I keep doing it” (Patient 14_1, p. 3).  
Relationships with children and grandchildren were usually sources of strength 
and struggle.  Hair loss forced an explanation that some were not prepared to address, 
while others used their baldness as a conversational opening to discuss their illness.  Four 
participants (17%) were mothers to children and young adults, ranging from 10-24 years 
of age.  Eleven women (49%) discussed their grandchildren and their relationship 
influencing how they cope with alopecia and wearing head coverings.    
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There were specific moments after hair loss, around the early-middle phases of 
chemotherapy, when some children and young adult children withdrew from their 
mothers or grandmothers.  Patients who experienced this unwanted shift in their 
relationships communicated deep sadness.  These stories were among the most difficult 
for patients to articulate.  The experience of Patient 5 exemplifies the hurtful 
repercussions hair loss can have on relational dynamics.      
“There are some women who come in [to the salon where she worked] and are 
getting their hair done because they don’t feel well…they don’t get visited by 
their children very often, and they look sick.  I told my 20 year-old son I don’t 
ever see him [begins to cry].  He speaks five words [when he sees me].  But he 
sees [my husband] and talks to him (Patient 5_2, p. 5). 
Patient 5’s younger children were handling her illness better than the oldest.  Mothering 
was one of Patient 5’s most valued roles, and she tried to prepare the family for her 
changing appearance.  
“I explained to the kids that [my hair] is on its way out.  I showed them [my bald 
spots] and said if they had any questions to not be scared and if they want to 
touch it they can.  They all just laughed and said I was weird. I thought, nah, I’m 
hitting a nerve here…”(Patient 5_1, p. 4). 
A few grandmothers said they had hair loss conversations similar to the one 
above, but Patient 5 was the only mother who shared having one.  Patient 14 staged a hair 
loss conversation by asking her grandchild to pick out her favorite wigs. 
“I have a granddaughter who’s ten now.  She was only four when this started.  I 
was concerned.  I wondered how she was going to take this.  I would wear a 
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wig.  Another time [recurrence], I let her tell me which wig was her favorite.  I 
told her I have a sickness and my hair fell out but it was going to come back. 
She helped me…I don’t know if a boy would be the same.  If you let them 
participate and make it not depressing…I think they are resilient” (Patient 
14_2, p. 12).    
Conversations with young adults are difficult partially because the patient knows the 
grandchild is aware of the meaning behind chemotherapy and hair loss.  Cancer is 
pervasive.  While the patient might be the first relative of the child/young adult to 
undergo chemotherapy and alopecia, different forms of media have featured cancer 
patients and characters who die from cancer.   
Grandmother to an 18 year old, Patient 1 redirected hair loss conversations away 
from the subject, reassuring him “nothing’s going to happen.” 
“My grandson is suffering.  It’s giving him a hard time.  He’s not used to 
seeing me sick.  He took a different route home school yesterday [starts 
crying].  He’s very close to us.  I told him this morning, everything’s fine and 
I’m strong.  Nothing’s going to happen [husband and adult daughter start crying]. 
Adult Daughter:  He had a meltdown.  His grades are suffering because he’s 
stressed.  He started crying and went to the principal’s office, and my son’s a 
bodybuilder, taekwondo type.  
Interviewer:  I am so sorry. That’s a hard age for this.  What do you think was the 
tipping point for him?  
118 
When my hair came out.  His school is next to our house.  He checks in every 
day and he didn’t come visit for two days. I figured it out.  That was after my 
hair fell out…”(Patient 1_2, pp. 3-5). 
Recognizing shifts in close relationships such as those among parents and children could 
harm the patient’s ability to progress through chemotherapy.  In preparing for 
chemotherapy, Patient 6 shared distress over how her adult children and grandchildren 
would react and how their potential reactions determined her decision to shop for a wig.  
“I don’t know how painful or uncomfortable wearing a wig is.  I don’t know if it  
hurts…I mean, it’s like what I said to the kids last night.  I need hair.  I am 
not a beautiful woman.  I have not…[starts crying] I can’t look phenomenal and 
have a shaved head.  That’s not me.  It’s not going to work, so either I have a 
wig or I have some kind of scarf that is going to at least make me feel like I 
look less like a freak.  I don’t want my kids to go, ‘Oh my God, Mom.’  I 
don’t want them to see my head…I don’t know how resilient kids are.  I don’t 
know” (Patient 6_ 1, p. 5).  
The anticipation of “looking like a freak” was reflected in Patient 4’s description of an 
emotionally taxing memory when her child said her appearance was scary.  Patient 4 did 
not complete chemotherapy.  When asked why, she shared the following:  
“[Chemotherapy] got harder.  In my last chemotherapy I lost all my 
eyelashes…When I lost my eyelashes, that’s when I thought, I’m not going to 
do this anymore.  One time I had to dress my daughter for school.  She didn’t 
know because I always have fake eyelashes, and I forgot.  She said, ‘Mommy, 
what’s wrong with you?’ I said I did it on purpose, but this [signaled] a big 
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change.  It was a big, big difference.  She even told me, ‘You scare me.’  It was 
hard” (Patient 4_3, p. 2).  
As the mother of elementary school age children, Patient 4 said one of her main 
responsibilities as a mother was to maintain a sense of normalcy for herself and for her 
children.  The surprise questions from her daughter and being told she looked “scary” 
was emotionally damaging, especially after altering her daily routine to include applying 
false eyelashes before waking her children.   
Those who elaborated on performing the role of mother to adult children did so 
because the relationships were contentions.  These experiences were rare.  When adult 
children were mentioned, it was usually reiterating how they enjoy their friendship or in 
connection with stories about being a grandparent.  Adult children frequently 
accompanied patients to appointments.  When they did, patients almost always voiced 
their appreciation, saying general statements about feeling supported.   
Patient 16 was the only participant who attributed her high quality-of- life (5 out 
of 5, spanning all three interviews) to her daughter.  During the third interview, she said it 
was her daughter and grandchildren, but the previous times were directed only to the 
daughter.  “I’m a 5 out of 5…why?  Because of my daughter”(Patient 16_1, p. 2). With 
the exception of Patient 3 who attributed her “5 out of 5” quality-of- life to God, no one 
else provided such succinct associations pinpointing one source of gratification above 
any else.   
In contrast, some patients were able to draw direct associations between their 
relationships with adult children and stress related to wearing wigs.  Patient 2 clarifies: 
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“My daughter inherited some vanity I used to have, and I think she’s worried 
about me going out in public and not being confident about who I 
am…That’s probably why she bought me a wig…She’ll come to our house and 
say, ‘let’s take a girls afternoon and find your wig again.’  I’m going to say, ‘No, 
if you’re embarrassed by me and want to go someplace, I’ll put on a baseball 
cap.’  I don’t want to invoke aggravation.  I don’t want that sweaty thing sitting 
on my head and having to make sure it’s sitting right up there” (Patient 2_1, p. 3). 
The description above is a brief exemplar of a longer, more complicated conflict between 
mother and daughter.  The wig and wearing the wig remained a serious point of 
contention throughout the four interviews.  By the fourth interview, Patient 2 was seeing 
a therapist to help address the conflict.  The role of grandmother overlaps onto the 
mother-daughter relationship, demonstrating how the topic of baldness can signify a 
longer lasting problem of concern.  
“My daughter’s [reason for buying a wig] could be because she doesn’t want the 
grandkids to see me bald.  They lost their other grandmother two years ago…a 
lot of her anger is when we say cancer, to her, I am already dead and gone” 
(Patient 2_1, p. 4). 
Most relational conflict between adult child and parent concerning wearing wigs 
did not have roots as deep as that of Patient 2 and her daughter.  For example, Patient 12 
was only one of two patients who were almost always bald in private and public spaces.  
The other participant, Patient 3, was the mother of younger teenagers and did not mention 
her role as a mother as influencing her alopecia experience.  Patient 12, however, had an 
adult son who insisted on buying a wig “because my daughters told him that I said I was 
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ugly [starts crying]” (Patient 12_2, p. 19).  The purchase was perceived as a thoughtful 
gesture, but Patient 12 never wore it for herself.   
“This morning, he and my daughter-in- law drove me [to the clinic] so I had the 
wig on.  If I took it off when he wasn’t there, my daughter-in-law would go 
back, saying, ‘your mother takes that wig off as soon as you’re not around.’  
So I waited until after I had my blood drawn and got back here [in the clinic].  I 
didn’t want her to come back saying ‘Oh I forgot something.’ I’m like, ‘Okay 
I’m taking this off [laughs].  It has tiny combs that hit the back of my neck and 
dig into me” (Patient 12_1, pp. 26-27).  
For the majority of the interview, Patient 12 held the wig in her lap.  It was as if 
she was prepared for her son and daughter-in- law to burst into the closed consultation 
room and demand proof of her wig wearing.  For Patient 12, the wig became a symbol of 
self-sacrifice, paralleling the selfless and uncomfortable performance most grandmothers 
and mothers already enact long before chemotherapy-induced alopecia.  
Three patients did not have children and three patients did not specify whether 
they did or not, making 26% of the total patient population under analysis.  One of these 
six women mentioned mothering, saying she might have handled hair loss differently if 
she was a mother.  She explains, “My situation might be different if I had children, 
maybe.  To look more like myself for them so they wouldn’t be sad.  But me not 
having children…I would have done everything [regarding hair loss] the same” (Patient 
10_2, p. 9).  
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The remaining five did not mention mothering unless it was in reference to their 
mother or grandmother or themselves as a child.  For example, Patient 22 discussed how 
the challenges of her childhood prepared her for cancer and its side effects.  
“[My cancer] was one of those sneaky things…It was a death sentence and I had 
to deal with it.  I have an explanation for my attitude.  I was a child growing up 
during the war in France…My family was almost killed…I will always 
remember my parents saying, ‘don’t cry for anything.  Save your tears for 
later.  You’ll need them.’  You have to keep quiet.  This was part of my 
upbringing” (Patient 22_2, p. 3). 
This patient’s motivation for caps was for functionality (e.g., to keep warm) and to 
appease her friends who would spend too much time talking about her baldness.  In 
seventeen pages of transcript data, Patient 22 made mention of family, 
childhood/children, or parenting only once, which is featured in the above excerpt.  
Patient 22 did, however, spend time explaining her role as a wife and a widow, making 
sure I understood how the role of widow influenced her perception of hair as 
unimportant.   
Similar to Patient 22, Patient 23 did not mention children or mothering, except for 
once when she mentioned the difference between herself and her grandmother.   
“I know my grandmother, oh my God.  She probably would have refused 
chemo rather than lose her hair and I know people who have actually done that. 
[Hair] was everything to her.  And to keep her husband happy and attracted.  She 
lives for him.  She didn’t have an identity of her own” (Patient 23_2, p. 12). 
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This excerpt is more about the role of partner than the role of mother.  The two roles 
overlapped less than expected before the analysis was performed.  The motivation behind 
managing alopecia rarely exists as one, family-orientated performance where spouse and 
mother are interchangeable roles.  That is not the case.   Patients perceive their baldness 
as signaling a similar message to spouse and child (i.e., “mommy is sick/grandma is 
sick;” “your partner is seriously ill/might die”), but the patient experiences the role of 
bald partner and the role of bald mother in different relational contexts.   
Patient 18 described the difference in how she approached her marriage and her 
mothering. 
“If my husband were still alive, I know he wouldn’t care if I was bald, but I’m 
wondering…I’m trying to think how my kids, if they had been little, how I 
would’ve reacted and how I would’ve handled that…I can see myself saying, 
mommy’s bald and that’s why [I have no hair]” (Patient 18_2, p. 22).   
The spousal relationship seems to be matter-of-fact and accepting, while the role of 
mother would require more strategic communication.  Ultimately, Patient 18 would use 
similarly candid communication with her children, but she did not mention them “not 
caring” about her appearance in the same way she suspected her husband would not.  
The role of partner: Perceptions of intimacy.  The relational dynamics of hair 
loss has not garnered enough attention in extant literature.  Some of the most salient 
descriptions of experiencing hair loss are from patients’ stories about fulfilling the role of 
partner.  Sixty-one percent of participants were in committed relationships, including 
partnerships, unions, and marriages while interviews were conducted.  Including those 
who were widowed and were divorced, 91% had experience performing the role of 
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partner.  With the exception of one participant, those who were widowed said with 
certainty they would have greater difficulty losing their hair if their husbands were still 
living.  
The role of partner was described as one of the most intimate, having a strong 
connection with how ovarian and uterine cancer patients make sense of their changing 
appearance and what it signals to those patients love.  For example, the decision to 
purchase a head covering can be motivated by wanting to feel physically wanted.  Patient 
5 explained:   
“I feel very undesirable without my hair…in my love life [starts crying]… 
Husband: It did hurt her 
“That’s why we got a wig and it made me feel a lot better, but as often as I wear 
a wig, my hair is still a wig” (Patient 5_2, p. 4) 
Her hair “still being a wig” implies Patient 5 remains uncomfortable wearing a 
wig.  Most participants who wore wigs shared similar opinions, saying they were 
physically and emotionally difficult to wear.  I observed multiple wig fittings during my 
time in the cancer center’s salon, including a session with Patient 5.  Friends were more 
vocal during appointments than partners.  Partners showed more nonverbal support, 
where partners would react to patients’ body language to help set the tone of the 
appointment.  Physical touch was rare between patients and their partners or their friends. 
This is not surprising when considering the wig stylist is already touching the patient’s 
head a lot more than someone with hair might contemplate.  Many patients said it was an 
odd feeling to go from having hair to being bald and having someone touching their 
scalp.    
125  
The decision to purchase head coverings differs from deciding when and how to 
wear them.  It is common for patients to cover their heads while they sleep to maintain a 
warmer body temperature.  Both Patients 7 and 15 wore head covering to sleep for 
reasons unrelated to warmth and more related to their partnerships.  
“I wear a tube thing at night to sleep.  I don’t like him to see me bald.  It’s 
what people wear when they’re fishing.  I told you about it last time.  He doesn’t 
like it for some reason, but… 
Husband: I rather [her head] be naked  
No, I’m self-conscious about it.  My scalp is pale” (Patient 7_3, pp. 5-6). 
 
“When I didn’t have any hair at all, I wouldn’t let [my partner] see me without 
any hair.  I would even wear a little cap at night when I was sleeping.  Of 
course it would fall off during the night [laughs] so I’m sure he saw me many 
times without it, but I just didn’t feel comfortable without it”  (Patient 15_3, p. 4).  
Both of the excerpts above were from third-round interviews, supporting the argument 
hair loss continued to interfere with patients’ relationships over the course of 
chemotherapy.  Some elements of the experience do not improve over time.  During the 
first interview before her hair loss, Patient 15 said the image of her bald head “could get 
burned in your brain” and she wanted to avoid allowing her partner to have such an 
image.  She later shared relief for already being in committed relationship, saying, “If I 
wasn’t in a relationship already and I was trying to date, I would not date without hair.  
I just wouldn’t.  I would feel so unattractive without my hair” (Patient 15_3, p. 5).  
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Longitudinal, compassionate interviewing (see Ellis & Patti, 2014) laid a 
conversational foundation for patients to share stories of self-consciousness and intimate 
moments throughout their hair loss.  Because we were discussing a “softer side effect” of 
chemotherapy as opposed a side effect less gendered and socially visible, women took the 
time to share how they think their partners see them with cancer and without hair.  A 
common thread among those who spoke about their partnerships and hair loss was the 
issue of security.   
“My appearance used to be a big concern.  It isn’t now.  Every hair, it had to be in 
the right place.  The makeup had to be just right.  [Because of my relationship] I 
don’t have to trap anybody to take care of me…sex itself is not an issue.  Yes, 
I enjoy it but it’s not something at this stage.  Right now, I don’t have the energy 
for it and with all the crap going on down here [e.g., colostomy bag, surgical 
healing], sex is something I don’t want to consider…but [I feel] settled and 
secure” (Patient 2_4, pp. 9-10).  
The patient population under examination has, for the most part, committed to enduring 
chemotherapy and its side effects.  For some, the effects are unknown and for others in 
recurrence, effects such as hair loss are less startling.  The women who communicated 
associated their committed relationship with feeling better about being bald might 
connect with the idea of a double commitment, where the partnership and the 
chemotherapy overlap.  Patient 6 explained:  
“My husband…you know I just wanted to know…what do women and men do 
when they’re alone?  I mean, I don’t even need to push on the ice machine to get 
a glass of water because he’s taking care of everything (Patient 6_1, p. 2). 
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The idea of being “taken care of” was unsettling to Patient 6 and Patient 5 because they 
identified as the caretakers of their families.  Patient 6 “loved to clean” and Patient 5 
enjoyed planning and executing family activities.  The role reversal of caretaker was 
subtle and difficulty for some participants.  Beyond the role of caretaker, Patient 5 valued 
the feminine role she played in parts of her marriage.  
“This is something I would not necessarily share, but [my husband] is very sweet 
to me and he makes me feel wanted…because I think all girls like to feel they 
are wanted.  That’s why I bought the wig” (Patient 5_2, p. 11).  
The support of “feeling wanted” did not resonate with other patients who performed 
partner in a friendlier manner.  For example, Patient 9 and her husband “got matching 
head shaves” and joked about needing my hair.  In the second interview, she shared 
annoyance with her husband’s attitude toward her needing a hat.  
“Why do I wear hats? Because my husband is always telling me the hair on the 
back of my head is sticking out and to go put a hat on” (Patient 9_2, p.2) 
Interviewer: So if it wasn’t for that would you go completely without hats or head 
coverings now that it’s growing back? 
“Probably…I’m incredibly fatigued” (Patient 9_2, p.2) 
The slight criticism and banter between Patient 9 and her husband seemed to be a 
way of coping with the serious change in their lives together.  The first interview 
transcript was sprinkled with banter and appeared to serve as distraction.  The 
commanding tone Patient 9’s husband used regarding a head covering differs from the 
tone communicated in Patient 17’s account.  
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“I basically started wearing a wig when my husband told me I got a big bald 
spot on the back of my scalp...My husband’s balding on the top of his head…he 
said, ‘It’s really starting to get noticeable in the back…I still had hair but I started 
wearing a wig…it just kept coming out” (Patient 17_1, p. 13).   
Her husband’s balding head seemed to make him more aware of how noticeable 
her bald spot was.  The underlying message of Patient 17’s story about wearing wigs was 
she made the decision, but the decision was easier because of her husband’s 
communication.  The two references to him and the multiple uses of “I” suggest shared 
decision-making.  The mutuality made more sense in the second interview when Patient 
17 mentioned she and her husband work together and are “around each other 24 hours a 
day.”   
Summary.  Performing the roles of mother, career women, and partner impacted 
how participants experienced alopecia.  While patients are visiting the gynecologic 
oncology clinic, the roles of mother, career women, and partner exist on the periphery, as 
they are not the center of attention during a medical exam, for example.  Outside the 
clinic, these social roles remain key contributors for how patients interpret their 
experience of CIA.   When asked, “how do you define quality-of- life,” many participants 
mentioned mothering, their career, and/or their relationship with their spouse/partner.  
Because alopecia impacted the performance of these three roles, it also impacted 
participants’’ quality-of- life.  
Patients who mentioned the role of career woman identified it as central to how 
they managed alopecia.  Data demonstrated the difficulties of workplace interaction, 
including a heightened self-awareness pertaining to wearing wigs, which was done to 
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reduce the chance for unsolicited conversations with colleagues about hair loss and 
cancer.  Those who were retired said they would be more bothered by CIA if were still 
reporting to their place of work and interacting with colleagues.      
The role of partner was the most complicated of the three because it was the most 
intimate and included feelings of security and feelings of self-doubt related to alopecia.  
For example, patients reported feeling undesirable after hair loss, some not allowing their 
husbands to see them bald and wanting to sleep in wigs.  These same conversations 
featured stories of feeling secure and supported.  Patient 2 explained the aspect of 
security, saying, “I don’t have to trap anybody to take care of me” (Patient 2_4, p. 9).  
Security in their marriage (commitment) was strongly associated with feeling secure in 
their altered appearance.  Almost all who were widowed said managing alopecia would 
be of greater importance if their husbands were still alive because they would want to 
appear attractive.   
Mothering was an active role most participants discussed in reference to their 
quality-of- life.  Grandmothers and mothers to children and young adults often reported 
their alopecia as having a negative impact of their relationships.  Some children and 
young adults withdrew from these relationships, creating emotional distance by 
physically avoiding patients or not talking when they were around each other.  This was a 
source of additional distress for participants who were able to locate the shift in behavior 
as taking place after they lost their hair.   
The language used to discuss chemotherapy- induced alopecia was gendered, 
especially when patients spoke about social interaction.  Everyday errands, for example, 
became an instance of becoming visible to the public eye.  Patients were aware of being 
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noticed by strangers as a woman with cancer, and it impacted their willingness to leave 
the privacy of their home.  Functioning in public was an experience of “gendered 
visibility,” and is the next section of analysis.  
Theme 4: Gendered Visibility  
 The analysis of the data revealed ovarian and uterine cancer patients had a high 
level of concern toward being perceived in public as a cancer patient.  Alopecia was the 
top reason for being recognized as having cancer, and being recognized was contingent 
on patients’ gender.  Almost all participants repeatedly spoke about the gendered 
elements of CIA and how difficult it was for them to blend in because their appearance 
went against social norms.   
Participants acknowledged American culture at large as more accepting of 
different appearances than in the past.  They also said cancer was steadily becoming more 
prevalent in today’s society, resulting in most people knowing someone who has endured 
chemotherapy.  Social progress specific to alopecia was rare, with most patients’ 
experiencing CIA as a gendered binary.  Patients compared their experience of CIA in 
public to men’s, arguing women with bald heads or scarves/caps were recognized as 
cancer patients because they were women.   
Data led to the development of the theme, “gendered visibility.”  The theme 
emerged from data represented by numerous axial codes such as privacy, stigma, gender, 
recognized, control and loss of control, and treatment in public.  For some, being 
recognized was an issue because they wanted more control over who knew their health 
status.  Others were less concerned with strangers knowing their health status but 
adamantly against being approached by people who had questions or stories about cancer.  
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Whether viewed as a breach of privacy or not, increased visibility impacted patients who 
valued social interaction as part of their QoL.   
Described with precision, Patient 21 stated, “Your head is speaking for you.”  
The “you” in this statement was not universal, and Patient 21 did not suggest it was.  The 
“you” Patient 21 was referencing applies to women, particularly in a society with 
Western values and expectations such as the one where this research took place.  Both 
Patient 21 and her husband have had cancer.  Both are bald.  And yet, he was not 
approached by strangers asking, “what kind of cancer do you have?”  Years after 
treatment, her husband remains “bald by choice” (Patient 21_1, p. 9).   
“When he started coming [to the cancer center] as a patient, he commented, 
‘I don’t want people to think that I’m bald because I’m having chemo.  
They’ll think I’m sick…I don’t want people to think…’and I’m like, ‘they would 
never think that.  They wouldn’t have a clue.’  He finally got it…”(Patient 
21_1, p. 9).  
The husband knew what a bald head in a cancer center communicated.  Patient 
21’s reassurance could not be reciprocated because it would be disingenuous.  The 
difference between the husband’s angst and Patient 21’s is hers is not reserved for the 
cancer center.  She explains: 
I will not go anywhere without a hat.  I feel bare.  Even seeing the doctor, I 
leave my hat on…I would not go to the store.  I would not go pump gas.  [If] I 
forget my hat, I’ll turn the car around and go home” (Patient 21_1, p. 6).  
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Her husband’s awareness of the public’s perception and Patient 21 feeling compelled to 
return home when forgetting a hat are evidence of the worry CIA can add to an already 
taxing situation.   
Some patients’ husbands who were not sick and were “bald by choice” or 
naturally balding compared their appearance to patients’ in an effort to connect.  A 
frustrating exchange took place between Patient 17 and her husband who was naturally 
balding when he stated, “hey, I’m bald too.”  Patient 15 experienced similar frustrations 
with a partner who was bald.  “He’d say, I understand.  I get it.  A couple weeks ago, I 
exploded on him because he doesn’t understand…this is chronic” (Patient 15_1, p. 5).  
These types of conversations did not ease the distress patients felt toward their 
appearance.  Patients noted the shock of the rather speedy timeframe in which they lost 
their hair and compared to their partners’ years of natural progression toward balding.  
The shock Patients 17 and 15 referenced was more personal than social, though the two 
are intertwined.  Being personally shocked by the drastic change in the appearance was 
analyzed in “the mirror moment” theme.  Uncomfortable reactions from strangers were a 
social experience that relied on socially constructed, gendered standards of appearance.  
Patient 5 makes a gendered comparison to explain this.    
“It’s hard for some people because hair is part of your identity.  But I think it’s 
easier for men because if you shave your head, it’s not shocking.  You know, 
as far as a woman with no hair, it’s a little bit more shocking to society.  But I 
think you sort of have to get the right mindset…”(Patient 5_1, p. 7). 
Data established a communicative pattern of comparable aesthetics, where 
ovarian and uterine cancer patients enduring alopecia differentiated their experience of 
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alopecia to that of men and also compared their “gendered visibility” to other women 
with cancer.  Patient 14 demonstrated this in the following excerpt:   
“I see other patients here and compare myself to how they look.  I think, gee I 
look better than I thought!  I see women in the [hospital] lobby walking 
around with bald heads and [they] look really sick.  I don’t look as bad as 
they do” (Patient 14_1, p. 1). 
Ovarian and uterine cancer patients spend significant amounts of time in the clinic.  From 
an interpersonal communication perspective, it is natural to compare appearances and 
establish an informal order to interpret one’s surroundings and position as a patient (see 
D’hont, 2002; Goffman, 1963).  Jorgenson and Steier’s (2013) argument for “lower order 
frames” suggests patients use the social norms of the physical environment to construct 
“higher order meanings.”  In this case, the lower order frame is the clinic’s lobby, 
signaling to those who are in the space that all are there for treatment or to support those 
in treatment.  Higher order meanings are constructed based on how patients see 
themselves, how they see other female patients, and how they think other female patients 
should look.  
Some patients’ perceptions of being bald in the public sphere went beyond Patient 
14’s comparison, making gendered claims of value concerning other women’s 
appearances and head covering choices.  The following two are exemplars.  
“I wonder about women [who don’t wear wigs].  Do they want the attention?  
Do they like sympathy?  Why are they doing that?  But of course, I never ask” 
(Patient 11_1, p. 3).  
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“I can’t figure out why some [women] go around looking as ugly as possible 
[without head coverings].  I mean, certainly we are going through some ugly 
stuff so why look ugly?” (Patient 19_2, p. 3) 
These statements reflect social norms and expectations about how women are supposed 
to handle their alopecia.  Extant research provided a foundational understanding of how 
social norms influence experiences of chemotherapy- induced alopecia (Choi et al., 2014, 
Freedman, 1994, Frith et al., 2007; Hansen, 2007; Rosman, 2004), yet the problem of 
relational communication among women with CIA has not been addressed except in 
ways that showed evidence of only positive support (Koszalinski & Williams, 2012).  
The excerpts above feature patients’ judgmental interpretations of other women with 
cancer.  This humanized the image of cancer patients who were not always lone warriors 
(Lerner, 2004) who do not pass judgment and were only concerned with survival.  Some 
women with cancer superimposed their best practices for how other women with cancer 
should manage alopecia.   
The clinical environment of the cancer center does not negate the effects of 
gendered expectations.  Being bald in the clinic is being bald in society.  For example, 
Patient 5 commented, “There was a time when I was coming to [the clinic] and forgot 
my hat.  I was really upset so [my husband] stopped and bought me a hat” (Patient 
5_2, p. 12).  Head coverings are often perceived as an issue for women by women.  
Patient 5 did not differentiate the expectations of the clinic from other public spaces.  
Other patients reiterated Patient 5’s perspective and attributed the pressure to cover (see 
Yoshino, 2006) to wanting to appear attractive.  Patient 23 described how this is 
gendered.    
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“[Hair is] important for women to be sexually attractive.  I’m not trying to 
attract the opposite sex.  I’ve had bad relationships in the past, and I’m just done 
with it.  [Hair loss] is more for the opposite sex and for sex life.  It’s not an 
internal type of thing.  A lot of women are out to find their partner when 
they’re older too…you’re just not trying to nest” (Patient 23_1, p. 12).  
The value of women’s hair is historically situated and dependent on culture values 
(Freedman, 1994; Hansen, 2007).  Almost all participants (96%) described CIA in 
gendered terms.  During her explanation of alopecia being a women’s issue, Patient 23 
compared having hair to having breasts.   
“[Having hair] is just like having breasts…it is important in a sexually 
attractive sense…like women who’ve done breast reconstruction after 
mastectomy.  I think if that was important to your life early in life, it’s still going 
to be later in life” (Patient 23_1, p. 13). 
The excerpt suggested appearing sexually attractive was synonymous with appearing 
womanly in American society.  Considering the average age of participants was 62 years 
and 91% identified as straight/heterosexual, it was unsurprising that these data reflected 
heteronormative standards.  It was also unsurprising because heteronormative standards 
are the standards of American society where this research took place.  Patient 6 described 
her hair regrowth as “looking dykey.”  One of Patient 10’s top concerns related to hair 
loss was being perceived as gay.  “Not that there’s anything wrong with it, but I live in a 
very gay community and I know people are going to think I’m a lesbian.”  Patient 15 
reflected Patient 10’s concerns, but in a less serious sense.    
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“I haven’t been going out in public much without [my wig], but I’m trying not to 
go back to the wig unless there is a wedding.  I think people’s problem with me 
right now is, ‘yeah, she’s probably recovering from cancer treatment’ or they 
think I’m a gay woman that shaves her hair [laughs]” (Patient 15_3, p. 9).  
As discussed in the “performing social roles” theme section, the issue of 
attractiveness and desirability was closely connected to marriage.  Patient 16, who was in 
her 80’s, attributed women’s marital status to managing alopecia.  She also turned the 
questions back to the interviewer, which is an example of how control over the direction 
of interviews was not unilateral2. 
“It probably has something to do with vanity. I mean, you have beautiful 
hair, wouldn’t you be vain about it?” 
Interviewer: Oh, I’m pretty vain about it.  Yes, I am.  It would be devastating. 
“Are you married?” 
Interviewer:  No.  
“So you’re looking. So the hair means a lot too.  Because [my hair] doesn’t 
matter to me now that I’m single.  I’ve been widowed for sixteen years” 
(Patient 16_1, p. 2).   
Because hair grows at such a slow rate, the aesthetic of chemotherapy- induced alopecia 
lasts far longer than chemotherapy.  Patient 16’s statement suggests “still looking” to date 
and “looking like a cancer patient” exist in opposition, regardless of health status.   
2 Refer to Golombisky (2006) for a detailed analysis of shifting power dynamics during 
interviews.   
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Gendered visibility extended beyond becoming visible to other women or men.  It 
applied to moments when children recognized the difference in a patient’s appearance in 
comparison to other adults.  Patients used these stories to explain the heightened visibility 
they experienced.  Excerpts from Patients 1 and 3 serve as examples.  
“[I’m recognized in public] by kids mostly…they will look at me, then look at 
me again.  I give them a wink and smile and that throws them off a little bit. 
They don’t want to look back and check [me] out.  At least I’m trying to let them 
know its okay” (Patient 2_4, p. 5).  
 
“Kids are always looking, asking themselves ‘what happened to this lady?’  
In church or the grocery store, they look. And it’s not a judgmental look.  It is just 
questioning, like what happened?  Other people look, like, ‘oh poor lady.’ I keep 
smiling and talking and acting full of life, and they realize I am good.  People 
don’t have to be scared” (Patient 3_1, p. 4).  
Young children were not perceived as accountable for their actions in the ways adults 
were.  Patients intervened in easing children’s processing of their appearances, adding to 
the burden of functioning in public.  Most participants who shared moments of visibility 
between themselves and children did so to demonstrate their awareness of others noticing 
them (see Goffman, 1963).  Patient 18 describes her appearance as a “stunner” for 
children:    
“Once in a while, I would be out in public like in a store and there’d be a little 
kid walking on their own, maybe four or so, and they would catch me with 
my hat on and you could tell they were trying to process why I was wearing this 
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thing.  If [I] were bald, I’m sure the four year old would’ve gotten –I’ve 
gotten even more demonstrative reactions because you see bald men but you 
don’t see bald women walking around very much.  I would’ve been a huge 
curiosity.  A kind of stunner for a small person” (Patient 18_2, p. 7).  
As demonstrated earlier, a female patient’s experience of becoming visible was 
explained in contrast to a man’s.  There was no actual man with chemotherapy- induced 
alopecia in this encounter, yet Patient 18 was confident in her juxtaposition.  Her 
confidence in children being comfortable seeing a bald man as opposed to a bald woman 
was rooted in stigmatizing norms she has personally endured for the sake of maintaining 
social order (Rosman, 2004).   
Among the most frequent reasons for wearing head coverings in public was the 
desire to “blend in” among strangers without being recognized as having cancer.    
Patient 14’s appearance made her hyperaware of employees’ reactions at stores she 
regularly visited.  
“When I went to the supermarket and didn’t have a wig on the employees 
would come and offer their help [laughter].  I would say, ‘is it really that 
obvious?  One time, I was leaving Walgreens, and they said, ‘Be Well.’ And I 
thought, ‘Do I really look that bad?  I asked, and they said no, it was a new 
policy to say that to everybody [laughs].  I said, tell your manager it’s ridiculous” 
(Patient 14_2, p. 10).  
Patient 14 mentioned the employee’s “be well” farewell during both interviews.  The “be 
well” moment signified Patient 14 dividing her lived experience into stages of “before 
alopecia” and “after alopecia.”  Before, she was able to blend in and regularly function 
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without thinking strangers were staring.   The noticeable change in attention led to an 
increase in self-consciousness.  She attributed moments like this to her reasoning for 
wearing a wig in public more often than she wanted.  According to Patient 14, the 
physical discomfort of a wig was worth the feeling of blending.   
Rosman’s (2004) research on CIA and stigma argued head coverings such as 
wigs, scarves, and caps function as “camouflage.”  Yeager and Olsen’s (2011) research 
on scalp cooling and alopecia used the same phrasing to present their work.  Though one 
of this study’s participants used the word “disguise” in reference to wearing a wig and 
others described wigs as “fake,” none of the patients responded positively to the question 
of whether they thought head coverings were different forms of camouflage.  Even the 
patient who said her wig was a “disguise” contradicted her statement when asked the 
question about wigs as camouflage. 
“I like to blend in…I always disguised myself.  I never ever went out without 
my wig and when my hair was like an half inch long, I rarely wore hats and 
kept wearing my wig except one time when I went out to a bar with my 
niece…the only thing I was missing then was a nose ring and a tattoo (Patient 
11_2, pp. 7-8).   
Patient 11’s cancer journey has spanned fifteen years.  As a self-described “tomboy” 
(Patient 11_2, p. 14), wearing wigs was not an act of femininity but an act of blending.  
Having hair allowed her to blend in to a society that expects women to have hair.  When 
a patient’s identity is inextricably linked to blending into society, it is highly likely that 
patient will then place a high value on head coverings, especially wigs, regardless of 
perceived femininity.   
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For those like Patient 11, wearing a wig is not about looking good to feel better.  
Rather, it is about complying with socially constructed norms to which she does not 
object.  It is about blending in for the purpose of not being bothered.   
“I don’t consider the wig camouflage.  I just want to be normal and not draw 
attention to myself.  I don’t run out with a bald head because I don’t want 
sympathy.  I don’t want people giving me advice.  Everybody wants to say, ‘oh, 
there’s a fantastic cure for cancer,’ and I’ve heard all of those comments.  I just 
want to get through things normally and the wig makes me normal…I’m not 
trying to hide the fact that I have cancer, but I don’t want strangers who 
don’t know me barging into my life.  I’m very much a private person” (Patient 
11_2, p. 9) 
As the conversation continued, we discussed the topic of taking a stance against blending 
into the norm by “going bald” in public.  I summarized Lorde’s (2009) call to action for 
women with cancer to reject wigs and be bald in public for the political purpose of 
challenging patriarchal norms.  Lorde’s (2009) approach to alopecia was discussed with 
multiple patients.  Each time, it failed to resonate.  When asked why, responses were 
reflective of Patient 11’s, saying, “you know, I don’t have the energy for –I do kind of 
protest some things, but this I just can’t.  I personally can’t do that” (Patient 11_2, p. 
13).  
An analysis of patients’ perceptions argues against Rosman’s (2004) and Yeager 
and Olsen’s (2011) concept of head coverings as “camouflage.”  It was too harsh.  
Camouflaging was a linguistic frame that structures the expectation for wigs and caps to 
effectively conceal alopecia (Tannen, 1993; Tannen & Wallat, 1982).  This could 
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dishearten a patient who continued to feel exposed while wearing a wig, cap, or scarf, 
perhaps perceiving her efforts as ineffective.  It can also miss the actual meaning of a 
patient’s actions, as demonstrated by Patient 13 who wears wigs to avoid conversations.   
“I hesitate a little bit with the idea of camouflage because I don’t mind people 
knowing that I’m sick but I don’t want to have to talk about it all the time when 
I have other things I need to get done.  It’s not that I’m trying to hide 
something…I don’t want to divert people’s attention from why I’m [visiting 
their place of business]” (Patient 13_2, p. 6)   
For Patient 13, the wig is worn to signal a desire to be left alone, which was not 
an attempt to camouflage her health status.  She was not invested in caring whether a 
stranger thinks her wig was real hair or not.  The wig might have communicated her 
health status of “cancer patient,” but she believed it signals “cancer patient making an 
effort to blend in” which, in turn, achieved her goal of being left alone in public spaces.   
Camouflaging alopecia implies a degree of success in concealing one’s health 
status.  It was rare for participants to communicate the feeling of achieving such success 
in their efforts to manage alopecia.  More commonly, participants shared stories of 
unwanted recognition.  Patient 19 recounted an example of this when she yet left their 
house thinking she blended in but was recognized as a cancer patient.   
“I was at the farmer’s market and I thought I looked pretty good.  And 
everybody was being so solicitous and saying, ‘You take care of yourself.’ I 
saw a friend who had a booth at the market a week later.  She said, ‘[name] you 
looked like shit on Saturday.’ I said, ‘I wondered about that because everybody 
was being so nice’ [laughs]…next time I won’t come” (Patient 19_2, p. 14). 
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Patients reported rarely leaving their homes during chemotherapy.  This was 
largely because of physical side effects such as pain, neuropathy, or fatigue, yet some 
patients also said it was because wearing head coverings and managing other aesthetic-
related tasks like choosing an outfit or applying makeup were too mentally and/or 
physically exhausting.  Patient 15 explains: 
“There were times I was invited to the beach and I wouldn’t go.  Not because 
I was too tired or didn’t feel well but because I didn’t want the hassle of 
fooling with my wig, but the thought of going without it was too much” 
(Patient 15_3).  
Participants like Patient 15 said their wigs tended to ward off strangers, making 
them less approachable for those who want to speak about cancer and hair loss.  Patient 
19 illustrated this in the following excerpt.  
“I don’t know why, but men get more pity [laughs].  Women are looked 
at…from a different point of view.  I walk into a restaurant and the hostess 
will say, ‘oh what kind of cancer do you have?’  You talk about it and she 
launches into her story.  People come up to me at the grocery store and start 
chatting.  I don’t know whether it’s me or my bald head.  It’s amazing how 
people look at you and say, ‘oh I can tell her all my troubles and it will just 
fall by the wayside” (Patient 19_1, p. 5). 
Increased approachability is one of the most notably gendered aspects of chemotherapy-
induced alopecia.  Instances of unwanted advice were frequent and widespread across 
interview transcriptions.  An excerpt from Patient 5 serves as an example.  
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“I will wear my wig sometimes. I get funny comments from people about the wig. 
‘You shouldn’t wear that. You’re very beautiful without the wig.’ People 
don’t know what to say so they talk before they think” (Patient 5_2, p. 9).  
Assuming women with cancer need or want advice speaks to Patient 19’s argument that 
women are perceived as more approachable than men.  And as a result, women like 
Patient 5 endure inappropriate conversations.   
The issue of distancing oneself from the public eye is complicated in the digital 
era.  Being approached in-person is often perceived as different than online interaction.  
Patient 11, who is a self-described “private person,” wears wigs to blend in and deter 
unwanted conversations like the one Patient 5 shared.  The issue of digital distancing and 
physical distancing has not been examined in previous literature on CIA and patient 
experience, yet it is an important distinction that adds to the field’s understanding of 
coping with alopecia.  Patient 11 describes the difference:  
“It’s normal for guys to be bald and it’s not normal for women to be bald…I 
have a good bald head.  I actually posted it on Facebook.  I got a picture with 
my brothers because they’re already bald.  At this point in time, I thought is 
was kind of funny…I felt it’s appropriate to publically post [the picture], and I 
have 300-something Facebook friends, and they’re not all close.  But I don’t 
want to go out in public with strange strangers next door or whatever” 
(Patient 11_1, p. 5). 
Digital distance is greater than the in-person distance between neighbors and 
others with whom she might interact in public.  Patient 11 perceived a gendered division 
between men and women as well as a spatial division between digital and in-person 
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interaction.  The digital public sphere is part of today’s social systems of interaction, but 
does not require synchronous communication between the patient and acquaintances.  
The choice to post a photo featuring her brothers who are naturally bald suggests 
solidarity, which was something Patient 11 did not communicate as part of her CIA 
experience except when sharing this story.  
Solidarity across the gendered experience of hair loss was not reserved for 
relationships among family members and loved ones.  As a sign of the times during 
which this data were collected, multiple participants referenced then presidential 
candidate, now President Donald Trump’s hair.  
“I think women are more concerned with their hair than men, but I know men 
who [are too]…just look at Donald Trump.  Just see what he’s doing to try 
and keep his hair...he’s like my mentor.  If he can go out looking like that, I 
can wear scarves” (Patient 15_1, p. 8). 
The comparison of hairstyles and appearing in public was done to lessen the severity of 
the situation.  Over the course of chemotherapy, Patient 15 described her experience of 
alopecia as “progressively sadder.”  Even so, the reference to Trump demonstrates how 
much public attention a different hairstyle can garner, especially one that does not mirror 
gendered expectations.  
Summary.  Being a women and having alopecia were the top reasons patients 
were recognized as cancer patients.  Patients had difficulty blending into society because 
of their alopecia and their gender, and they explained this difficulty by comparing their 
experience to that of a man’s.  Some had personal examples when they were in public 
with their bald husbands and the husbands were not assumed to have cancer.   
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One of the most challenging issues patients faced in public situations was an 
increase in approachability.  Patients who valued social interaction as part of their QoL 
were often uncomfortable with the sudden breach in privacy after hair loss.  Gendered 
visibility extended beyond becoming visible to other women and men. Being recognized 
by children in public was a memorable experience for some and demonstrated the 
emotional burden of being bald in public.  
Head coverings were often perceived as an issue for women by women.  
Participants were cognizant of this, often wearing head coverings to appease other 
women.  This finding led to a more complete understanding of why some women wore 
head coverings though they found them uncomfortable.  Data established a 
communicative pattern of comparable aesthetics, where patients compared their 
appearance to other women with alopecia.  Data provided evidence that women did not 
differentiate their expectations for how other women should look when visiting the clinic 
from other public interactions.  Though this was a cancer center and a space of patient 
care, it was still part of the larger public sphere within which individuals construct and 
reinforce gendered aesthetics and social norms.     
Chapter Conclusion   
The codes used to analyze the data organized findings and led to the development 
of four themes: 1) chemotherapy- induced alopecia; 2) the “mirror moment”; 3) 
performing social roles; and 4) gendered visibility.  These themes demonstrated how the 
experience of an individual connects to others in a shared network of patient experience.  
How patients communicate about their experience of alopecia and strategies to manage it 
over time exist in tension with how they communicate about quality-of- life.  For 
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example, patients shared similar “mirror moments” that revealed tension in seeing a 
reflection that did not match their perception of self.  Such tension can be a source of 
distress and lower quality-of-life.  An of CIA impacting QoL was the shared experience 
of being approached by strangers because their gendered aesthetic signaled “cancer 
patient.”  Participants’ emotional accounts of heightened visibility inspired the theme, 
gendered visibility, revealing the everyday struggles of social interaction during 
chemotherapy-induced alopecia.  
Ovarian and uterine cancer patients may feel more supported and able to discuss 
CIA when healthcare practitioners put it in conversation with quality-of- life.  The inverse 
is also applicable.  Efforts to evaluate patients’ quality-of- life should incorporate hair loss 
into clinical conversations because it is a topic that often leads patients to disclose other 
issues of concern.  Doing this can better gauge the degree to which a patient’s concern for 
the public’s perception and perception of self will impact her quality-of- life during and 
shortly after cancer treatment.  This is discussed further in the concluding chapter.      
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CHAPTER FIVE: 
CONCLUSION  
Introduction 
This dissertation’s findings confirm that chemotherapy-induced alopecia was a 
quality-of- life issue patients experienced differently over time.  Findings were based on 
an analysis of communication patterns across a data set of 55 interview transcripts (1,750 
minutes of audio) that resulted from interviewing 23 ovarian and uterine cancer patients 
at least twice each over the course of their chemotherapy.  Upon completing a review of 
existing literature and developing the research questions, longitudinal interviewing that 
incorporated Ellis and Patti’s (2014) compassionate interviewing technique was 
determined to be the optimal approach to collecting data for an interpretative analysis.   
Compassionate interviewing (Ellis & Patti, 2014) encouraged more open 
communication, and was a more natural fit with the clinical context because patients were 
accustomed to telling and retelling personal stories in medical settings (Roscoe et al., 
2016).  Discussing her participation in the study, Patient 14 said, “I will continue to share 
my story.  I will tell my whole health history for someone else to feel better and learn 
something” (Patient 14_1, p. 4).  Her willingness to share demonstrated how interviewing 
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should be understood as an opportunity to embrace co-construction and abstain from 
using a strict question-and-answer script.   
Efforts to improve patient-centered care can benefit from learning how patients 
actually experience quality-of- life and chemotherapy-induced alopecia.  Because patient-
centered research is meaning-centered research, an emphasis on communication is 
critical.  Understanding communication as central to an examination of perception, this 
study posed the following research questions:  
RQ1: How do ovarian and uterine cancer patients communicate about their 
experience of alopecia over the course of chemotherapy? 
RQ2: How does chemotherapy-induced alopecia influence patients’ 
understandings of quality-of- life?  
While the two research questions that guided this research were useful in 
developing interview questions, the findings reveal a single research question is a more 
useful framework for examining CIA and QoL over time.  The revised research question 
that will be used in future research is: How do ovarian and uterine cancer patients 
communicate about their experience of alopecia and its impact on quality-of- life over the 
course of chemotherapy?  An effective examination of patients’ perceptions of CIA 
requires the researcher to incorporate quality-of- life, thus it is more effective to combine 
the two research questions into one.   
 A review of the literature indicated there was a lack of research examining 
chemotherapy-induced alopecia from a communication perspective and there were few 
studies on CIA generated in the U.S. compared to other nations, particularly those in the 
West.  Clinicians and other healthcare professionals in the health sciences produced the 
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vast majority of research on chemotherapy- induced alopecia, specifically dermatology 
(Chon et al., 2012; Yeager & Olsen, 2011) and oncology (Frith et al., 2007; Gunnars et 
al., 2001; Hesketh et al., 2004), including nursing in oncology (Borsellino & Young, 
2010; Can et al., 2012; Cline, 1984; Freedman, 1994; Lemieux et al., 2008; Wagner & 
Gorely, 1979; Williams et al., 1999) and psychology in oncology (Choi et al., 2014; Dua 
et al., 2015; Koszalinski & Williams, 2012).  Research efforts made by scholars outside 
the health sciences were best represented by Hansen’s (2007) ethnography of Danish 
rehabilitation courses with women cancer patients and Rosman’s (2004) qualitative study 
of stigma with lung and breast cancer patients in a Parisian cancer hospital.   
 Excluding Williams et al.’s (1999) narrative research in nursing, most of the 
heavily cited literature on chemotherapy-induced alopecia and patient experience comes 
from Western nations outside the U.S. (e.g., Batchelor, 2001; Freedman, 1994; Frith et 
al., 2007; Lemieux et al., 2008; Munstadt et al., 1997).  Such an absence suggested 
producing qualitative data on hair loss and patient experience would benefit from a health 
communication studies perspective focused on the ways in which language and 
relationships constituted meaning making and influenced quality-of- life over the course 
of chemotherapy.   
Contributions  
Quality-of-life was held to a “deathbed” standard of reflection, where only the 
most important elements of a life well lived were included.  This way of conceptualizing 
QoL was useful for the sake of making sense of one’s diagnosis but it was too limiting, 
even for patients such as those included here who were nearing the end-of-life with late-
stage or recurrent disease.  Reserving the highest tier of QoL to issues of extreme 
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importance excluded day-to-day issues, which should be accounted for when examining 
QoL.  Daily QoL concerns contributing to daily functions or pleasures were the center of 
concern for most patients, yet most did not directly label these experiences as pertaining 
to quality-of-life because of the misconception that QoL was reserved for only top tier, 
“deathbed” reflections.  Asserting control over when and where one’s head shave will 
take place was a quality-of-life issue.  How to function at work while managing alopecia 
was a quality-of- life issue. Grocery shopping becoming a distressing experience was a 
quality-of- life issue.  These were some of hundreds of examples of daily quality-of- life 
issues that embody the experience of chemotherapy-induced alopecia for ovarian and 
uterine cancer patients.     
It was difficult for this patient population with late stage cancer to discuss quality-
of-life issues in the context of the everyday instead of in the context of survival or overall 
reflections regarding “a life well lived.”  To help explain the impact of alopecia on their 
everyday lives, patients used “mirror moments” and looking in the mirror as reference 
points in their stories.  Patient 22’s description of entering and exiting her shower 
differently to avoid the bathroom mirror and Patient 10 covering her mirrors with towels 
were examples of how patients experience the everyday effects of CIA.  “Mirror 
moment” stories about small changes in behavior signified larger shifts in quality-of- life 
while living with alopecia.  Encouraging patients to broaden the concept of quality-of- life 
to include everyday hardships and pleasures could allow for more open communication 
that could lead to improved patient care.  
 During the beginning phase of chemotherapy, almost all participants interpreted 
their experience of hair loss in comparison with the larger goal of fighting and surviving 
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their cancer.  Speaking about cancer in this way parallels Lerner’s (2004) argument that 
society uses the language of war to frame the experience of having cancer and seeking 
treatment.  For most, emphasizing the battle and downplaying the aesthetics became less 
important for patients nearing the end of chemotherapy or the end-of-life.  Data suggested 
the value of aesthetics increased as health improved or significantly worsened.  Most 
patients continued to view their alopecia as a social issue.  For participants in remission 
whose hair was slowly returning, their health status was complicated by the public 
perception of being a cancer patient when they no longer felt they should be seen as such.  
 Theme 4, gendered visibility was generated from the data and helped fill the need 
for research on chemotherapy-induced alopecia and quality-of- life with a gendered focus.   
This project highlighted how CIA made patients recognizable as cancer patients because 
they were women and because they were bald.  Patients were adamant about CIA being a 
women’s issue because of socially constructed gendered standards of aesthetics in the 
U.S.  A critical discourse analysis could be performed on this data set in the future using 
feminist theory to examine gendered norms and how patients’ language often reinforced 
existing standards.   
Head coverings were often perceived as an issue for women by women.  Data 
established a communicative pattern of comparable aesthetics, where patients compared 
their appearance to other women with alopecia.  Data provided evidence that women did 
not differentiate their expectations for how other women should look when visiting the 
clinic from other public interactions.  Though this was a cancer center and a space of 
patient care, it was still part of the larger public sphere within which individuals construct 
and reinforce gendered aesthetics and social norms.  Participants were cognizant of this, 
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often wearing head coverings to appease other women.  This finding led to a more 
complete understanding of why some women wore head coverings.   
 Existing arguments framing alopecia and head coverings as an issue of 
camouflage (Rosman, 2004; Yeager & Olsen, 2011) failed to resonate with interview 
participants because it was interpreted as existing in a state of hiding.  Patients were open 
to discussing their diagnosis and alopecia with others, but on their own time and at their 
own volition.  The concept of camouflage was an interpretive claim that did not parallel 
the language participants used to communicate their experience and should not be used in 
future interviews with this patient population.  
 Hair loss was an emotionally taxing shift in identity, especially for those who 
connected hair loss to a no longer appearing womanly, which was not synonymous with a 
loss of femininity.  “Looking like a cancer patient” and “appearing womanly” were the 
same issues.  This was not because patients wanted to “look good to feel better” as the 
American Cancer Society’s LGFB Program implied.  That was far less of an important 
issue for the majority.  Patients wanted to look less like a cancer patients and appear 
womanly because they were aware their appearance challenged social expectations and 
wanted to avoid being approached by strangers in public because they were bald and had 
cancer.  CIA was largely an issue of aesthetics for the sake of functionality.   
 When patients spoke about their frustrations with CIA in terms of how it added 
complication to everyday functioning in public, they were more likely to connect CIA 
with quality-of-life.  Patients were more reluctant to connect CIA with QoL when CIA 
was discussed in more personal terms, like it was in theme 1, the “mirror moment.”  
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The “mirror moment” discussed how CIA represented a disconnection between 
perception of self and reflection of self.  Patients connected the “knowing” in “knowing 
others see my alopecia as signaling cancer and dying” to quality-of- life on an everyday, 
mundane level.  However, when “knowing how others perceive my alopecia” was taken 
out of the conversation and the focus was redirected to how managing appearance 
impacted quality-of- life, most patients rejected the idea of the two being connected in the 
context of their personal experience but “saw how other women” could view the issue in 
that way.  In contrast, patients were inclined to connect CIA, social interaction, and 
quality-of- life.  Social interaction was understood as an element of QoL, and CIA 
hindered social interaction, therefore CIA was a day-to-day QoL issue because of its 
hindrance on social interaction.  Concern for managing alopecia was motivated more by 
managing appearance for the sake of social functioning than it was for vanity.   
Making distinctions between the personal and social elements of CIA was 
important to understanding how patients experience it.  From a communication 
perspective, it is equally important to acknowledge the interplay between the two, 
understanding how the social experience and the personal are often one and the same. 
Goffman’s (1956) argument for the presentation of self in public and private spheres 
provides a language to discuss differences in the private “mirror moment” theme in 
conjunction with public experiences of theme 3, performing social roles and theme 4, 
gendered visibility but as argued in theme 1, chemotherapy- induced alopecia and quality-
of-life, the social and personal are linked in an “inseparable entanglement of 
interdependence” (Sheep et al., 2017).   
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Goffman’s (1963) Theory of Stigma 
Goffman’s (1963) theory of stigma helped in understanding patients’ angst toward 
social interaction during hair loss because they experienced what Goffman called, “an 
infinite regress of mutual consideration” (p. 18).  Patients described this “infinite regress” 
as taking place during routine errands when patients knew strangers were aware of their 
altered appearance and strangers sensed patients were conscious of their awareness.  The 
stigma of being “a cancer patient” (Rosman, 2004) was also revealed in the performance 
of social roles, especially that of career women and in family relationships.  Hair loss 
interfered with the workplace interaction, positioned patients in a constant state of 
consciousness for colleagues’ awareness of their CIA and head coverings that signaled a 
stigmatized disease.   
The degree to which stigma was productive beyond its usefulness as a conceptual 
frame was more complicated than expected.  Patients agreed with the premise of CIA and 
stigma in the context of comparing women’s experiences of CIA compared to men’s.  
However, they almost always rejected the association of CIA and stigma in terms of their 
lived reality.  In theory, stigma and CIA made sense because it explained why trying to 
avoid “looking like a cancer patient” was important.  In practice, the word “stigma” did not 
resonate.  According to participants, cancer was so prevalent that it was difficult to associate 
it with being ostracized.  This was key because the theory of stigma does not posit 
stigmatization as synonymous with exclusion or being ostracized, yet patients perceived it as 
such.  
Social disapproval and undesirability are two separate issues within the concept of 
stigma.  Patients communicated undesirability, which was represented in different ways 
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across all four themes.  Being a bald woman and “looking like a cancer patient” were 
stigmatized in terms of having an extremely undesirable condition.  The idea of the social 
majority disapproving of “looking like a cancer patient” does not parallel the experiences of 
participants.  It was useful to refer to Goffman’s (1963) theory of stigma as a conceptual 
frame from which to gain a better understanding of the social aspects of experiencing 
illness, but it was less useful during actual interviews.  
Based on the data analysis, it was determined ovarian and uterine cancer patients 
experienced substantial daily distress related to chemotherapy- induced alopecia.  Because 
these patients were experiencing late-stage cancer with some nearing end-of-life care, 
patients were reluctant to mention the side effect of alopecia when asked about their 
overall quality-of-life.  Patients’ distress concerning CIA was strongly related to the 
ability to function in social interaction without feeling approachable or being approached 
by “strangers” because of their alopecia.   
The ability to perform social roles deemed important to patients’ quality-of- life 
such as the familial roles of partner and mother/grandmother were negatively impacted 
by hair loss.  Most did not feel as badly about being bald as they did about their baldness 
signaling their diagnosis to others in their family and in the workplace and in everyday 
public spaces like church or the grocery store.  While the concept of stigma was useful in 
formulating the research questions and method of analysis, the language of stigma did not 
resonate with patients.    
Clinicians should repeatedly ask about chemotherapy- induced alopecia over the 
course of chemotherapy, both because it could help patients cope with the side effect and 
because it may generate dialogue related to other important concerns end-stage patients 
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may feel are too trivial to mention in clinical discussions since their disease is so serious 
and life-threatening.  Although men and women experience many of the same cancer 
diagnoses, working with gynecologic cancer patients revealed some ways in which 
women experience ovarian and uterine cancer and chemotherapy in ways different from 
men.  Women’s social and familial roles may be impacted by cancer and chemotherapy 
in unique ways that deserve additional study.   
Strengths and Limitations 
All studies have limitations and the present study is not an exception.  Prompted 
by Munstedt et al.’s (1997) argument to examine CIA using a longitudinal approach, data 
collection was designed to include two to three interviews per patient during the 
beginning and toward the end of chemotherapy, resulting in a rather succinct data set.  
However, Munstedt et al. (1997) used longitudinal surveys, and did not interview 
patients.  The reality of conducting in-depth interviews with seriously ill patients was 
more complicated than the plan suggested, especially when the patients are asked to 
participate in multiple interviews stretched over months.  Patients were willing and 
sometimes eager to adjust their schedules to speak with me, but their health sometimes 
prevented this.  Also, participants’ appointment schedules were often beyond their 
control.  Forming relationships with these patients, I observed how flexible they were 
forced to become as their lives revolved around managing chemotherapy.  From their 
perspective, participating in interviews about CIA was one part of a larger process.  For 
patients to continue spending hours in conversation reveling personal information, it was 
critical to emulate flexibility as an interviewer that was similar to what they demonstrated 
as patients.  
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The findings are limited by a small sample size of 23 participants and a relatively 
small data set of 55 interviews with 1,750 minutes of audio for analysis.  Those who 
perform discourse analysis, for example, could interpret this data set as too large, limiting 
the opportunity for close readings.  The data set used for this analysis was adequate to 
allow for a rigorous and thorough thematic analysis, however the patient population 
under analysis was limited in its diversity from a demographic perspective, especially in 
the areas of race/ethnicity, sexuality, and access to health insurance.  The study was 
limited to ovarian and uterine cancer patients, which was considered a strength because 
of its specificity but could be interpreted as a weakness because it involved only two 
types of cancers and was specific to women.     
Future Directions   
The project resulted in a wealth of data.  As a working document, this dissertation 
will be segmented into useful parts and published as journal articles in the fields of health 
communication, gynecologic oncology, quality-of-life studies, and qualitative method.  I 
am currently working on an arts-based project inspired by data collection and intend to 
involve online spaces as well as the local community in ways this dissertation did not.   
I envision this project moving in the direction of participatory action research 
while continuing to further Ellis and Patti’s (2014) argument for compassionate 
interviewing.  This research could encourage more collaboration among disciplines as 
well as between healthcare institutions the communities they serve.  I intend to continue 
building this research and exposing audiences to CIA as a women’s health issue and QoL 
issue.   
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Two years ago, I attended a grant-writing workshop where a professor said “think 
of all the things that could be done with your research if you had more resources.  Who 
would you include?  What ways could you expand the project’s reach?  I’m sure you 
have running lists.  A grant can help you achieve some of these goals, so keep adding to 
your list and apply for funding.”  This dissertation project was not funded, and the lack of 
funding limited what could be done.  Like the professor hosting the workshop, I have a 
list of aims that could be better met with funding.  I intend to secure grants to support 
studies inspired by this one that will have more layers of analysis and a greater reach.  
Holding a series of focus groups with gynecologic cancer patients who could help 
develop an improved interview guide could improve the interview content and format.  
Also, I intend to recruit a research team including gynecologic cancer patients who would 
be willing to serve as community stakeholders and co-interpreters who could help 
generate strategies for how to integrate the gynecologic cancer community and assess 
their needs and concerns, especially those related to chemotherapy- induced alopecia and 
quality-of- life.  
Recommendations for Clinicians 
In an era of individualized care, quality-of-life and side effect management is a 
growing interest in oncology and women’s health.  Those who care for patients on a daily 
basis would benefit from exposure to this project and research like it as well as 
recommendations for what to do with the information.  What are some practical, micro-
interventions that can be easily incorporated into everyday clinical communication?   
Physicians, social workers, and nurses, among others, are encouraged to 
incorporate dialogue that is focused on chemotherapy- induced alopecia into the patient-
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provider exchange over time.  A few focused questions that are addressed throughout the 
course of chemotherapy may help determine how much of an issue CIA is and provide 
insight into patients’ coping processes.  Knowing the topic of hair loss was perceived as 
more of a social deterrent than other side effects and less dire than other side effects such 
as fatigue or neuropathy, healthcare practitioners can use the topic of CIA as a way into 
discussions of larger scale issues such as quality-of-life.  Questions along the lines of the 
following are recommended: 1)“How does your hair loss impact you?” or 2)“How are 
you handling hair loss?” The next step involves putting QoL and CIA in conversation 
with one another using questions such as the following: 3)“How does your hair loss 
impact your quality-of- life?” 4)“What would it take for you to have a higher quality-of-
life during chemotherapy?” or 5)“What would it take for you to feel more comfortable 
with your hair loss?”   
Question 5 could be used as a conversational opening to make referrals if patients 
communicated interest in seeking direction/information.  Using this project’s site of 
research of example, some patients who were interested in wigs were unsure where to 
start, saying they spent too much money and time online searching for wigs.  Those who 
did this said it was isolating and confusing.  The spaces and people to which patients can 
be referred are limited, but there are more options than most participants were aware, 
which furthers the argument for needing to incorporate the above questions into the 
clinic.  For example, this project’s site of research had a non-profit lodging facility that 
was largely unknown to have free wigs and employees who helped patients sort through 
options and make decisions.  Only one interview participant was aware of the lodge’s 
free wig program, yet it was located approximately 300 yards from the gynecologic 
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clinic.  This was a missed opportunity to increase access to wigs, and will be part of 
future research critically examining cranial prostheses as a symbol of access to resources 
that can help patients who want to manage their appearance by wearing wigs.   
Data confirmed a referral to the American Cancer Society’s “Look good, feel 
better” Program does not resonate with patients who are concerned about CIA in a way 
that does not involve femininity, which is all LGFB represents.  Patient 16, for example, 
wanted to “look like my natural self” but was adamant against incorporating cosmetics 
into her cancer experience, which is the overall intention of the LGFB Program.  A 
second example was Patient 7 who was “a hippie” with a ponytail and wanted a wig with 
a ponytail.  She was interested in the “Look good, fell better” motto but against the values 
of the program.  Referring patients like these to the LGFB program may dissuade them 
from wearing wigs.  Putting alopecia in conjunction with quality-of- life helps ground the 
conversation in issues of social interaction, meaning making, and everyday function and 
may improve the patient experience in and outside the clinic.    
Chapter Conclusion  
Working with this patient population reinforced health and relationships as key 
tenets of a high quality-of- life.  Patient 13, who had recurring ovarian cancer, explained 
how seriously ill patients lived in a state of oscillating from poor health to manageable 
health, then back to poor.  Health remained important, but it took on a less hopeful 
meaning3 that was rooted in uncertainty.  Meanwhile, relationships came to the forefront 
of importance, positioning communication and interaction as central components of 
                                                 
3Refer to Basu (2010) for an analysis of women’s health and hopelessness when access to 
healthcare is an impossibility  
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quality living.  As a result, chemotherapy- induced alopecia became embedded in the 
larger schema of quality-of- life because hair loss impacted patients’ relationships and 
often served as a barrier between patients and social interaction.  As discussed in the 
theme 3, performing social roles, mothering children and young adults became a source 
of emotional struggle for patients whose children/grandchildren withdrew after hair 
loss/head shaves.  CIA shifted the relationship, as patients perceived their children 
struggling with their alopecia because it signified the severity of their disease.       
Research on chemotherapy- induced alopecia and quality-of- life must continue to 
emphasize communication because patient-centered care is meaning-centered care.  This 
research functions with an epistemological understanding that there was no single starting 
point by which to measure patient experience nor was it possible to have a complete 
understanding.  Patients’ experiences of CIA were already being crafted, told, and retold 
before interviewing took place and continued after they were completed (Bochner, 2014; 
Charon, 2004; Frank, 2013; Roscoe et al., 2016).   
For many, hair loss was “a top concern” during chemotherapy ranging from top 
five to top ten of concerns, but it was not concerning in comparison to substantial losses, 
like the loss of normalcy that accompanied a cancer diagnosis, or the loss of 
independence, or loss of life.  Some referred to CIA as trivial in comparison to life-or-
death and then said they were unsure why they made such a drastic comparison.  
American society’s standards construct the expectation for cancer patients to fight for 
survival and downplay experiences that are not life-or-death (Mukherjee, 2010; Lerner, 
2004).  If this was the standard from which to measure everyday life, than we run the risk 
of snowballing the lived experience into a frame of thinking where “nothing really 
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matters.”  Such thinking does not do justice to the lived reality of being a bald woman 
with cancer who has to function in public while knowing everyone else knows she has 
cancer.   
Ovarian and uterine cancer patients may feel more supported and able to discuss 
chemotherapy-induced alopecia when it is put it in conversation with quality-of- life.    
Efforts to evaluate patients’ quality-of- life should incorporate chemotherapy- induced 
alopecia because it is a topic that often leads patients to disclose other issues of concern, 
especially issues with other side effects as well as outside-the-clinic concerns that impact 
their ability to endure chemotherapy.  Communicating chemotherapy- induced alopecia as 
a daily quality-of- life issue can better gauge the degree to which a patient’s concern for 
public perception, social interaction, and perception of self will impact her quality-of-life 
during and possibly after chemotherapy.   
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APPENDIX A:  
INTERVIEW GUIDE 
MCC 18102: Expanding Conceptions of Patient-Centered Dialogue 
Date initially submitted: 11/26/14  
Date of revisions: 02/15/15 
Final date of revisions: 03/26/15 
IRB study 19393  
How are women cancer patients expected to look? 
What is your defining of coping? 
In what ways has the loss of your hair impacted you?  
What are some strategies you use to help you cope with the loss of your hair? 
On a scale of 1-5, how would you rate the quality of life, where  
1= very poor 2= poor 3= average 4= good 5=very good 
In what ways does a patient’s appearance matter? Are there times when it does not? 
What are the appearance-related expectations for women experiencing illness? 
In what ways are expectations related to appearance different for women who are 
considered healthy? 
Do you feel you are expected to look a certain way? 
Does the way a woman looks relate to the way she might feel? Does this change after 
receiving a diagnosis? 
Do you consider visiting this salon part of the overall Moffitt experience? 
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APPENDIX B: 
PATIENT DEFINITIONS FOR QOL 
Sequence ID   Participants’ responses to the prompt: “To me, quality-of- life 
means…” 
1 "Going out to eat with family; being my own person; not to be waited 
on by anyone; walking by myself; being me" 
2 "Feeling good about my Self, health, and spiritual faith. Centered and 
in good relationship with myself"  &  
“Support, loving care, desire and trust God to help through each trial" 
3 Written in Spanish: “Calidad de vida es tener presente a Dios y 
acceptar su voluntad” 
Translated in English: “Quality of life is to have God present and 
accept his will” 
4 "Quality of life means Health body and image, so if you look great 
you will feel better with that being said it will be easier to cope with 
depression and anxiety"  
5 "Able to care for my family and myself. Become more faith-full 
towards God. Stay soft in spirit and be more to 'play' with my kids" 
6 "Faith, Family, Friends" 
7 "Love, kindness, consideration, family, mobility, nature, God" 
8 "Looking forward to the day; always looking forward to something 
and caring for God" 
9 "Having family and friends that you enjoy being with and interests 
that keep you involved and alert" 
10 "Staying healthy enough to work and support myself. It was hard for 
me to be financially dependent on others. But also making the time to 
enjoy life. Spending time with family and friends. If I learned 
anything from this experience it is that life is precious and you never 
know how much time you have on this earth." 
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11 "Being able to enjoy life and having energy: time to do lots of 'fun' 
things-travel, music, etc. Being able to feel 'normal'-not to have people 
feel sorry for you-ever."  
12 "Being there for my family as long as possible and doing things that 
pass the time" 
13 N/A 
14 "Independence, lack of pain, interest in doing things and socializing, 
being able to lead a 'normal' life" 
15 N/A 
16 "To be who I am, that is the most important thing to me" 
17 "Being able to walk around, get out, not reliant on people taking care 
of you; when you are not in treatment all the time"  
18 "Quality of life for me is getting the most of each day that my mind 
and body can sustain" 
19 "Living a life that is supported by loved ones and friends; to achieve 
desires and to respond; interact and share with like-minded 
individuals; Love is the basis of all thought, words, and action" 
20 "When I am not in pain; able to do for myself and not depend on 
someone else; able to cook and take a bath" 
21 "Being able to function and live life as close to what life was prior to 
diagnosis, maybe with some restrictions but not to the point of those 
restrictions are prohibiting you from living, loving, laughing" 
22 "Independence and doing what I want when I want" 
23 "The ability to experience all the pleasures of life in the moment- 
mindfulness" 
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APPENDIX C:  
DEMOGRAPHIC CATEGORY 1 
Sequence ID Diagnosis Age Marital Status Children 
1 Ovarian_metastatic 73 Y Y 
2 Ovarian_IIIc 67 Y Unioned Y 
3 Ovarian_IIIc_ 
high grade serous 46 Y Y 
4 Uterine_Ia_grade 3 39 Y Y 
5 Ovarian_III_ 
late stage 49 Y Y 
6 Uterine_Ic_ 
high grade serous 65 Y Y 
7 Uterine_IIIa_ 
Grade 3 59 Y N/A 
8 Ovarian_IIIc_ 
high grade serous 81 
N 
Widowed Y 
9 Uterine_IIIc 
recurrence 73 Y Y 
10 Ovarian_IIIc_ 
high grade serous 44 
N 
Single N 
11 Ovarian_IIIc 
recurrence 54 Y N 
12 Uterine_IIIc 62 N Divorced Y 
13 Ovarian_IIIc 
recurrence 58 
N 
Single N/A 
14 Uterine_IIa 
recurrence 77 Y Y 
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15 Ovarian_IIIb 
high grade 61 
Y 
Partnered Y 
16 Ovarian_IIIc 83 N Widowed Y 
17 Ovarian_low 
Grade serous 41 Y N 
18 Ovarian_IIIb_ 
high grade serous 66 
N 
Widowed Y 
19 Ovarian_IIIb 
recurrence 70 Y Y 
20 Ovarian_IV serous 
recurrence 76 
N 
Single Y 
21 Ovarian_IIIc 
recurrence 49 Y Y 
22 Ovarian_high 
grade 78 
N 
Widowed N/A 
23 Ovarian_IV 63 N Divorced N/A 
*(avg.= 62 years; range 39-83 years) (14 Married/Partnered) (16 have children) 
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APPENDIX D: 
DEMOGRAPHIC CATEGORY 2 
Sequence ID Sexuality Race Hispanic Education Insurance Physician 
1 
S W Y < High school 
Y 
Private 
Medicare 
Shahzad 
2 
G W Y Some college 
Y 
Private 
Medicare 
Shahzad 
3 
S W Y College N Uninsured Shahzad 
4 
S Other Y College Y Private Wenham 
5 
S W N Technical school 
Y 
Spouse 
Workplace 
Shahzad 
6 
S W N Postgraduate 
Y 
Private 
Medicare 
Shahzad 
7 
S W N N/A N/A Wenham 
8 
S W N Postgraduate N/A Wenham 
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9 
S W N College 
Y 
Private 
Medicare 
Shahzad 
10 
S W N College Y Private Wenham 
11 
S W N College Y Private Apte 
12 
S W N < High school 
Y 
Medicare 
Medicade 
Apte 
13 
N/A W N Postgraduate N/A Apte 
14 
S W N College 
Y 
Private 
Medicare 
Wenham 
15 
S W N High school Y Workplace Wenham 
16 
S W N/A N/A N/A Wenham 
17 
S W N/A N/A N/A Shahzad 
18 
S W N College 
Y 
Private 
Medicare 
Shahzad 
19 
S W N Postgraduate Y Private Shahzad 
20 
S AfAm N N/A N/A Shahzad 
21 
S W N/A N/A N/A Chon 
22 
S W N/A N/A N/A Shahzad 
23 
S W N/A N/A N Uninsured Shahzad 
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APPENDIX E: 
IRB AND SRC APPROVAL LETTERS 
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7/14/2015 
Meredith  Clements 
USF Department of Communication 
4202 E Fowler Ave CIS 3057 
Tampa, FL 33620 
RE: Expedited Approval for Initial Review 
IRB#: Pro00019393 
Title: Expanding Conceptions of Patient-Centered Dialogue: Female Cancer Patients and the 
Aesthetics of Disease 
Study Approval Period: 7/14/2015 to 7/14/2016 
Dear Ms. Clements: 
On 7/14/2015, the Institutional Review Board (IRB) reviewed and APPROVED the above 
application and all documents contained within, including those outlined below.  
Approved Item(s): 
Protocol Document(s): 
2015.03.17_Letter of Support from Salon Supervisor 
2015.06.01_Protocol 
Dr. Thomas Brandon HOB Program Leader Approval Letter 
Consent/Assent Document(s)*: 
07.05.15_Consent Form.pdf 
*Please use only the official IRB stamped informed consent/assent document(s) found under the
"Attachments" tab. Please note, these consent/assent document(s) are only valid during the 
approval period indicated at the top of the form(s). 
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It was the determination of the IRB that your study qualified for expedited review which 
includes activities that (1) present no more than minimal risk to human subjects, and (2) involve 
only procedures listed in one or more of the categories outlined below. The IRB may review 
research through the expedited review procedure authorized by 45CFR46.110 and 21 CFR 
56.110. The research proposed in this study is categorized under the following expedited review 
category: 
(6) Collection of data from voice, video, digital, or image recordings made for research purposes. 
(7) Research on individual or group characteristics or behavior (including, but not limited to, 
research on perception, cognition, motivation, identity, language, communication, cultural 
beliefs or practices, and social behavior) or research employing survey, interview, oral history, 
focus group, program evaluation, human factors evaluation, or quality assurance methodologies. 
As the principal investigator of this study, it is your responsibility to conduct this study in 
accordance with IRB policies and procedures and as approved by the IRB. Any changes to the 
approved research must be submitted to the IRB for review and approval via an amendment. 
Additionally, all unanticipated problems must be reported to the USF IRB within five (5) 
calendar days. 
We appreciate your dedication to the ethical conduct of human subject research at the University 
of South Florida and your continued commitment to human research protections.  If you have 
any questions regarding this matter, please call 813-974-5638. 
Sincerely, 
John Schinka, Ph.D., Chairperson 
USF Institutional Review Board 
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November 23, 2015 
Meredith L. Clements, MA 
University of South Florida 
Department of Communication 
4202 E. Fowler Avenue, CIS 3057 
Tampa, Florida  33620 
RE: MCC 18102: “Expanding Conceptions of Patient-Centered Dialogue “ 
Dear Ms. Clements, 
The Behavioral Sub-Committee of the Moffitt Cancer Center’s Scientific Review 
Committee (SRC) has reviewed your response to approvable determination dated 
11/20/2015 for your research protocol.  The revised protocol dated 11/20/2015 is 
approved as written for use at the Moffitt Cancer Center pending approval of the 
Institutional Review Board (IRB).   
It is your responsibility to ensure that all Moffitt staff (Nursing, Pharmacy, Data 
Management, etc.) are informed and aware of the details of the project.  The Scientific 
Review Committee encourages the use of in-services for those projects which are 
complex or require special attention. 
All changes made to protocols approved by the SRC must be submitted to the Protocol 
Review and Monitoring System office. Changes made to the protocol document require 
SRC review and approval. Minor changes (i.e. changes to personnel, non-scientific 
changes, changes that do not affect patient participation) will be expedited through the 
SRC review process.  
If this project is not being managed by the Clinical Trials Office or Clinical Research Unit, 
then it is your responsibility to follow through with all requirements for submission to the 
IRB.  All IRB approvals are required to be documented in Oncore, and all associated 
regulatory documentation (signed applications, IRB approval letters and IRB approved 
consent forms, etc.) are to be saved in the appropriate study folder in the e-binders 
directory at J:\ebinders. 
Oncore is the Cancer Center’s mechanism for submission and review of materials 
requiring Scientific Review (SRC) and Protocol Monitoring (PMC).  If you need access to 
Oncore, please contact Jeryl Madden, Oncore Administrator, at 745-6964 for assistance. 
Sincerely, 
Susan Vadaparampil, PhD. 
Vice-Chair, Behavioral Sub-Committee 
Scientific Review Committee 
cc: Lori Roscoe, PhD, Co-Principal Investigator 
APPENDIX F: 
PUBLICATION STATEMENT 
Both Annals of Internal Medicine and JAMA Oncology gave me permission via 
the telephone to feature the poems I previously published in their journals.  JAMA 
Oncology said they did not need to provide me with written permission to reprint because 
the poem would be featured in a dissertation.  Annals of Internal Medicine said they do 
not provide written permission because I am the author and have the right feature my 
work in other venues pending their journal is cited, which it is.   
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